Professor David J Nutt

Publications


Journals

  • Green A; Kaul A; O'Shea J; Sharma E; Bennett L; Mullings EL; Munafo MR; Nutt DJ; et alMelichar JK; Donaldson LF. (1 Mar 2013). Opiate agonists and antagonists modulate taste perception in opiate-maintained and recently detoxified subjects. JOURNAL OF PSYCHOPHARMACOLOGY. 27:265-275. Author weblink DOI.
  • van Amsterdam J; Nutt D; van den Brink W. (1 Mar 2013). Generic legislation of new psychoactive drugs. JOURNAL OF PSYCHOPHARMACOLOGY. 27:317-324. Author weblink DOI.
  • Stokes PRA; Benecke A; Myers J; Erritzoe D; Watson B; Kalk N; Riano Barros D; Hammers A; et alNutt D; Lingford-Hughes AR. (1 Apr 2013). History of cigarette smoking is associated with higher limbic GABAA receptor availability. Neuroimage. 69:70-77. DOI.
  • Diaper A; Osman-Hicks V; Rich AS; Craig K; Dourish CT; Dawson GR; Nutt DJ; Bailey JE. (1 Feb 2013). Evaluation of the effects of venlafaxine and pregabalin on the carbon dioxide inhalation models of Generalised Anxiety Disorder and panic. JOURNAL OF PSYCHOPHARMACOLOGY. 27:135-145. Author weblink DOI.
  • Baldwin DS; Nutt DJ. (1 Dec 2012). On assessing potential efficacy for vortioxetine in generalized anxiety disorder. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 22:841-843. Author weblink DOI.
  • Kealey S; Turner EM; Husbands SM; Salinas CA; Jakobsen S; Tyacke RJ; Nutt DJ; Parker CA; et alGee AD. (Jan 2013). Imaging imidazoline-I2 binding sites in porcine brain using 11C-BU99008. J Nucl Med. 54:139-144. Author weblink DOI.
  • Hyman S; Volkow N; Nutt D. (1 Jan 2013). Pharmacological cognitive enhancement in healthy people: Potential and concerns. NEUROPHARMACOLOGY. 64:8-12. Author weblink DOI.
  • Diaper A; Papadopoulos A; Rich AS; Dawson GR; Dourish CT; Nutt DJ; Bailey JE. (1 Nov 2012). The effect of a clinically effective and non-effective dose of lorazepam on 7.5% CO2-induced anxiety. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL. 27:540-548. Author weblink DOI.
  • Coghlan S; Horder J; Inkster B; Mendez MA; Murphy DG; Nutt DJ. (1 Oct 2012). GABA system dysfunction in autism and related disorders: From synapse to symptoms. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 36:2044-2055. Author weblink DOI.
  • Mitchell EN; Marston HM; Nutt DJ; Robinson ESJ. (1 Oct 2012). Evaluation of an operant successive negative contrast task as a method to study affective state in rodents. BEHAVIOURAL BRAIN RESEARCH. 234:155-160. Author weblink DOI.
  • Maron E; Nutt D; Shlik J. (2012). Neuroimaging of serotonin system in anxiety disorders. Curr Pharm Des. 18:5699-5708. Author weblink.
  • Clark L; Stokes PR; Wu K; Michalczuk R; Benecke A; Watson BJ; Egerton A; Piccini P; et alNutt DJ; Bowden-Jones H; Lingford-Hughes AR. (15 Oct 2012). Striatal dopamine D₂/D₃ receptor binding in pathological gambling is correlated with mood-related impulsivity. Neuroimage. 63:40-46. Author weblink DOI.
  • Nutt DJ; Ove Ögren S; van Ree JM. (Dec 2012). Neuropsychopharmacology across brain diseases. Eur Neuropsychopharmacol. 22:844-846. Author weblink DOI.
  • Carhart-Harris RL; Leech R; Erritzoe D; Williams TM; Stone JM; Evans J; Sharp DJ; Feilding A; et alWise RG; Nutt DJ. (27 Oct 2012). Functional Connectivity Measures After Psilocybin Inform a Novel Hypothesis of Early Psychosis. Schizophr Bull. Author weblink DOI.
  • Davies SJC; Bjerkeset O; Nutt DJ; Lewis G. (1 Sep 2012). A U-shaped relationship between systolic blood pressure and panic symptoms: the HUNT study. PSYCHOLOGICAL MEDICINE. 42:1969-1976. Author weblink DOI.
  • Nutt D. (1 Jan 2012). NEW CLASSIFICATION OF PSYCHIATRIC MEDICATIONS: REPORT OF WORK IN PROGRESS. EUROPEAN PSYCHIATRY. 27. Author weblink.
  • Quelch DR; Parker CA; Nutt DJ; Tyacke RJ; Erritzoe D. (Dec 2012). Influence of different cellular environments on [(3)H]DASB radioligand binding. Synapse. 66:1035-1039. Author weblink DOI.
  • Chick J; Nutt D. (1 Jul 2012). Author's reply: 'Suppressing addiction using high-dose baclofen, rather than using substitution therapy'. JOURNAL OF PSYCHOPHARMACOLOGY. 26:1044-1044. Author weblink DOI.
  • White J; Nutt D. (9 Jun 2012). One minute with ... David Nutt. NEW SCIENTIST. 214:29-29. Author weblink.
  • Bolea B; Adamou M; Arif M; Asherson P; Gudjonsson G; Mueller U; Nutt DJ; Pitts M; et alThome J; Young S. (1 Jun 2012). ADHD matures: time for practitioners to do the same?. JOURNAL OF PSYCHOPHARMACOLOGY. 26:766-770. Author weblink DOI.
  • Bould H; Wiles N; Potokar J; Cowen P; Nutt DJ; Peters TJ; Lewis G. (1 May 2012). Does baseline fatigue influence treatment response to reboxetine or citalopram in depression? An open label randomized controlled trial. JOURNAL OF PSYCHOPHARMACOLOGY. 26:663-669. Author weblink DOI.
  • Schlaepfer TE; Agren H; Monteleone P; Gasto C; Pitchot W; Rouillon F; Nutt DJ; Kasper S. (1 May 2012). The hidden third: improving outcome in treatment-resistant depression. JOURNAL OF PSYCHOPHARMACOLOGY. 26:587-602. Author weblink.
  • Lingford-Hughes AR; Welch S; Peters L; Nutt DJ; British Association for Psychopharmacology, Expert Reviewers Group. (Jul 2012). BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP. J Psychopharmacol. 26:899-952. Author weblink DOI.
  • Diaper A; Nutt DJ; Munafo MR; White JL; Farmer EW; Bailey JE. (1 Apr 2012). The effects of 7.5% carbon dioxide inhalation on task performance in healthy volunteers. JOURNAL OF PSYCHOPHARMACOLOGY. 26:487-496. Author weblink DOI.
  • Mendez MA; Horder J; Myers J; Coghlan S; Stokes P; Erritzoe D; Howes O; Lingford-Hughes A; et alMurphy D; Nutt D. (May 2013). The brain GABA-benzodiazepine receptor alpha-5 subtype in autism spectrum disorder: a pilot [(11)C]Ro15-4513 positron emission tomography study. Neuropharmacology. 68:195-201. Author weblink DOI.
  • Myers JFM; Rosso L; Watson BJ; Wilson SJ; Kalk NJ; Clementi N; Brooks DJ; Nutt DJ; et alTurkheimer FE; Lingford-Hughes AR. (2011). Characterization of the contribution of the GABA-benzodiazepine α1 receptor subtype to [11C]Ro15-4513 PET images. Journal of Cerebral Blood Flow and Metabolism.
  • Owen DR; Rupprecht R; Nutt DJ. (Feb 2013). Stratified medicine in psychiatry: a worrying example or new opportunity in the treatment of anxiety?. J Psychopharmacol. 27:119-122. Author weblink DOI.
  • Wiles NJ; Mulligan J; Peters TJ; Cowen PJ; Mason V; Nutt D; Sharp D; Tallon D; et alThomas L; O'Donovan MC; Lewis G. (1 Feb 2012). Severity of depression and response to antidepressants: GENPOD randomised controlled trial. BRITISH JOURNAL OF PSYCHIATRY. 200:130-136. Author weblink DOI.
  • Colasanti A; Searle GE; Long CJ; Hill SP; Reiley RR; Quelch D; Erritzoe D; Tziortzi AC; et alReed LJ; Lingford-Hughes AR; Waldman AD; Schruers KR; Matthews PM; Gunn RN; Nutt DJ; Rabiner EA. (1 Sep 2012). Endogenous opioid release in the human brain reward system induced by acute amphetamine administration. Biol Psychiatry. 72:371-377. Author weblink DOI.
  • Carhart-Harris RL; Leech R; Williams TM; Erritzoe D; Abbasi N; Bargiotas T; Hobden P; Sharp DJ; et alEvans J; Feilding A; Wise RG; Nutt DJ. (Mar 2012). Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin. Br J Psychiatry. 200:238-244. Author weblink DOI.
  • Carhart-Harris RL; Erritzoe DE; Williams TM; Stone JM; Leech R; Reed L; Colasanti A; Tyacke R; et alMalizia A; Evans J; Hobden P; Murphy K; Feilding A; Wise RG; Nutt DJ. (2012). The neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. Proceedings of the National Academy of Sciences of USA.
  • Weissenborn R; Nutt DJ. (1 Feb 2012). Popular intoxicants: what lessons can be learned from the last 40 years of alcohol and cannabis regulation?. JOURNAL OF PSYCHOPHARMACOLOGY. 26:213-220. Author weblink DOI.
  • Chick J; Nutt DJ. (1 Feb 2012). Substitution therapy for alcoholism: time for a reappraisal?. JOURNAL OF PSYCHOPHARMACOLOGY. 26:205-212. Author weblink DOI.
  • Carhart-Harris RL; Erritzoe D; Williams T; Stone JM; Reed LJ; Colasanti A; Tyacke RJ; Leech R; et alMalizia AL; Murphy K; Hobden P; Evans J; Feilding A; Wise RG; Nutt DJ. (7 Feb 2012). Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. Proc Natl Acad Sci U S A. 109:2138-2143. Author weblink DOI.
  • Nutt D. (Feb 2012). Massive overuse or appropriate medical intervention? The modern-day use of antidepressants. Curr Opin Pharmacol. 12:109-110. Author weblink DOI.
  • Tyacke RJ; Fisher A; Robinson ES; Grundt P; Turner EM; Husbands SM; Hudson AL; Parker CA; et alNutt DJ. (Jun 2012). Evaluation and initial in vitro and ex vivo characterization of the potential positron emission tomography ligand, BU99008 (2-(4,5-dihydro-1H-imidazol-2-yl)-1- methyl-1H-indole), for the imidazoline₂ binding site. Synapse. 66:542-551. Author weblink DOI.
  • Nutt DJ; Lingford-Hughes A; Chick J. (Feb 2012). Through a glass darkly: can we improve clarity about mechanism and aims of medications in drug and alcohol treatments?. J Psychopharmacol. 26:199-204. Author weblink DOI.
  • Nutt D. (1 Nov 2011). Low serotonergic tone and elevated risk for substance misuse. BRITISH JOURNAL OF PSYCHIATRY. 199:353-354. Author weblink DOI.
  • Stone JM; Dietrich C; Edden R; Mehta MA; De Simoni S; Reed LJ; Krystal JH; Nutt D; et alBarker GJ. (Jul 2012). Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine-induced psychopathology. Mol Psychiatry. 17:664-665. Author weblink DOI.
  • Nutt DJ. (1 Oct 2011). The full cost and burden of disorders of the brain in Europe exposed for the first time. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 21:715-717. Author weblink DOI.
  • Kalk NJ; Melichar J; Holmes RB; Taylor LG; Daglish MR; Hood S; Edwards T; Lennox-Smith A; et alLingford-Hughes AR; Nutt DJ. (Apr 2012). Central noradrenergic responsiveness to a clonidine challenge in Generalized Anxiety Disorder: a Single Photon Emission Computed Tomography study. J Psychopharmacol. 26:452-460. Author weblink DOI.
  • Nutt D. (Nov 2011). Let not the best be the enemy of the good. Addiction. 106:1892-1893. Author weblink DOI.
  • Stokes PR; Egerton A; Watson B; Reid A; Lappin J; Howes OD; Nutt DJ; Lingford-Hughes AR. (Jan 2012). History of cannabis use is not associated with alterations in striatal dopamine D2/D3 receptor availability. J Psychopharmacol. 26:144-149. Author weblink DOI.
  • Bailey JE; Papadopoulos A; Diaper A; Phillips S; Schmidt ME; van der Ark P; Dourish CT; Dawson GR; et alNutt DJ. (1 Sep 2011). Preliminary evidence of anxiolytic effects of the CRF1 receptor antagonist R317573 in the 7.5% CO2 proof-of-concept experimental model of human anxiety. JOURNAL OF PSYCHOPHARMACOLOGY. 25:1199-1206. Author weblink DOI.
  • Bailey JE; Dawson GR; Dourish CT; Nutt DJ. (1 Sep 2011). Validating the inhalation of 7.5% CO2 in healthy volunteers as a human experimental medicine: a model of generalized anxiety disorder (GAD). JOURNAL OF PSYCHOPHARMACOLOGY. 25:1192-1198. Author weblink DOI.
  • Watson BJ; Wilson S; Griffin L; Kalk NJ; Taylor LG; Munafo MR; Lingford-Hughes AR; Nutt DJ. (1 Jul 2011). A pilot study of the effectiveness of D-cycloserine during cue-exposure therapy in abstinent alcohol-dependent subjects. PSYCHOPHARMACOLOGY. 216:121-129. Author weblink DOI.
  • Paterson LM; Kornum BR; Nutt DJ; Pike VW; Knudsen GM. (Jan 2013). 5-HT radioligands for human brain imaging with PET and SPECT. Med Res Rev. 33:54-111. Author weblink DOI.
  • Nutt DJ. (Jun 2011). Highlights of the international consensus statement on major depressive disorder. J Clin Psychiatry. 72:e21. Author weblink DOI.
  • Lewis G; Mulligan J; Wiles N; Cowen P; Craddock N; Ikeda M; Grozeva D; Mason V; et alNutt D; Sharp D; Tallon D; Thomas L; O'Donovan MC; Peters TJ. (1 Jun 2011). Polymorphism of the 5-HT transporter and response to antidepressants: randomised controlled trial. BRITISH JOURNAL OF PSYCHIATRY. 198:464-471. Author weblink DOI.
  • Amara SG; Grillner S; Insel T; Nutt D; Tsumoto T. (1 May 2011). Neuroscience in recession?. NATURE REVIEWS NEUROSCIENCE. 12:297-+. Author weblink DOI.
  • Paterson LM; Nutt DJ; Wilson SJ. (Sep 2011). Sleep and its disorders in translational medicine. J Psychopharmacol. 25:1226-1234. Author weblink DOI.
  • Carhart-Harris RL; King LA; Nutt DJ. (1 Oct 2011). A web-based survey on mephedrone. Drug Alcohol Depend. 118:19-22. Author weblink DOI.
  • Nutt D; Phillips L; King L. (12 Feb 2011). Drugs and harm to society reply. LANCET. 377:555-555. Author weblink DOI.
  • Cooper RM; Bailey JE; Diaper A; Stirland R; Renton LE; Benton CP; Penton-Voak IS; Nutt DJ; et alMunafo MR. (1 Jan 2011). Effects of 7.5% CO2 inhalation on allocation of spatial attention to facial cues of emotional expression. COGNITION & EMOTION. 25:626-638. Author weblink DOI.
  • Nutt DJ. (2011). NHS drug budget. Flawed assumption in analysis. BMJ. 342:d448. Author weblink.
  • Kealey S; Husbands SM; Casey E; Salinas CA; Parker CA; Jakobsen S; Tyacke RJ; Nutt DJ; et alGee AD. (1 Jan 2011). Synthesis and in vivo evaluation of [C-11]BU99008 as a ligand for the imidazoline I-2 binding site. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS. 54:S304-S304. Author weblink.
  • Nutt D. (1 Jan 2011). Synthetic Spirits. SCIENTIST. 25:23-23. Author weblink.
  • Maron E; Tõru I; Hirvonen J; Tuominen L; Lumme V; Vasar V; Shlik J; Nutt DJ; et alHelin S; Någren K; Tiihonen J; Hietala J. (Jul 2011). Gender differences in brain serotonin transporter availability in panic disorder. J Psychopharmacol. 25:952-959. Author weblink DOI.
  • Owen DR; Lewis AJ; Reynolds R; Rupprecht R; Eser D; Wilkins MR; Bennacef I; Nutt DJ; et alParker CA. (Mar 2011). Variation in binding affinity of the novel anxiolytic XBD173 for the 18 kDa translocator protein in human brain. Synapse. 65:257-259. Author weblink DOI.
  • Wilson SJ; Nutt DJ; Alford C; Argyropoulos SV; Baldwin DS; Bateson AN; Britton TC; Crowe C; et alDijk D-J; Espie CA; Gringras P; Hajak G; Idzikowski C; Krystal AD; Nash JR; Selsick H; Sharpley AL; Wade AG. (1 Nov 2010). British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders. JOURNAL OF PSYCHOPHARMACOLOGY. 24:1577-1600. Author weblink DOI.
  • Nutt DJ; King LA; Phillips LD; Independent Scientific Committee on Drugs. (6 Nov 2010). Drug harms in the UK: a multicriteria decision analysis. Lancet. 376:1558-1565. Author weblink DOI.
  • Christmas DM; Badawy AA-B; Hince D; Davies SJC; Probert C; Creed T; Smithson J; Afzal M; et alNutt DJ; Potokar JP. (1 Oct 2010). Increased serum free tryptophan in patients with diarrhea-predominant irritable bowel syndrome. NUTRITION RESEARCH. 30:678-688. Author weblink DOI.
  • Lingford-Hughes A; Reid AG; Myers J; Feeney A; Hammers A; Taylor LG; Rosso L; Turkheimer F; et alBrooks DJ; Grasby P; Nutt DJ. (Feb 2012). A [11C]Ro15 4513 PET study suggests that alcohol dependence in man is associated with reduced α5 benzodiazepine receptors in limbic regions. J Psychopharmacol. 26:273-281. Author weblink DOI.
  • Rogers PJ; Hohoff C; Heatherley SV; Mullings EL; Maxfield PJ; Evershed RP; Deckert J; Nutt DJ. (1 Aug 2010). Association of the Anxiogenic and Alerting Effects of Caffeine with ADORA2A and ADORA1 Polymorphisms and Habitual Level of Caffeine Consumption. NEUROPSYCHOPHARMACOLOGY. 35:1973-1983. Author weblink DOI.
  • Deakin B; Ferrier N; Holt RIG; Millar H; Nutt DJ; Reynolds G; Samani N; Taylor D. (1 Aug 2010). The physical health challenges in patients with severe mental illness: cardiovascular and metabolic risks. JOURNAL OF PSYCHOPHARMACOLOGY. 24:1-8. Author weblink DOI.
  • Nutt DJ; Feetam CL. (Aug 2010). What one hand giveth the other taketh away: some unpredicted effects of enantiomers in psychopharmacology. J Psychopharmacol. 24:1137-1141. Author weblink DOI.
  • Wood E; Werb D; Kazatchkine M; Kerr T; Hankins C; Gorna R; Nutt D; Des Jarlais D; et alBarré-Sinoussi F; Montaner J. (31 Jul 2010). Vienna Declaration: a call for evidence-based drug policies. Lancet. 376:310-312. Author weblink DOI.
  • Paterson LM; Tyacke RJ; Nutt DJ; Knudsen GM. (Oct 2010). Measuring endogenous 5-HT release by emission tomography: promises and pitfalls. J Cereb Blood Flow Metab. 30:1682-1706. Author weblink DOI.
  • Garcia de Miguel B; Nutt DJ; Hood SD; Davies SJ. (Apr 2012). Elucidation of neurobiology of anxiety disorders in children through pharmacological challenge tests and cortisol measurements: a systematic review. J Psychopharmacol. 26:431-442. Author weblink DOI.
  • Nutt D. (Jul 2010). Science and non-science in UK drug policy. Addiction. 105:1154. Author weblink DOI.
  • Colasanti A; Rabiner EA; Lingford-Hughes A; Nutt DJ. (Nov 2011). Opioids and anxiety. J Psychopharmacol. 25:1415-1433. Author weblink DOI.
  • Kalk NJ; Nutt DJ; Lingford-Hughes AR. (Jan 2011). The role of central noradrenergic dysregulation in anxiety disorders: evidence from clinical studies. J Psychopharmacol. 25:3-16. Author weblink DOI.
  • Papadopoulos A; Chandramohan Y; Collins A; Droste SK; Nutt DJ; Reul JM. (Apr 2011). GABAergic control of novelty stress-responsive epigenetic and gene expression mechanisms in the rat dentate gyrus. Eur Neuropsychopharmacol. 21:316-324. Author weblink DOI.
  • Baldwin DS; Allgulander C; Altamura AC; Angst J; Bandelow B; den Boer J; Boyer P; Davies S; et aldell'Osso B; Eriksson E; Fineberg N; Fredrikson M; Herran A; Maron E; Metspalu A; Nutt D; van der Wee N; Luis Vazquez-Barquero J; Zohar J. (1 Jun 2010). Manifesto for a European Anxiety Disorders Research Network. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 20:426-432. Author weblink DOI.
  • Guloksuz S; Cetin EA; Cetin T; Deniz G; Oral ET; Nutt DJ. (Nov 2010). Cytokine levels in euthymic bipolar patients. J Affect Disord. 126:458-462. Author weblink DOI.
  • Stokes PR; Egerton A; Watson B; Reid A; Breen G; Lingford-Hughes A; Nutt DJ; Mehta MA. (1 Oct 2010). Significant decreases in frontal and temporal [11C]-raclopride binding after THC challenge. Neuroimage. 52:1521-1527. Author weblink DOI.
  • Davies SJ; Esler M; Nutt DJ. (May 2010). Anxiety--bridging the heart/mind divide. J Psychopharmacol. 24:633-638. Author weblink DOI.
  • Hood SD; Potokar JP; Davies SJ; Hince DA; Morris K; Seddon KM; Nutt DJ; Argyropoulos SV. (May 2010). Dopaminergic challenges in social anxiety disorder: evidence for dopamine D3 desensitisation following successful treatment with serotonergic antidepressants. J Psychopharmacol. 24:709-716. Author weblink DOI.
  • Papadopoulos A; Rich A; Nutt DJ; Bailey JE. (May 2010). The effects of single dose anxiolytic medication on the CO2 models of anxiety: differentiation of subjective and objective measures. J Psychopharmacol. 24:649-656. Author weblink DOI.
  • Hill LE; Droste SK; Nutt DJ; Linthorst AC; Reul JM. (May 2010). Voluntary exercise alters GABA(A) receptor subunit and glutamic acid decarboxylase-67 gene expression in the rat forebrain. J Psychopharmacol. 24:745-756. Author weblink DOI.
  • Carhart-Harris RL; Williams TM; Sessa B; Tyacke RJ; Rich AS; Feilding A; Nutt DJ. (Nov 2011). The administration of psilocybin to healthy, hallucinogen-experienced volunteers in a mock-functional magnetic resonance imaging environment: a preliminary investigation of tolerability. J Psychopharmacol. 25:1562-1567. Author weblink DOI.
  • Seddon K; Morris K; Bailey J; Potokar J; Rich A; Wilson S; Bettica P; Nutt DJ. (Jan 2011). Effects of 7.5% CO2 challenge in generalized anxiety disorder. J Psychopharmacol. 25:43-51. Author weblink DOI.
  • Nutt D. (27 Feb 2010). Nutt damage reply. LANCET. 375:724-724. Author weblink.
  • Nutt DJ. (Feb 2010). Antagonist-agonist combinations as therapies for heroin addiction: back to the future?. J Psychopharmacol. 24:141-145. Author weblink DOI.
  • Hood SD; Hince DA; Davies SJC; Argyropoulos S; Robinson H; Potokar J; Nutt DJ. (1 Feb 2010). Effects of acute tryptophan depletion in serotonin reuptake inhibitor-remitted patients with generalized anxiety disorder. PSYCHOPHARMACOLOGY. 208:223-232. Author weblink DOI.
  • Morgan CJA; Muetzelfeldt L; Muetzelfeldt M; Nutt DJ; Curran HV. (1 Feb 2010). Harms associated with psychoactive substances: findings of the UK National Drug Survey. JOURNAL OF PSYCHOPHARMACOLOGY. 24:147-153. Author weblink DOI.
  • Zhang L; Gough J; Christmas D; Mattey DL; Richards SCM; Main J; Enlander D; Honeybourne D; et alAyres JG; Nutt DJ; Kerr JR. (1 Feb 2010). Microbial infections in eight genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis. JOURNAL OF CLINICAL PATHOLOGY. 63:156-164. Author weblink DOI.
  • Corrigan FM; Fisher JJ; Nutt DJ. (Jan 2011). Autonomic dysregulation and the Window of Tolerance model of the effects of complex emotional trauma. J Psychopharmacol. 25:17-25. Author weblink DOI.
  • Hood SD; Melichar JK; Taylor LG; Kalk N; Edwards TR; Hince DA; Lenox-Smith A; Lingford-Hughes AR; et alNutt DJ. (Jan 2011). Noradrenergic function in generalized anxiety disorder: impact of treatment with venlafaxine on the physiological and psychological responses to clonidine challenge. J Psychopharmacol. 25:78-86. Author weblink DOI.
  • Davidson JR; Zhang W; Connor KM; Ji J; Jobson K; Lecrubier Y; McFarlane AC; Newport DJ; et alNutt DJ; Osser DN; Stein DJ; Stowe ZN; Tajima O; Versiani M. (Jan 2010). A psychopharmacological treatment algorithm for generalised anxiety disorder (GAD). J Psychopharmacol. 24:3-26. Author weblink DOI.
  • Maron E; Nutt DJ; Kuikka J; Tiihonen J. (1 Jan 2010). Dopamine transporter binding in females with panic disorder may vary with clinical status. JOURNAL OF PSYCHIATRIC RESEARCH. 44:56-59. Author weblink DOI.
  • Tyacke RJ; Lingford-Hughes A; Reed LJ; Nutt DJ. (2010). GABAB receptors in addiction and its treatment. Adv Pharmacol. 58:373-396. Author weblink DOI.
  • Nutt DJ; Davidson JR; Gelenberg AJ; Higuchi T; Kanba S; Karamustafalioğlu O; Papakostas GI; Sakamoto K; et alTerao T; Zhang M. (2010). International consensus statement on major depressive disorder. J Clin Psychiatry. 71 Suppl E1:e08. Author weblink DOI.
  • Nutt DJ. (2010). Rationale for, barriers to, and appropriate medication for the long-term treatment of depression. J Clin Psychiatry. 71 Suppl E1:e02. Author weblink DOI.
  • Carhart-Harris RL; Nutt DJ. (1 Jan 2010). User perceptions of the benefits and harms of hallucinogenic drug use: A web-based questionnaire study. JOURNAL OF SUBSTANCE USE. 15:283-300. Author weblink DOI.
  • Nutt D. (5 Dec 2009). Nutt controversy Reply. NEW SCIENTIST. 204:30-30. Author weblink.
  • Bolea-Alamanac BM; Davies SJ; Christmas DM; Baxter H; Cullum S; Nutt DJ. (Jan 2011). Cyproterone to treat aggressivity in dementia: a clinical case and systematic review. J Psychopharmacol. 25:141-145. Author weblink DOI.
  • Nutt DJ; Stahl SM. (Nov 2010). Searching for perfect sleep: the continuing evolution of GABAA receptor modulators as hypnotics. J Psychopharmacol. 24:1601-1612. Author weblink DOI.
  • Nutt D. (21 Nov 2009). Government vs science over drug and alcohol policy. Lancet. 374:1731-1733. Author weblink DOI.
  • Nutt D. (7 Nov 2009). A dangerous attitude to drugs. NEW SCIENTIST. 204:5-5. Author weblink.
  • Nutt D; Mandel F; Baldinetti F. (Nov 2009). Early onset anxiolytic efficacy after a single dose of pregabalin: double-blind, placebo- and active-comparator controlled evaluation using a dental anxiety model. J Psychopharmacol. 23:867-873. Author weblink DOI.
  • Nutt DJ. (1 Nov 2009). Prescribing antidepressants post Cipriani et al. JOURNAL OF PSYCHOPHARMACOLOGY. 23:865-866. Author weblink DOI.
  • Bell C; Hood S; Potokar J; Nash J; Adrover M; Frampton C; Hince D; Rich A; et alArgyropoulos S; Nutt D. (Feb 2011). Rapid tryptophan depletion following cognitive behavioural therapy for panic disorder. Psychopharmacology (Berl). 213:593-602. Author weblink DOI.
  • Williams TM; Davies SJ; Taylor LG; Daglish MR; Hammers A; Brooks DJ; Nutt DJ; Lingford-Hughes A. (Oct 2009). Brain opioid receptor binding in early abstinence from alcohol dependence and relationship to craving: an [11C]diprenorphine PET study. Eur Neuropsychopharmacol. 19:740-748. Author weblink DOI.
  • Carhart-Harris RL; Nutt DJ; Munafo MR; Christmas DM; Wilson SJ. (Oct 2009). Equivalent effects of acute tryptophan depletion on REM sleep in ecstasy users and controls. Psychopharmacology (Berl). 206:187-196. Author weblink DOI.
  • Tolchard S; Burns PA; Nutt DJ; Fitzjohn SM. (Oct 2009). Hypothermic responses to infection are inhibited by alpha2-adrenoceptor agonists with possible clinical implications. Br J Anaesth. 103:554-560. Author weblink DOI.
  • Nutt DJ. (1 Sep 2009). Beyond psychoanaleptics - can we improve antidepressant drug nomenclature? (vol 23, pg 343, 2009). JOURNAL OF PSYCHOPHARMACOLOGY. 23:861-861. Author weblink DOI.
  • Argyropoulos SV; Hicks JA; Nash JR; Bell CJ; Rich AS; Nutt DJ; Wilson S. (Sep 2009). Redistribution of slow wave activity of sleep during pharmacological treatment of depression with paroxetine but not with nefazodone. J Sleep Res. 18:342-348. Author weblink DOI.
  • Kimura A; Tyacke RJ; Robinson JJ; Husbands SM; Minchin MC; Nutt DJ; Hudson AL. (7 Jul 2009). Identification of an imidazoline binding protein: creatine kinase and an imidazoline-2 binding site. Brain Res. 1279:21-28. Author weblink DOI.
  • Araya R; Hu X; Heron J; Enoch MA; Evans J; Lewis G; Nutt D; Goldman D. (5 Jul 2009). Effects of stressful life events, maternal depression and 5-HTTLPR genotype on emotional symptoms in pre-adolescent children. Am J Med Genet B Neuropsychiatr Genet. 150B:670-682. Author weblink DOI.
  • Paterson LM; Wilson SJ; Nutt DJ; Hutson PH; Ivarsson M. (Jul 2009). Characterisation of the effects of caffeine on sleep in the rat: a potential model of sleep disruption. J Psychopharmacol. 23:475-486. Author weblink DOI.
  • Maron E; Eller T; Vasar V; Nutt DJ. (Jul 2009). Effects of bupropion augmentation in escitalopram-resistant patients with major depressive disorder: an open-label, naturalistic study. J Clin Psychiatry. 70:1054-1056. Author weblink.
  • Paterson LM; Nutt DJ; Ivarsson M; Hutson PH; Wilson SJ. (1 Jul 2009). Effects on sleep stages and microarchitecture of caffeine and its combination with zolpidem or trazodone in healthy volunteers. JOURNAL OF PSYCHOPHARMACOLOGY. 23:487-494. Author weblink DOI.
  • Corchs F; Nutt DJ; Hood S; Bernik M. (1 Jul 2009). Serotonin and sensitivity to trauma-related exposure in selective serotonin reuptake inhibitors-recovered posttraumatic stress disorder. Biol Psychiatry. 66:17-24. Author weblink DOI.
  • Sinclair LI; Christmas DM; Hood SD; Potokar JP; Robertson A; Isaac A; Srivastava S; Nutt DJ; et alDavies SJ. (Jun 2009). Antidepressant-induced jitteriness/anxiety syndrome: systematic review. Br J Psychiatry. 194:483-490. Author weblink DOI.
  • Nutt DJ. (1 Jun 2009). Beyond psychoanaleptics - can we improve antidepressant drug nomenclature?. JOURNAL OF PSYCHOPHARMACOLOGY. 23:343-345. Author weblink DOI.
  • Maron E; Tammiste A; Kallassalu K; Eller T; Vasar V; Nutt DJ; Metspalu A. (Jun 2009). Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depression. Eur Neuropsychopharmacol. 19:451-456. Author weblink DOI.
  • Lowry CA; Lightman SL; Nutt DJ. (Jun 2009). That warm fuzzy feeling: brain serotonergic neurons and the regulation of emotion. J Psychopharmacol. 23:392-400. Author weblink DOI.
  • Hood SD; Davies SJ; Nutt DJ. (May 2009). Cardiac slowing and acute tryptophan depletion: a comment on the paper by van der Veen et al. Psychopharmacology (Berl). 203:831-833. Author weblink DOI.
  • Carhart-Harris RL; Nutt DJ; Munafò M; Wilson SJ. (May 2009). Current and former ecstasy users report different sleep to matched controls: a web-based questionnaire study. J Psychopharmacol. 23:249-257. Author weblink DOI.
  • Munafò M; Bailey J; Diaper A; Cooper R; Benton C; Penton-Voak I; Nutt D. (13 Mar 2009). RETRACTION: Effects of 7.5% CO2 inhalation on allocation of spatial attention to facial cues of emotional expression. J Psychopharmacol. Author weblink DOI.
  • Evans J; Xu K; Heron J; Enoch MA; Araya R; Lewis G; Timpson N; Davies S; et alNutt D; Goldman D. (5 Mar 2009). Emotional symptoms in children: The effect of maternal depression, life events, and COMT genotype. Am J Med Genet B Neuropsychiatr Genet. 150B:209-218. Author weblink DOI.
  • Bailey JE; Papadopoulos A; Seddon K; Nutt DJ. (Mar 2009). A comparison of the effects of a subtype selective and non-selective benzodiazepine receptor agonist in two CO(2) models of experimental human anxiety. J Psychopharmacol. 23:117-122. Author weblink DOI.
  • Nutt DJ; Attridge J. (1 Mar 2009). Innovation Processes in Psychopharmacology and the Implications for Assessing the Relative Effectiveness of New Medicines. JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS. 12:S32-S32. Author weblink.
  • Nutt D. (1 Jan 2009). Changes in neurotransmission in relation to early treatment and outcome in depression. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE. 13:21-21. Author weblink.
  • Stein DJ; Cloitre M; Nemeroff CB; Nutt DJ; Seedat S; Shalev AY; Wittchen HU; Zohar J. (Jan 2009). Cape Town consensus on posttraumatic stress disorder. CNS Spectr. 14:52-58. Author weblink.
  • Nutt DJ. (Jan 2009). Equasy-- an overlooked addiction with implications for the current debate on drug harms. J Psychopharmacol. 23:3-5. Author weblink DOI.
  • Paterson LM; Nutt DJ; Wilson SJ. (1 Jan 2009). NAPSAQ-1: National Patient Sleep Assessment Questionnaire in depression. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE. 13:48-58. Author weblink DOI.
  • Shufflebotham J; Wetherell MA; Hince D; Hood S; Lightman S; Nutt D; Probert C; Potokar J. (Jan 2009). Women with diarrhoea-predominant irritable bowel syndrome show an increased pressure response to 35% carbon dioxide stress challenge. Stress. 12:30-36. Author weblink DOI.
  • Davies SJ; Jackson PR; Lewis G; Hood SD; Nutt DJ; Potokar JP. (Dec 2008). Is the association of hypertension and panic disorder explained by clustering of autonomic panic symptoms in hypertensive patients?. J Affect Disord. 111:344-350. Author weblink DOI.
  • Taylor C; Nash J; Rich A; Lingford-Hughes A; Nutt D; Potokar J. (Nov 2008). Assessment of GABAA benzodiazepine receptor (GBzR) sensitivity in patients with alcohol dependence. Alcohol Alcohol. 43:614-618. Author weblink DOI.
  • Sessa B; Nutt DJ. (1 Nov 2008). MDMA, politics and medical research: have we thrown the baby out with the bathwater? (vol 21, pg 787, 2007). JOURNAL OF PSYCHOPHARMACOLOGY. 22:932-932. Author weblink DOI.
  • Robbins TW; Everitt BJ; Nutt DJ. (12 Oct 2008). Introduction. The neurobiology of drug addiction: new vistas. Philos Trans R Soc Lond B Biol Sci. 363:3109-3111. Author weblink DOI.
  • Wilson S; Nutt D. (Sep 2008). Drug treatment of chronic insomnia -- dawn at the end of a long night?. J Psychopharmacol. 22:703-706. Author weblink DOI.
  • Nash JR; Sargent PA; Rabiner EA; Hood SD; Argyropoulos SV; Potokar JP; Grasby PM; Nutt DJ. (1 Sep 2008). Serotonin 5-HT1A receptor binding in people with panic disorder: positron emission tomography study. BRITISH JOURNAL OF PSYCHIATRY. 193:229-234. Author weblink DOI.
  • Daglish MRC; Williams TM; Wilson SJ; Taylor LG; Eap CB; Augsburger M; Giroud C; Brooks DJ; et alMyles JS; Grasby P; Lingford-Hughes AR; Nutt DJ. (1 Jul 2008). Brain dopamine response in human opioid addiction. BRITISH JOURNAL OF PSYCHIATRY. 193:65-72. Author weblink DOI.
  • Hickman M; Lingford-Hughes A; Bailey C; Macleod J; Nutt D; Henderson G. (Jul 2008). Does alcohol increase the risk of overdose death: the need for a translational approach. Addiction. 103:1060-1062. Author weblink DOI.
  • Bailey JE; Nutt DJ. (Jul 2008). GABA-A receptors and the response to CO(2) inhalation - a translational trans-species model of anxiety?. Pharmacol Biochem Behav. 90:51-57. Author weblink DOI.
  • Reul JM; Nutt DJ. (Jul 2008). Glutamate and cortisol--a critical confluence in PTSD?. J Psychopharmacol. 22:469-472. Author weblink DOI.
  • Hickman M; Lingford-Hughes A; Bailey C; Macleod J; Nutt D; Henderson G. (1 Jul 2008). Understanding causal pathways: A response to the commentaries. ADDICTION. 103:1067-1068. Author weblink DOI.
  • Allgulander C; Nutt D; Detke M; Erickson J; Spann M; Walker D; Ball S; Russell J. (Jun 2008). A non-inferiority comparison of duloxetine and venlafaxine in the treatment of adult patients with generalized anxiety disorder. J Psychopharmacol. 22:417-425. Author weblink DOI.
  • Nutt D; Allgulander C; Lecrubier Y; Peters T; Wittchen U. (Jun 2008). Establishing non-inferiority in treatment trials in psychiatry: guidelines from an Expert Consensus Meeting. J Psychopharmacol. 22:409-416. Author weblink DOI.
  • Sessa B; Nutt D. (Jun 2008). Reply to letter by Green, Marsden and Fone (2007) about Sessa and Nutt's editorial (MDMA: baby with the bath water) in the November 2007 journal. J Psychopharmacol. 22:457-458. Author weblink DOI.
  • Kerr JR; Burke B; Petty R; Gough J; Fear D; Mattey DL; Axford JS; Dalgleish AG; et alNutt DJ. (Jun 2008). Seven genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis: a detailed analysis of gene networks and clinical phenotypes. J Clin Pathol. 61:730-739. Author weblink DOI.
  • Allgulander C; Nutt D. (Jun 2008). Wine and drug evaluations: lessons on making comparisons of noninferiority. J Psychopharmacol. 22:341-342. Author weblink DOI.
  • Nutt D; Lingford-Hughes A. (May 2008). Addiction: the clinical interface. Br J Pharmacol. 154:397-405. Author weblink DOI.
  • Nutt D. (May 2008). Reply to OCD letter. J Psychopharmacol. 22:338. Author weblink.
  • Nutt D. (1 May 2008). Untitled - Reply to OCD letter. JOURNAL OF PSYCHOPHARMACOLOGY. 22:338-338. Author weblink DOI.
  • Nutt DJ; Malizia AL. (May 2008). Why does the world have such a 'down' on antidepressants?. J Psychopharmacol. 22:223-226. Author weblink DOI.
  • Nutt DJ. (1 Apr 2008). Shifting schizophrenia treatment paradigms: The scope for adjunctive therapies. EUROPEAN PSYCHIATRY. 23:S11-S11. Author weblink DOI.
  • Hitsman B; MacKillop J; Lingford-Hughes A; Williams TM; Ahmad F; Adams S; Nutt DJ; Munafò MR. (Mar 2008). Effects of acute tyrosine/phenylalanine depletion on the selective processing of smoking-related cues and the relative value of cigarettes in smokers. Psychopharmacology (Berl). 196:611-621. Author weblink DOI.
  • Trivedi MH; Hollander E; Nutt D; Blier P. (Feb 2008). Clinical evidence and potential neurobiological underpinnings of unresolved symptoms of depression. J Clin Psychiatry. 69:246-258. Author weblink.
  • Thomas L; Mulligan J; Mason V; Tallon D; Wiles N; Cowen P; Nutt D; O'Donovan M; et alSharp D; Peters T; Lewis G. (2008). GENetic and clinical predictors of treatment response in depression: the GenPod randomised trial protocol. Trials. 9:29. Author weblink DOI.
  • Carhart-Harris RL; Mayberg HS; Malizia AL; Nutt D. (2008). Mourning and melancholia revisited: correspondences between principles of Freudian metapsychology and empirical findings in neuropsychiatry. Ann Gen Psychiatry. 7:9. Author weblink DOI.
  • Christmas D; Hood S; Nutt D. (2008). Potential novel anxiolytic drugs. Curr Pharm Des. 14:3534-3546. Author weblink.
  • Reid AG; Daglish MRC; Kempton MJ; Williams TM; Watson B; Nutt DJ; Lingford-Hughes AR. (1 Jan 2008). Reduced thalamic grey matter volume in opioid dependence is influenced by degree of alcohol use: a voxel-based morphometry study. JOURNAL OF PSYCHOPHARMACOLOGY. 22:7-10. Author weblink DOI.
  • Nutt DJ. (2008). Relationship of neurotransmitters to the symptoms of major depressive disorder. J Clin Psychiatry. 69 Suppl E1:4-7. Author weblink.
  • Nutt D; Wilson S; Paterson L. (2008). Sleep disorders as core symptoms of depression. Dialogues Clin Neurosci. 10:329-336. Author weblink.
  • Nutt DJ; Sharpe M. (Jan 2008). Uncritical positive regard? Issues in the efficacy and safety of psychotherapy. J Psychopharmacol. 22:3-6. Author weblink DOI.
  • Nutt DJ; Besson M; Wilson SJ; Dawson GR; Lingford-Hughes AR. (Dec 2007). Blockade of alcohol's amnestic activity in humans by an alpha5 subtype benzodiazepine receptor inverse agonist. Neuropharmacology. 53:810-820. Author weblink DOI.
  • Sessa B; Nutt DJ. (Nov 2007). MDMA, politics and medical research: have we thrown the baby out with the bathwater?. J Psychopharmacol. 21:787-791. Author weblink DOI.
  • Montgomery SA; Baldwin DS; Blier P; Fineberg NA; Kasper S; Lader M; Lam RW; Lépine JP; et alMöller HJ; Nutt DJ; Rouillon F; Schatzberg AF; Thase ME. (Nov 2007). Which antidepressants have demonstrated superior efficacy? A review of the evidence. Int Clin Psychopharmacol. 22:323-329. Author weblink DOI.
  • Bailey JE; Papadopoulos A; Lingford-Hughes A; Nutt DJ. (Sep 2007). D-Cycloserine and performance under different states of anxiety in healthy volunteers. Psychopharmacology (Berl). 193:579-585. Author weblink DOI.
  • Wilson S; Nutt D. (Sep 2007). Management of insomnia: treatments and mechanismsi. Br J Psychiatry. 191:195-197. Author weblink DOI.
  • Hume SP; Lingford-Hughes AR; Nataf V; Hirani E; Ahmad R; Davies AN; Nutt DJ. (Aug 2007). Low sensitivity of the positron emission tomography ligand [11C]diprenorphine to agonist opiates. J Pharmacol Exp Ther. 322:661-667. Author weblink DOI.
  • Nutt D. (1 Aug 2007). Media care and patient pressure - Reply. JOURNAL OF PSYCHOPHARMACOLOGY. 21:670-670. Author weblink.
  • Davies SJ; Lowry CA; Nutt DJ. (Aug 2007). Panic and hypertension: brothers in arms through 5-HT?. J Psychopharmacol. 21:563-566. Author weblink DOI.
  • Montgomery AJ; Lingford-Hughes AR; Egerton A; Nutt DJ; Grasby PM. (Aug 2007). The effect of nicotine on striatal dopamine release in man: A [11C]raclopride PET study. Synapse. 61:637-645. Author weblink DOI.
  • King LA; Nutt D. (21 Jul 2007). Seizures in a night club. Lancet. 370:220. Author weblink DOI.
  • Abu Ghazaleh H; Lalies MD; Husbands SM; Nutt DJ; Hudson AL. (11 Jul 2007). The effect of 1-(4,5-dihydro-1H-imidazol-2-yl) isoquinoline on monoamine release and turnover in the rat frontal cortex. Neurosci Lett. 422:109-113. Author weblink DOI.
  • Williams TM; Daglish MRC; Lingford-Hughes A; Taylor LG; Hammers A; Brooks DJ; Grasby P; Myles JS; et alNutt DJ. (1 Jul 2007). Brain opioid receptor binding in early abstinence from opioid dependence - Positron emission tomography study. BRITISH JOURNAL OF PSYCHIATRY. 191:63-69. Author weblink DOI.
  • Nutt D; Demyttenaere K; Janka Z; Aarre T; Bourin M; Canonico PL; Carrasco JL; Stahl S. (Jul 2007). The other face of depression, reduced positive affect: the role of catecholamines in causation and cure. J Psychopharmacol. 21:461-471. Author weblink DOI.
  • Nutt D; King L; Saulsbury W; Blakemore C. (2 Jun 2007). Assessing drug-related harm - Reply. LANCET. 369:1857-1857. Author weblink DOI.
  • Paterson LM; Wilson SJ; Nutt DJ; Hutson PH; Ivarsson M. (1 May 2007). A translational, caffeine-induced model of onset insomnia in rats and healthy volunteers. PSYCHOPHARMACOLOGY. 191:943-950. Author weblink DOI.
  • Nutt D; King LA; Saulsbury W; Blakemore C. (24 Mar 2007). Development of a rational scale to assess the harm of drugs of potential misuse. Lancet. 369:1047-1053. Author weblink DOI.
  • Argyropoulos SV; Ploubidis GB; Wright TS; Palm ME; Hood SD; Nash JR; Taylor AC; Forshall SW; et alAnderson IM; Nutt DJ; Potokar JP. (Mar 2007). Development and validation of the Generalized Anxiety Disorder Inventory (GADI). J Psychopharmacol. 21:145-152. Author weblink DOI.
  • Kerr JR; Christian P; Hodgetts A; Langford PR; D Devanur L; Petty R; Burke B; Sinclair LI; et alRichards SCM; Montgomery J; McDermott CR; Harrison TJ; Kellam P; Nutt DJ; Holgate ST. (1 Feb 2007). Current research priorities in chronic fatigue syndrome/myalgic encephalomyelitis: disease mechanisms, a diagnostic test and specific treatments. JOURNAL OF CLINICAL PATHOLOGY. 60:113-116. Author weblink DOI.
  • Paterson LM; Tyacke RJ; Robinson ES; Nutt DJ; Hudson AL. (Feb 2007). In vitro and in vivo effect of BU99006 (5-isothiocyanato-2-benzofuranyl-2-imidazoline) on I2 binding in relation to MAO: evidence for two distinct I2 binding sites. Neuropharmacology. 52:395-404. Author weblink DOI.
  • Bailey JE; Kendrick A; Diaper A; Potokar JP; Nutt DJ. (Jan 2007). A validation of the 7.5% CO2 model of GAD using paroxetine and lorazepam in healthy volunteers. J Psychopharmacol. 21:42-49. Author weblink DOI.
  • Nutt DJ; Kessler RC; Alonso J; Benbow A; Lecrubier Y; Lépine JP; Mechanic D; Tylee A. (2007). Consensus statement on the benefit to the community of ESEMeD (European Study of the Epidemiology of Mental Disorders) survey data on depression and anxiety. J Clin Psychiatry. 68 Suppl 2:42-48. Author weblink.
  • Nutt D. (1 Jan 2007). Ecstasy versus alcohol: Tolstoy and the variations of unhappiness - Reply from the Editor. JOURNAL OF PSYCHOPHARMACOLOGY. 21:7-7. Author weblink DOI.
  • Nutt DJ; Fone K; Asherson P; Bramble D; Hill P; Matthews K; Morris KA; Santosh P; et alSonuga-Barke E; Taylor E; Weiss M; Young S; British Association for Psychopharmacology. (Jan 2007). Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 21:10-41. Author weblink DOI.
  • Kalueff AV; Nutt DJ. (2007). Role of GABA in anxiety and depression. Depress Anxiety. 24:495-517. Author weblink DOI.
  • Papakostas GI; Nutt DJ; Hallett LA; Tucker VL; Krishen A; Fava M. (15 Dec 2006). Resolution of sleepiness and fatigue in major depressive disorder: A comparison of bupropion and the selective serotonin reuptake inhibitors. Biol Psychiatry. 60:1350-1355. Author weblink DOI.
  • Heath TP; Melichar JK; Nutt DJ; Donaldson LF. (6 Dec 2006). Human taste thresholds are modulated by serotonin and noradrenaline. J Neurosci. 26:12664-12671. Author weblink DOI.
  • Robinson HM; Hood SD; Bell CJ; Nutt DJ. (Dec 2006). Dopamine and social anxiety disorder. Rev Bras Psiquiatr. 28:263-264. Author weblink.
  • Shufflebotham J; Hood S; Hendry J; Hince DA; Morris K; Nutt D; Probert C; Potokar J. (Nov 2006). Acute tryptophan depletion alters gastrointestinal and anxiety symptoms in irritable bowel syndrome. Am J Gastroenterol. 101:2582-2587. Author weblink DOI.
  • Nutt D; Malizia A. (Nov 2006). Anxiety and OCD - the chicken or the egg?. J Psychopharmacol. 20:729-731. Author weblink DOI.
  • Saczewski F; Tabin P; Tyacke RJ; Maconie A; Saczewski J; Kornicka A; Nutt DJ; Hudson AL. (1 Oct 2006). 2-(4,5-Dihydroimidazol-2-yl)benzimidazoles as highly selective imidazoline I2/adrenergic alpha2 receptor ligands. Bioorg Med Chem. 14:6679-6685. Author weblink DOI.
  • Nutt DJ; Stein DJ. (Oct 2006). Understanding the neurobiology of comorbidity in anxiety disorders. CNS Spectr. 11:13-20. Author weblink.
  • Davies SJC; Hood SD; Argyropoulos SV; Morris K; Bell C; Witchel HJ; Jackson PR; Nutt DJ; et alPotokar JP. (1 Aug 2006). Depleting serotonin enhances both cardiovascular and psychological stress reactivity in recovered patients with anxiety disorders. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY. 26:414-418. Author weblink DOI.
  • Davies SJ; Hood SD; Argyropoulos SV; Morris K; Bell C; Witchel HJ; Jackson PR; Nutt DJ; et alPotokar JP. (Aug 2006). Depleting serotonin enhances both cardiovascular and psychological stress reactivity in recovered patients with anxiety disorders. J Clin Psychopharmacol. 26:414-418. Author weblink DOI.
  • Papadopoulos V; Baraldi M; Guilarte TR; Knudsen TB; Lacapère JJ; Lindemann P; Norenberg MD; Nutt D; et alWeizman A; Zhang MR; Gavish M. (Aug 2006). Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci. 27:402-409. Author weblink DOI.
  • Nutt D. (1 Aug 2006). What we know and what we don't know about how antipsychotics work. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY. 40:A106-A106. Author weblink.
  • Nutt D; Argyropoulos S; Hood S; Potokar J. (Jul 2006). Generalized anxiety disorder: A comorbid disease. Eur Neuropsychopharmacol. 16 Suppl 2:S109-S118. Author weblink DOI.
  • Nutt DJ; Baldwin DS; Clayton AH; Elgie R; Lecrubier Y; Montejo AL; Papakostas GI; Souery D; et alTrivedi MH; Tylee A. (1 Jan 2006). The role of dopamine and norepinephrine in depression and antidepressant treatment. JOURNAL OF CLINICAL PSYCHIATRY. 67:46-49. Author weblink.
  • Nutt DJ. (May 2006). A tale of two Es. J Psychopharmacol. 20:315-317. Author weblink DOI.
  • Nutt DJ. (May 2006). Alcohol alternatives--a goal for psychopharmacology?. J Psychopharmacol. 20:318-320. Author weblink DOI.
  • Nutt D. (1 May 2006). Harm reduction: lessons learned from tobacco control - Reply to commentaries. JOURNAL OF PSYCHOPHARMACOLOGY. 20:331-331. Author weblink DOI.
  • Tõru I; Shlik J; Maron E; Vasar V; Nutt DJ. (May 2006). Tryptophan depletion does not modify response to CCK-4 challenge in patients with panic disorder after treatment with citalopram. Psychopharmacology (Berl). 186:107-112. Author weblink DOI.
  • Nutt D. (15 Apr 2006). GABAA receptors: subtypes, regional distribution, and function. J Clin Sleep Med. 2:S7-11. Author weblink.
  • Anderson NJ; Seif I; Nutt DJ; Hudson AL; Robinson ES. (Mar 2006). Autoradiographical distribution of imidazoline binding sites in monoamine oxidase A deficient mice. J Neurochem. 96:1551-1559. Author weblink DOI.
  • Lingford-Hughes AR; Daglish MRC; Stevenson BJ; Feeney A; Pandit SA; Wilson SJ; Myles J; Grasby PM; et alNutt DJ. (1 Mar 2006). Imaging alcohol cue exposure in alcohol dependence using a PET O-15-H2O paradigm: results from a pilot study. ADDICTION BIOLOGY. 11:107-115. Author weblink DOI.
  • Anderson NJ; Tyacke RJ; Husbands SM; Nutt DJ; Hudson AL; Robinson ES. (Mar 2006). In vitro and ex vivo distribution of [3H]harmane, an endogenous beta-carboline, in rat brain. Neuropharmacology. 50:269-276. Author weblink DOI.
  • Nutt DJ; Baldwin DS; Clayton AH; Elgie R; Lecrubier Y; Montejo AL; Papakostas GI; Souery D; et alTrivedi MH; Tylee A. (2006). Consensus statement and research needs: the role of dopamine and norepinephrine in depression and antidepressant treatment. J Clin Psychiatry. 67 Suppl 6:46-49. Author weblink.
  • Nutt DJ. (Jan 2006). Informed consent--a new approach to drug regulation?. J Psychopharmacol. 20:3-4. Author weblink DOI.
  • Nutt DJ. (2006). The role of dopamine and norepinephrine in depression and antidepressant treatment. J Clin Psychiatry. 67 Suppl 6:3-8. Author weblink.
  • Ruddick JP; Evans AK; Nutt DJ; Lightman SL; Rook GA; Lowry CA. (2006). Tryptophan metabolism in the central nervous system: medical implications. Expert Rev Mol Med. 8:1-27. Author weblink DOI.
  • Baldwin DS; Anderson IM; Nutt DJ; Bandelow B; Bond A; Davidson JR; den Boer JA; Fineberg NA; et alKnapp M; Scott J; Wittchen HU; British Association for Psychopharmacology. (Nov 2005). Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 19:567-596. Author weblink DOI.
  • Davies SJ; Pandit SA; Feeney A; Stevenson BJ; Kerwin RW; Nutt DJ; Marshall EJ; Boddington S; et alLingford-Hughes A. (Nov 2005). Is there cognitive impairment in clinically 'healthy' abstinent alcohol dependence?. Alcohol Alcohol. 40:498-503. Author weblink DOI.
  • Kornicka A; Saczewski F; Tyacke RJ; Hudson AL; Nutt DJ. (Nov 2005). Preparation, structure and affinity for imidazoline I2 receptors and alpha2-adrenoceptors of 1-[(4,5-dihydroimidazolidin-2-yl)imino]indan-2-ols. Acta Pol Pharm. 62:497-502. Author weblink.
  • Wilson SJ; Bailey JE; Rich AS; Nash J; Adrover M; Tournoux A; Nutt DJ. (Nov 2005). The use of sleep measures to compare a new 5HT1A agonist with buspirone in humans. J Psychopharmacol. 19:609-613. Author weblink DOI.
  • Anderson NJ; Lupo PA; Nutt DJ; Hudson AL; Robinson ES. (5 Sep 2005). Characterisation of imidazoline I2 binding sites in pig brain. Eur J Pharmacol. 519:68-74. Author weblink DOI.
  • Nutt DJ. (Sep 2005). Dr Shipman's last legacy: e-surveillance of the medical profession. J Psychopharmacol. 19:441. Author weblink DOI.
  • Robinson ES; Nutt DJ; Jackson HC; Hudson AL. (30 Aug 2005). The uptake of a fluorescently labelled antisense oligonucleotide in vitro and in vivo. J Neurosci Methods. 147:48-54. Author weblink DOI.
  • Lingford-Hughes A; Wilson SJ; Feeney A; Grasby PG; Nutt DJ. (1 Aug 2005). A proof-of-concept study using [C-11]flumazenil PET to demonstrate that pagoclone is a partial agonist. PSYCHOPHARMACOLOGY. 180:789-791. Author weblink DOI.
  • Robbins TW; Nutt DJ; de Wit H. (1 Aug 2005). Brain imaging - Editorial. PSYCHOPHARMACOLOGY. 180:581-582. Author weblink DOI.
  • Lingford-Hughes AR; Wilson SJ; Cunningham VJ; Feeney A; Stevenson B; Brooks DJ; Nutt DJ. (1 Aug 2005). GABA-benzodiazepine receptor function in alcohol dependence: a combined C-11-flumazenil PET and pharmacodynamic study. PSYCHOPHARMACOLOGY. 180:595-606. Author weblink DOI.
  • Hood SD; Bell CJ; Nutt DJ. (Jul 2005). Acute tryptophan depletion. Part I: rationale and methodology. Aust N Z J Psychiatry. 39:558-564. Author weblink DOI.
  • Bell CJ; Hood SD; Nutt DJ. (Jul 2005). Acute tryptophan depletion. Part II: clinical effects and implications. Aust N Z J Psychiatry. 39:565-574. Author weblink DOI.
  • Slattery DA; Morrow JA; Hudson AL; Hill DR; Nutt DJ; Henry B. (Jul 2005). Comparison of alterations in c-fos and Egr-1 (zif268) expression throughout the rat brain following acute administration of different classes of antidepressant compounds. Neuropsychopharmacology. 30:1278-1287. Author weblink DOI.
  • Nutt DJ. (Jul 2005). Foresight brain science, addiction and drugs project. J Psychopharmacol. 19:325. Author weblink DOI.
  • Wilson SJ; Bailey JE; Nutt DJ. (Jun 2005). Dizziness produced by a potent 5HT(1A) receptor agonist (eptapirone) is not due to postural hypotension. Psychopharmacology (Berl). 179:895-896. Author weblink DOI.
  • Nutt DJ. (May 2005). Making sense of GABA(A) receptor subtypes: is a new nomenclature needed?. J Psychopharmacol. 19:219-220. Author weblink DOI.
  • Wilson S; Nutt D. (Mar 2005). Assessment and management of insomnia. Clin Med. 5:101-104. Author weblink.
  • Nutt DJ. (Mar 2005). Death by tricyclic: the real antidepressant scandal?. J Psychopharmacol. 19:123-124. Author weblink DOI.
  • Gonzalez A; Nutt DJ. (Mar 2005). Gamma hydroxy butyrate abuse and dependency. J Psychopharmacol. 19:195-204. Author weblink.
  • Nutt DJ. (Mar 2005). NICE: The National Institute of Clinical Excellence -- or Eccentricity? Reflections on the Z-drugs as hypnotics. J Psychopharmacol. 19:125-127. Author weblink DOI.
  • Tyacke RJ; Robinson ESJ; Lalies MDM; Hume SP; Hudson AL; Nutt DJ. (1 Feb 2005). Estimation of endogenous noradrenaline release in rat brain in vivo using [H-3]RX 821002. SYNAPSE. 55:126-132. Author weblink DOI.
  • Fone KC; Nutt DJ. (Feb 2005). Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder. Curr Opin Pharmacol. 5:87-93. Author weblink DOI.
  • Saczewski F; Kobierska E; Tyacke RJ; Hudson AL; Nutt DJ; Gdaniec M. (Feb 2005). Synthesis of 2,3,5,6-tetrahydro-3H-imidazo[2,1-b] [1,3,5]benzotriazepines and their oxidative ring contraction into 1-(4,5-dihydro-1H-imidazol-2-yl)-1H-benzimidazoles. Farmaco. 60:127-134. Author weblink DOI.
  • Bailey JE; Argyropoulos SV; Kendrick AH; Nutt DJ. (2005). Behavioral and cardiovascular effects of 7.5% CO2 in human volunteers. Depress Anxiety. 21:18-25. Author weblink DOI.
  • Nutt D. (Jan 2005). Cannabis antagonists: a new era of social psychopharmacology?. J Psychopharmacol. 19:3-4. Author weblink DOI.
  • Nutt DJ. (1 Jan 2005). Discontinuation of Vioxx. Lancet. 365:28. Author weblink DOI.
  • Daglish M; Lingford-Hughes A; Nutt D. (2005). Human functional neuroimaging connectivity research in dependence. Rev Neurosci. 16:151-157. Author weblink.
  • Nutt DJ. (Jan 2005). Overview of diagnosis and drug treatments of anxiety disorders. CNS Spectr. 10:49-56. Author weblink.
  • Nash JR; Nutt DJ. (2005). Pharmacotherapy of anxiety. Handb Exp Pharmacol. 469-501. Author weblink.
  • Kornicka A; Saczewski F; Petrusewicz J; Rejdych A; Tyacke RJ; Hudson AL; Nutt DJ. (1 Jan 2005). Synthesis and biological activities of novel 1,2,3,5-tetrahydroimidazo[2,1-b]quinazoline derivatives. POLISH JOURNAL OF CHEMISTRY. 79:89-100. Author weblink.
  • Melichar JK; Hume SP; Williams TM; Daglish MRC; Taylor LG; Ahmad R; Malizia AL; Brooks DJ; et alMyles JS; Lingford-Hughes A; Nutt DJ. (1 Jan 2005). Using [C-11]diprenorphine to image opioid receptor occupancy by methadone in opioid addiction: Clinical and preclinical studies. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 312:309-315. Author weblink DOI.
  • Parker CA; Anderson NJ; Robinson ES; Price R; Tyacke RJ; Husbands SM; Dillon MP; Eglen RM; et alHudson AL; Nutt DJ; Crump MP; Crosby J. (28 Dec 2004). Harmane and harmalan are bioactive components of classical clonidine-displacing substance. Biochemistry. 43:16385-16392. Author weblink DOI.
  • Argyropoulos SV; Hood SD; Adrover M; Bell CJ; Rich AS; Nash JR; Rich NC; Witchel HJ; et alNutt DJ. (1 Oct 2004). Tryptophan depletion reverses the therapeutic effect of selective serotonin reuptake inhibitors in social anxiety disorder. Biol Psychiatry. 56:503-509. Author weblink DOI.
  • Wilson SJ; Bailey JE; Rich AS; Adrover M; Potokar J; Nutt DJ. (Oct 2004). Using sleep to evaluate comparative serotonergic effects of paroxetine and citalopram. Eur Neuropsychopharmacol. 14:367-372. Author weblink DOI.
  • Lingford-Hughes AR; Welch S; Nutt DJ; British Association for Psychopharmacology. (Sep 2004). Evidence-based guidelines for the pharmacological management of substance misuse, addiction and comorbidity: recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 18:293-335. Author weblink DOI.
  • Walling SG; Nutt DJ; Lalies MD; Harley CW. (25 Aug 2004). Orexin-A infusion in the locus ceruleus triggers norepinephrine (NE) release and NE-induced long-term potentiation in the dentate gyrus. J Neurosci. 24:7421-7426. Author weblink DOI.
  • Nutt D; Lingford-Hughes A. (3 Aug 2004). Infecting the brain to stop addiction?. Proc Natl Acad Sci U S A. 101:11193-11194. Author weblink DOI.
  • Kaluev AV; Nutt DJ. (Jul 2004). [On the role of GABA in anxiety and depression]. Eksp Klin Farmakol. 67:71-76. Author weblink.
  • Robinson ES; Tyacke RJ; Finch L; Willmott G; Husbands S; Nutt DJ; Hudson AL. (May 2004). Pharmacological characterisation of novel alpha 2-adrenoceptor antagonists as potential brain imaging agents. Neuropharmacology. 46:847-855. Author weblink DOI.
  • Davies SJ; Jackson PR; Potokar J; Nutt DJ. (17 Apr 2004). Treatment of anxiety and depressive disorders in patients with cardiovascular disease. BMJ. 328:939-943. Author weblink DOI.
  • Pyle AC; Argyropoulos SV; Nutt DJ. (1 Apr 2004). The role of serotonin in panic: evidence from tryptophan depletion studies. ACTA NEUROPSYCHIATRICA. 16:79-84. Author weblink DOI.
  • Kaye J; Buchanan F; Kendrick A; Johnson P; Lowry C; Bailey J; Nutt D; Lightman S. (Mar 2004). Acute carbon dioxide exposure in healthy adults: evaluation of a novel means of investigating the stress response. J Neuroendocrinol. 16:256-264. Author weblink DOI.
  • Wilson SJ; Rich AS; Rich NC; Potokar J; Nutt DJ. (Mar 2004). Evaluation of actigraphy and automated telephoned questionnaires to assess hypnotic effects in insomnia. Int Clin Psychopharmacol. 19:77-84. Author weblink.
  • Finn DP; Hudson AL; Kinoshita H; Coventry TL; Jessop DS; Nutt DJ; Harbuz MS. (Mar 2004). Imidazoline2 (I2) receptor- and alpha2-adrenoceptor-mediated modulation of hypothalamic-pituitary-adrenal axis activity in control and acute restraint stressed rats. J Psychopharmacol. 18:47-53. Author weblink DOI.
  • Slattery DA; Hudson AL; Nutt DJ. (Feb 2004). Invited review: the evolution of antidepressant mechanisms. Fundam Clin Pharmacol. 18:1-21. Author weblink.
  • Ballenger JC; Davidson JR; Lecrubier Y; Nutt DJ; Marshall RD; Nemeroff CB; Shalev AY; Yehuda R. (2004). Consensus statement update on posttraumatic stress disorder from the international consensus group on depression and anxiety. J Clin Psychiatry. 65 Suppl 1:55-62. Author weblink.
  • Nutt DJ; Malizia AL. (2004). Structural and functional brain changes in posttraumatic stress disorder. J Clin Psychiatry. 65 Suppl 1:11-17. Author weblink.
  • Ballenger JC; Davidson JRT; Lecrubier Y; Nutt DJ. (1 Jan 2004). Update on posttraumatic stress disorder - Introduction. JOURNAL OF CLINICAL PSYCHIATRY. 65:3-3. Author weblink.
  • Daglish MR; Nutt DJ. (Dec 2003). Brain imaging studies in human addicts. Eur Neuropsychopharmacol. 13:453-458. Author weblink.
  • Robinson ES; Price RE; Nutt DJ; Hudson AL. (Dec 2003). BU98008, a highly selective imidazoline(1)-receptor ligand. Ann N Y Acad Sci. 1009:283-287. Author weblink.
  • Anderson NJ; Robinson ES; Husbands SM; Delagrange P; Nutt DJ; Hudson AL. (Dec 2003). Characterization of [(3)H]harmane binding to rat whole brain membranes. Ann N Y Acad Sci. 1009:175-179. Author weblink.
  • Nutt DJ. (Dec 2003). Death and dependence: current controversies over the selective serotonin reuptake inhibitors. J Psychopharmacol. 17:355-364. Author weblink.
  • Robinson ES; Anderson NJ; Crosby J; Nutt DJ; Hudson AL. (Dec 2003). Endogenous beta-carbolines as clonidine-displacing substances. Ann N Y Acad Sci. 1009:157-166. Author weblink.
  • Daglish MRC; Weinstein A; Malizia AL; Wilson S; Melichar JK; Lingford-Hughes A; Myles JS; Grasby P; et alNutt DJ. (1 Dec 2003). Functional connectivity analysis of the neural circuits of opiate craving: "more" rather than "different"?. NEUROIMAGE. 20:1964-1970. Author weblink DOI.
  • Kimura A; Tyacke RJ; Minchin MC; Nutt DJ; Hudson AL. (Dec 2003). Identification of an I(2) binding protein from rabbit brain. Ann N Y Acad Sci. 1009:364-366. Author weblink.
  • Paterson LM; Robinson ES; Nutt DJ; Hudson AL. (Dec 2003). In vivo estimation of imidazoline(2) binding site turnover. Ann N Y Acad Sci. 1009:367-370. Author weblink.
  • Tyacke RJ; Sazczewski F; Tabin P; Sazczewski J; Nutt DJ; Hudson AL. (Dec 2003). Initial evaluation of novel selective ligands for imidazoline(2) receptors in rat whole brain. Ann N Y Acad Sci. 1009:357-360. Author weblink.
  • Tyacke RJ; Lau A; Grella B; Glennon RA; Nutt DJ; Hudson AL. (Dec 2003). Investigation of the affinities of two new beta-carbolines for rat brain imidazoline(2) receptors. Ann N Y Acad Sci. 1009:361-363. Author weblink.
  • Hudson AL; Tyacke RJ; Lalies MD; Davies N; Finn DP; Marti O; Robinson E; Husbands S; et alMinchin MC; Kimura A; Nutt DJ. (Dec 2003). Novel ligands for the investigation of imidazoline receptors and their binding proteins. Ann N Y Acad Sci. 1009:302-308. Author weblink.
  • Paterson LM; Tyacke RJ; Nutt DJ; Hudson AL. (Dec 2003). Relationship between imidazoline(2) sites and monoamine oxidase. Ann N Y Acad Sci. 1009:353-356. Author weblink.
  • Nash JR; Wilson SJ; Potokar JP; Nutt DJ. (28 Oct 2003). Mirtazapine induces REM sleep behavior disorder (RBD) in parkinsonism. Neurology. 61:1161. Author weblink.
  • Saczewski F; Hudson AL; Tyacke RJ; Nutt DJ; Man J; Tabin P; Saczewski J. (Oct 2003). 2-(4,5-dihydro-1H-imidazol-2-yl)indazole (indazim) derivatives as selective I(2) imidazoline receptor ligands. Eur J Pharm Sci. 20:201-208. Author weblink.
  • Argyropoulos SV; Hicks JA; Nash JR; Bell CJ; Rich AS; Nutt DJ; Wilson SJ. (30 Sep 2003). Correlation of subjective and objective sleep measurements at different stages of the treatment of depression. Psychiatry Res. 120:179-190. Author weblink.
  • Smith A; Brice C; Nash J; Rich N; Nutt DJ. (Sep 2003). Caffeine and central noradrenaline: effects on mood, cognitive performance, eye movements and cardiovascular function. J Psychopharmacol. 17:283-292. Author weblink.
  • Bailey JE; Argyropoulos SV; Lightman SL; Nutt DJ. (Sep 2003). Does the brain noradrenaline network mediate the effects of the CO2 challenge?. J Psychopharmacol. 17:252-259. Author weblink.
  • Bailey JE; Argyropoulos SV; Lightman SL; Nutt DJ. (1 Sep 2003). Does the brain noradrenaline network mediate the effects of the CO2 challenge? Reply to reviewers' comments. JOURNAL OF PSYCHOPHARMACOLOGY. 17:267-268. Author weblink DOI.
  • Nutt DJ. (Sep 2003). The unhappy saga of 'happy pills'. J Psychopharmacol. 17:251. Author weblink.
  • Allgulander C; Bandelow B; Hollander E; Montgomery SA; Nutt DJ; Okasha A; Pollack MH; Stein DJ; et alSwinson RP; World Council of Anxiety. (Aug 2003). WCA recommendations for the long-term treatment of generalized anxiety disorder. CNS Spectr. 8:53-61. Author weblink.
  • Greist JH; Bandelow B; Hollander E; Marazziti D; Montgomery SA; Nutt DJ; Okasha A; Swinson RP; et alZohar J; World Council of Anxiety. (Aug 2003). WCA recommendations for the long-term treatment of obsessive-compulsive disorder in adults. CNS Spectr. 8:7-16. Author weblink.
  • Pollack MH; Allgulander C; Bandelow B; Cassano GB; Greist JH; Hollander E; Nutt DJ; Okasha A; et alSwinson RP; World Council of Anxiety. (Aug 2003). WCA recommendations for the long-term treatment of panic disorder. CNS Spectr. 8:17-30. Author weblink.
  • Stein DJ; Bandelow B; Hollander E; Nutt DJ; Okasha A; Pollack MH; Swinson RP; Zohar J; et alWorld Council of Anxiety. (Aug 2003). WCA Recommendations for the long-term treatment of posttraumatic stress disorder. CNS Spectr. 8:31-39. Author weblink.
  • Van Ameringen M; Allgulander C; Bandelow B; Greist JH; Hollander E; Montgomery SA; Nutt DJ; Okasha A; et alPollack MH; Stein DJ; Swinson RP; World Council of Anxiety. (Aug 2003). WCA recommendations for the long-term treatment of social phobia. CNS Spectr. 8:40-52. Author weblink.
  • Weinstein A; Feldtkeller B; Feeney A; Lingford-Hughes A; Nutt D. (Jun 2003). A pilot study on the effects of treatment with acamprosate on craving for alcohol in alcohol-dependent patients. Addict Biol. 8:229-232. Author weblink DOI.
  • Nutt DJ. (1 Jun 2003). British Association for Psychopharmacology consensus on the treatment of bipolar disorder. JOURNAL OF PSYCHOPHARMACOLOGY. 17:147-147. Author weblink DOI.
  • Finn DP; Martí O; Harbuz MS; Vallès A; Belda X; Márquez C; Jessop DS; Lalies MD; et alArmario A; Nutt DJ; Hudson AL. (May 2003). Behavioral, neuroendocrine and neurochemical effects of the imidazoline I2 receptor selective ligand BU224 in naive rats and rats exposed to the stress of the forced swim test. Psychopharmacology (Berl). 167:195-202. Author weblink DOI.
  • Coupland NJ; Wilson SJ; Potokar JP; Bell C; Nutt DJ. (1 May 2003). Increased sympathetic response to standing in panic disorder. Psychiatry Res. 118:69-79. Author weblink.
  • Hood SD; Argyropoulos SV; Nutt DJ. (1 Apr 2003). New directions in the treatment of anxiety disorders. EXPERT OPINION ON THERAPEUTIC PATENTS. 13:401-423. Author weblink DOI.
  • Bell C; Wilson S; Rich A; Bailey J; Nutt D. (Mar 2003). Effects on sleep architecture of pindolol, paroxetine and their combination in healthy volunteers. Psychopharmacology (Berl). 166:102-110. Author weblink DOI.
  • Melichar JK; Myles JS; Eap CB; Nutt DJ. (Mar 2003). Using saccadic eye movements as objective measures of tolerance in methadone dependent individuals during the hydromorphone challenge test. Addict Biol. 8:59-66. Author weblink DOI.
  • Law FD; Nutt DJ. (22 Feb 2003). Maintenance buprenorphine for opioid users. Lancet. 361:634-635. Author weblink DOI.
  • Witchel HJ; Hancox JC; Nutt DJ; Wilson S. (Feb 2003). Antipsychotics, HERG and sudden death. Br J Psychiatry. 182:171-172. Author weblink.
  • Lingford-Hughes A; Nutt D. (Feb 2003). Neurobiology of addiction and implications for treatment. Br J Psychiatry. 182:97-100. Author weblink.
  • Witchel HJ; Hancox JC; Nutt DJ. (Feb 2003). Psychotropic drugs, cardiac arrhythmia, and sudden death. J Clin Psychopharmacol. 23:58-77. Author weblink.
  • Melichar JK; Nutt DJ; Malizia AL. (17 Jan 2003). Naloxone displacement at opioid receptor sites measured in vivo in the human brain. Eur J Pharmacol. 459:217-219. Author weblink.
  • Lingford-Hughes AR; Davies SJ; McIver S; Williams TM; Daglish MR; Nutt DJ. (2003). Addiction. Br Med Bull. 65:209-222. Author weblink.
  • Nutt D; Lingford-Hughes A; Daglish M. (2003). Future directions in substance dependence research. J Neural Transm Suppl. 95-103. Author weblink.
  • Wilson SJ; Bailey JE; Alford C; Weinstein A; Nutt DJ. (Dec 2002). Effects of 5 weeks of administration of fluoxetine and dothiepin in normal volunteers on sleep, daytime sedation, psychomotor performance and mood. J Psychopharmacol. 16:321-331. Author weblink.
  • Nutt DJ; Ballenger JC; Sheehan D; Wittchen HU. (Dec 2002). Generalized anxiety disorder: comorbidity, comparative biology and treatment. Int J Neuropsychopharmacol. 5:315-325. Author weblink DOI.
  • Nutt DJ; Hewett K; Bryson H; Iyengar M; Oakes R. (1 Oct 2002). Generalised anxiety disorder: Remission status in patients treated with paroxetine. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 12:S345-S346. Author weblink.
  • Nutt DJ; Law F. (1 Oct 2002). The ideal treatment of withdrawal. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 12:S121-S123. Author weblink.
  • Wilson S; Bailey J; Rich A; Adrover M; Nutt DJ. (1 Oct 2002). Using sleep to measure relative 5HT uptake blockade. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 12:S200-S200. Author weblink.
  • Daglish MRC; Lingford-Hughes A; Williams TM; Wilsona SJ; Brooksc DJ; Myles JS; Grasby P; Nutt DJ. (1 Sep 2002). A human pet study of dopamine response to hydromorphone. BEHAVIOURAL PHARMACOLOGY. 13:479-480. Author weblink.
  • Bell C; Vanderlinden H; Hiersemenzel R; Otoul C; Nutt D; Wilson S. (Sep 2002). The effects of levetiracetam on objective and subjective sleep parameters in healthy volunteers and patients with partial epilepsy. J Sleep Res. 11:255-263. Author weblink.
  • Hardy J; Argyropoulos S; Nutt DJ. (Sep 2002). Venlafaxine: a new class of antidepressant. Hosp Med. 63:549-552. Author weblink.
  • Robinson ES; Tyacke RJ; Nutt DJ; Hudson AL. (16 Aug 2002). Distribution of [(3)H]BU224, a selective imidazoline I(2) binding site ligand, in rat brain. Eur J Pharmacol. 450:55-60. Author weblink.
  • Argyropoulos SV; Bailey JE; Hood SD; Kendrick AH; Rich AS; Laszlo G; Nash JR; Lightman SL; et alNutt DJ. (Aug 2002). Inhalation of 35% CO(2) results in activation of the HPA axis in healthy volunteers. Psychoneuroendocrinology. 27:715-729. Author weblink.
  • Lingford-Hughes A; Hume S; Feeney A; Hirani E; Osman S; Cunningham V; Pike V; Brooks D; et alNutt D. (1 Jul 2002). [11C]Ro15 4513 PET predominantly labels the alpha 5-containing GABA-benzodiazepine receptor in vivo. NEUROIMAGE. 16:S27-S27. Author weblink.
  • Tyacke RJ; Robinson ES; Nutt DJ; Hudson AL. (Jul 2002). 5-Isothiocyanato-2-benzofuranyl-2-imidazoline (BU99006) an irreversible imidazoline(2) binding site ligand: in vitro and in vivo characterisation in rat brain. Neuropharmacology. 43:75-83. Author weblink.
  • Daglish M; Lingford-Hughes A; Williams T; Wilson S; Brooks D; Myles J; Grasby P; Nutt D. (1 Jul 2002). Does opioid induced dopamine release in humans require a subjective "high"? A pet study with 11C-raclopride. NEUROIMAGE. 16:S95-S95. Author weblink.
  • Lingford-Hughes A; Hume SP; Feeney A; Hirani E; Osman S; Cunningham VJ; Pike VW; Brooks DJ; et alNutt DJ. (1 Jul 2002). Imaging the GABA-benzodiazepine receptor subtype containing the alpha 5-subunit in vivo with [C-11]Ro15 4513 positron emission tomography. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 22:878-889. Author weblink.
  • Finn DP; Lalies MD; Harbuz MS; Jessop DS; Hudson AL; Nutt DJ. (Jun 2002). Imidazoline(2) (I(2)) binding site- and alpha(2)-adrenoceptor-mediated modulation of central noradrenergic and HPA axis function in control rats and chronically stressed rats with adjuvant-induced arthritis. Neuropharmacology. 42:958-965. Author weblink.
  • Hicks JA; Argyropoulos SV; Rich AS; Nash JR; Bell CJ; Edwards C; Nutt DJ; Wilson SJ. (Jun 2002). Randomised controlled study of sleep after nefazodone or paroxetine treatment in out-patients with depression. Br J Psychiatry. 180:528-535. Author weblink.
  • Nutt DJ. (Jun 2002). The neuropharmacology of serotonin and noradrenaline in depression. Int Clin Psychopharmacol. 17 Suppl 1:S1-12. Author weblink.
  • Nutt DJ. (Jun 2002). Tolerability and safety aspects of mirtazapine. Hum Psychopharmacol. 17 Suppl 1:S37-S41. Author weblink DOI.
  • Wilson SJ; Argyropoulos S; Nash J; Hicks JA; Bel CE; Nutt DJ. (1 May 2002). Exploring antidepressant mechanisms by acute and chronic sleep effects. EUROPEAN PSYCHIATRY. 17:72S-72S. Author weblink.
  • Tyacke RJ; Robinson ES; Schnabel R; Lewis JW; Husbands SM; Nutt DJ; Hudson AL. (May 2002). N1'-fluoroethyl-naltrindole (BU97001) and N1'-fluoroethyl-(14-formylamino)-naltrindole (BU97018) potential delta-opioid receptor PET ligands. Nucl Med Biol. 29:455-462. Author weblink.
  • Nutt DJ. (1 Apr 2002). Addiction. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 12:S29-S29. Author weblink.
  • Daglish MRC; Lingford-Hughes A; Williams TM; Davies SJC; Melichar JK; Brooks DJ; Myles JS; Nutt DJ. (1 Mar 2002). A PET study of brain opioid receptor changes after withdrawal from chronic methadone treatment. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 12:S22-S22. Author weblink.
  • Daglish MRC; Lingford-Hughes A; Williams T; Wilson S; Brooks DJ; Myles JS; Grasby P; Nutt DJ. (1 Mar 2002). A PET study testing the dopamine hypothesis in opiate dependence in humans. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 12:S22-S23. Author weblink.
  • Melichar JK; Taylor LG; Daglish MRC; Holmes RB; Parkin VJ; Rees MR; Lenox-Smith A; Lingford-Hughes AR; et alNutt DJ. (1 Mar 2002). A single photon emission tomography (SPET) study of noradrenergic function in generalised anxiety disorder (GAD). EUROPEAN NEUROPSYCHOPHARMACOLOGY. 12:S20-S21. Author weblink.
  • Wilson S; Lingford-Hughes A; Cunningham VJ; Gunn R; Feeney A; Stevenson BJ; Myles J; Brooks DJ; et alNutt DJ. (1 Mar 2002). Assessing the function of the GABA-benzodiazepine receptor in alcohol dependence using PET and EEG. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 12:S21-S21. Author weblink.
  • Lingford-Hughes A; Daglish MRC; Wilson S; Weinstein A; Malizia AL; Melichar JK; Stevenson BJ; Feeney A; et alPandit SA; Myles JS; Grasby PJ; Nutt DJ. (1 Mar 2002). Blood flow changes in abstinent addicts during cue exposure and craving for their drug of choice. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 12:S21-S22. Author weblink.
  • Bell C; Forshall S; Adrover M; Nash J; Hood S; Argyropoulos S; Rich A; Nutt DJ. (Mar 2002). Does 5-HT restrain panic? A tryptophan depletion study in panic disorder patients recovered on paroxetine. J Psychopharmacol. 16:5-14. Author weblink.
  • Lingford-Hughes A; Hume SP; Feeney A; Hirani E; Osman S; Cunningham VJ; Pike VW; Brooks DJ; et alNutt DJ. (1 Mar 2002). Imaging in vivo the GABA-benzodiazepine receptor containing the alpha 5 subunit in man and rat. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 12:S20-S20. Author weblink.
  • Willmott G; Robinson ESJ; Tyacke RJ; Nutt DJ; Hudson AL. (1 Feb 2002). Functional characterisation of novel alpha(2)-adrenoceptor ligands in the mouse vas deferens. BRITISH JOURNAL OF PHARMACOLOGY. 135. Author weblink.
  • Finch L; Tyacke RJ; Robinson ESJ; Nutt DJ; Hudson AL. (1 Feb 2002). In vitro evaluation of three potential SPECT ligands for the central alpha(2)-adrenoceptor. BRITISH JOURNAL OF PHARMACOLOGY. 135. Author weblink.
  • Edwards MM; Jackson HC; Nutt DJ; Hudson AL. (1 Feb 2002). Investigation of the acute administration of imidazoline ligands on food intake. BRITISH JOURNAL OF PHARMACOLOGY. 135. Author weblink.
  • Allgulander C; Hirschfeld RM; Nutt DJ. (2002). Long-term treatment strategies in anxiety disorders. Psychopharmacol Bull. 36 Suppl 2:79-92. Author weblink.
  • Artigas F; Nutt DJ; Shelton R. (2002). Mechanism of action of antidepressants. Psychopharmacol Bull. 36 Suppl 2:123-132. Author weblink.
  • Argyropoulos SV; Bell CJ; Nutt DJ. (Dec 2001). Brain function in social anxiety disorder. Psychiatr Clin North Am. 24:707-722. Author weblink.
  • Crofts HS; Wilson S; Muggleton NG; Nutt DJ; Scott EA; Pearce PC. (Dec 2001). Investigation of the sleep electrocorticogram of the common marmoset (Callithrix jacchus) using radiotelemetry. Clin Neurophysiol. 112:2265-2273. Author weblink.
  • Abrams JK; Bell CJ; Nutt DJ. (1 Dec 2001). Tryptophan depletion as a clinical tool: Current status and future directions. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE. 5:237-247. Author weblink.
  • Nutt DJ; Malizia AL. (Nov 2001). New insights into the role of the GABA(A)-benzodiazepine receptor in psychiatric disorder. Br J Psychiatry. 179:390-396. Author weblink.
  • Husbands SM; Glennon RA; Gorgerat S; Gough R; Tyacke R; Crosby J; Nutt DJ; Lewis JW; et alHudson AL. (1 Oct 2001). beta-carboline binding to imidazoline receptors. Drug Alcohol Depend. 64:203-208. Author weblink.
  • Daglish MRC; Weinstein A; Malizia AL; Wilson S; Melichar JK; Britten S; Brewer C; Lingford-Hughes A; et alMyles JS; Grasby P; Nutt DJ. (1 Oct 2001). Changes in regional cerebral blood flow elicited by craving memories in abstinent opiate-dependent subjects. AMERICAN JOURNAL OF PSYCHIATRY. 158:1680-1686. Author weblink DOI.
  • Sandford JJ; Forshall S; Bell C; Argyropoulos S; Rich A; D'Orlando KJ; Gammans RE; Nutt DJ. (Sep 2001). Crossover trial of pagoclone and placebo in patients with DSM-IV panic disorder. J Psychopharmacol. 15:205-208. Author weblink.
  • Hood SD; Argyropoulos SV; Nutt DJ. (Aug 2001). Arthritis and serotonergic antidepressants. J Clin Psychopharmacol. 21:458-461. Author weblink.
  • Feldtkeller B; Weinstein A; Cox WM; Nutt D. (Aug 2001). Effects of contextual priming on reactions to craving and withdrawal stimuli in alcohol-dependent participants. Exp Clin Psychopharmacol. 9:343-351. Author weblink.
  • Ballenger JC; Ballenger JC; Davidson JRT; Lecrubier Y; Nutt DJ. (1 Jan 2001). Focus on depression and anxiety disorders in general medicine - Introduction. JOURNAL OF CLINICAL PSYCHIATRY. 62:3-3. Author weblink.
  • Nutt DJ. (1 Jul 2001). Panic disorder: Clinical diagnosis, management and mechanism. AMERICAN JOURNAL OF PSYCHIATRY. 158:1176-1177. Author weblink.
  • Daglish M; Lingford-Hughes A; Stevenson B; Feeney A; Myles J; Grasby P; Nutt D. (1 Jun 2001). Mapping neural activation to alcohol cues in abstinent alcoholics - variability of behavioural and rCBF responses in the scanner environment. NEUROIMAGE. 13:S1039-S1039. Author weblink.
  • Robinson ESJ; Tyacke RJ; Nutt DJ; Hudson AL. (1 May 2001). Effect of BU99006, an irreversible imidazolme(2) binding site ligand, in the distribution of [H-3]2BFI and of [H-3]RX82I002 binding to rat brain sections. BRITISH JOURNAL OF PHARMACOLOGY. 133:U72-U72. Author weblink.
  • Tyacke RJ; Paterson LM; Nutt DJ; Hudson AL. (1 May 2001). Pre-treatment with imidazoline(2) binding site compounds increases the binding of [H-3]2BFI in rat brain membranes. BRITISH JOURNAL OF PHARMACOLOGY. 133:U72-U72. Author weblink.
  • Finn DP; Hudson AL; Harbuz MS; Nutt DJ; Marti O. (1 May 2001). The effect of the imidazoline(2) (I-2) site selective ligand BU224 in rat exposed to a forced swim test paradigm. BRITISH JOURNAL OF PHARMACOLOGY. 133:U94-U94. Author weblink.
  • Bell C; Abrams J; Nutt D. (May 2001). Tryptophan depletion and its implications for psychiatry. Br J Psychiatry. 178:399-405. Author weblink.
  • Clayson J; Jales A; Tyacke RJ; Hudson AL; Nutt DJ; Lewis JW; Husbands SM. (9 Apr 2001). Selective delta-opioid receptor ligands: potential PET ligands based on naltrindole. Bioorg Med Chem Lett. 11:939-943. Author weblink.
  • Ballenger JC; Davidson JR; Lecrubier Y; Nutt DJ. (Apr 2001). A Proposed Algorithm for Improved Recognition and Treatment of the Depression/Anxiety Spectrum in Primary Care. Prim Care Companion J Clin Psychiatry. 3:44-52. Author weblink.
  • Argyropoulos SV; Hood SD; Nutt DJ. (Apr 2001). Social phobia: illness or illusion?. Acta Psychiatr Scand. 103:241-243. Author weblink.
  • Coupland NJ; Bell C; Potokar JP; Bailey JE; Nutt DJ. (1 Mar 2001). Cardiovascular reflexes during treatment of social phobia with moclobemide. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE. 5:27-31. Author weblink.
  • Pandit SA; Argyropoulos S; Nutt DJ. (1 Mar 2001). Current status of anxiolytic drugs. PRIMARY CARE PSYCHIATRY. 7:1-5. Author weblink DOI.
  • Melichar JK; Daglish MR; Nutt DJ. (Feb 2001). Addiction and withdrawal--current views. Curr Opin Pharmacol. 1:84-90. Author weblink.
  • Okada M; Nutt DJ; Murakami T; Zhu G; Kamata A; Kawata Y; Kaneko S. (15 Jan 2001). Adenosine receptor subtypes modulate two major functional pathways for hippocampal serotonin release. J Neurosci. 21:628-640. Author weblink.
  • Ballenger JC; Davidson JR; Lecrubier Y; Nutt DJ; Roose SP; Sheps DS; International Consensus Group on Depression and Anxiety. (2001). Consensus statement on depression, anxiety, and cardiovascular disease. J Clin Psychiatry. 62 Suppl 8:24-27. Author weblink.
  • Ballenger JC; Davidson JR; Lecrubier Y; Nutt DJ; Lydiard RB; Mayer EA; International Consensus Group on Depression and Anxiety. (2001). Consensus statement on depression, anxiety, and functional gastrointestinal disorders. J Clin Psychiatry. 62 Suppl 8:48-51. Author weblink.
  • Ballenger JC; Davidson JR; Lecrubier Y; Nutt DJ; Jones RD; Berard RM; International Consensus Group on Depression and Anxiety. (2001). Consensus statement on depression, anxiety, and oncology. J Clin Psychiatry. 62 Suppl 8:64-67. Author weblink.
  • Ballenger JC; Davidson JR; Lecrubier Y; Nutt DJ; Borkovec TD; Rickels K; Stein DJ; Wittchen HU. (2001). Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry. 62 Suppl 11:53-58. Author weblink.
  • Ballenger JC; Davidson JR; Lecrubier Y; Nutt DJ; Kirmayer LJ; Lépine JP; Lin KM; Tajima O; et alOno Y. (2001). Consensus statement on transcultural issues in depression and anxiety from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry. 62 Suppl 13:47-55. Author weblink.
  • Nutt DJ. (2001). Neurobiological mechanisms in generalized anxiety disorder. J Clin Psychiatry. 62 Suppl 11:22-27. Author weblink.
  • Nutt D. (1 Jan 2001). Social phobia. NORDIC JOURNAL OF PSYCHIATRY. 55:78-78. Author weblink.
  • Melichar JK; Haida A; Rhodes C; Reynolds AH; Nutt DJ; Malizia AL. (1 Jan 2001). Venlafaxine occupation at the noradrenaline reuptake site: in-vivo determination in healthy volunteers. JOURNAL OF PSYCHOPHARMACOLOGY. 15:9-12. Author weblink.
  • Argyropoulos SV; Sandford JJ; Nutt DJ. (Dec 2000). The psychobiology of anxiolytic drug. Part 2: Pharmacological treatments of anxiety. Pharmacol Ther. 88:213-227. Author weblink.
  • Sandford JJ; Argyropoulos SV; Nutt DJ. (Dec 2000). The psychobiology of anxiolytic drugs. Part 1: Basic neurobiology. Pharmacol Ther. 88:197-212. Author weblink.
  • Nutt D. (Dec 2000). Treatment of depression and concomitant anxiety. Eur Neuropsychopharmacol. 10 Suppl 4:S433-S437. Author weblink.
  • Evans J; Reeves B; Platt H; Leibenau A; Goldman D; Jefferson K; Nutt D. (Nov 2000). Impulsiveness, serotonin genes and repetition of deliberate self-harm (DSH). Psychol Med. 30:1327-1334. Author weblink.
  • Weinstein AM; Feldtkeller BT; Law F; Myles J; Nutt DJ. (Nov 2000). The processing of automatic thoughts of drug use and craving in opiate-dependent individuals. Exp Clin Psychopharmacol. 8:549-553. Author weblink.
  • Finn DP; Lalies MD; Harbuz MS; Hudson AL; Nutt DJ. (1 Oct 2000). Effect of the imidazoline(2) (I-2) site-selective ligand BU224 on in vivo noradrenaline release and plasma corticosterone in control and chronically stressed rats. BRITISH JOURNAL OF PHARMACOLOGY. 131:U17-U17. Author weblink.
  • Tyacke RJ; Robinson ESJ; Hudson AL; Nutt DJ. (1 Oct 2000). In vivo inactivation of imidazoline(2) binding sites by a novel irreversible ligand. BRITISH JOURNAL OF PHARMACOLOGY. 131:U25-U25. Author weblink.
  • Slattery DA; Hudson AL; Nutt DJ. (1 Oct 2000). Inhibition of imidazoline I-2 site binding by potassium channel modulators. BRITISH JOURNAL OF PHARMACOLOGY. 131:U26-U26. Author weblink.
  • Nutt DJ; Price R; Tyacke R; Husbands S; Lewis J; Finn D; Lalies M; Hudson AL. (1 Oct 2000). New approaches to imidazoline receptors. EUROPEAN PSYCHIATRY. 15:280S-280S. Author weblink DOI.
  • Argyropoulos SV; Nutt DJ. (Aug 2000). Substance P antagonists: novel agents in the treatment of depression. Expert Opin Investig Drugs. 9:1871-1875. Author weblink DOI.
  • Hood SD; Argyropoulos SV; Nutt DJ. (1 Jun 2000). Agents in development for anxiety disorders - Current status and future potential. CNS DRUGS. 13:421-431. Author weblink DOI.
  • Potokar J; Nash J; Sandford J; Rich A; Nutt D. (Jun 2000). GABAAbenzodiazepine receptor (GBzR) sensitivity: test-retest reliability in normal volunteers. Hum Psychopharmacol. 15:281-286. Author weblink DOI.
  • Nutt DJ. (1 Jun 2000). New Directions in Anxiety: OCD Spectrum Disorders. CNS SPECTRUMS. 5:32-36. Author weblink.
  • Lingford-Hughes A; Nutt D. (1 May 2000). Alcohol and drug abuse. CURRENT OPINION IN PSYCHIATRY. 13:291-298. Author weblink DOI.
  • Williams K; Argyropoulos S; Nutt DJ. (May 2000). Amphetamine misuse and social phobia. Am J Psychiatry. 157:834-835. Author weblink.
  • Robinson ES; Nutt DJ; Jackson HC; Hudson AL. (May 2000). Behavioural and physiological effects induced by an infusion of antisense to alpha(2D)-adrenoceptors in the rat. Br J Pharmacol. 130:153-159. Author weblink DOI.
  • Daglish MR; Melichar JK; Lingford-Hughes AR; Brooks DJ; Myles JS; Nutt DJ. (1 May 2000). C-11-diprenorphine PET imaging of opioid binding during chronic methadone treatment and early abstinence. JOURNAL OF NUCLEAR MEDICINE. 41:106P-106P. Author weblink.
  • Hume SP; Hirani E; Opacka-Juffry J; Osman S; Myers R; Gunn RN; McCarron JA; Clark RD; et alMelichar J; Nutt DJ; Pike VW. (May 2000). Evaluation of [O-methyl-11C]RS-15385-197 as a positron emission tomography radioligand for central alpha2-adrenoceptors. Eur J Nucl Med. 27:475-484. Author weblink.
  • Wilson SJ; Bell C; Coupland NJ; Nutt DJ. (May 2000). Sleep changes during long-term treatment of depression with fluvoxamine--a home-based study. Psychopharmacology (Berl). 149:360-365. Author weblink.
  • Lingford-Hughes AR; Cunningham VJ; Feeney AJ; Wilson SJ; Gunn RN; Stephenson B; Brooks DJ; Nutt DJ. (1 May 2000). The function of the GABA-benzodiazepine receptor in alcohol dependence. JOURNAL OF NUCLEAR MEDICINE. 41:136P-136P. Author weblink.
  • Evans J; Platts H; Lightman S; Nutt D. (Apr 2000). Impulsiveness and the prolactin response to d-fenfluramine. Psychopharmacology (Berl). 149:147-152. Author weblink.
  • Coates PA; Grundt P; Robinson ES; Nutt DJ; Tyacke R; Hudson AL; Lewis JW; Husbands SM. (20 Mar 2000). Probes for imidazoline binding sites: synthesis and evaluation of a selective, irreversible I2 ligand. Bioorg Med Chem Lett. 10:605-607. Author weblink.
  • Malizia AL; Melichar JK; Rhodes CG; Haida A; Reynolds AH; Jones T; Nutt DJ. (17 Mar 2000). Desipramine binding to noradrenaline reuptake sites in cardiac sympathetic neurons in man in vivo. EUROPEAN JOURNAL OF PHARMACOLOGY. 391:263-267. Author weblink DOI.
  • Potokar JP; Nutt DJ. (Mar 2000). Chest pain: panic attack or heart attack?. Int J Clin Pract. 54:110-114. Author weblink.
  • Anderson IM; Nutt DJ; Deakin JFW. (1 Mar 2000). Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. JOURNAL OF PSYCHOPHARMACOLOGY. 14:3-20. Author weblink.
  • Anderson IM; Nutt DJ; Deakin JF. (Mar 2000). Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. British Association for Psychopharmacology. J Psychopharmacol. 14:3-20. Author weblink.
  • Parker CA; Hudson AL; Nutt DJ; Dillon MP; Eglen RM; Crosby J. (3 Jan 2000). Isolation of RP-HPLC pure clonidine-displacing substance from NG108-15 cells. Eur J Pharmacol. 387:27-30. Author weblink.
  • Ballenger JC; Davidson JR; Lecrubier Y; Nutt DJ; Foa EB; Kessler RC; McFarlane AC; Shalev AY. (2000). Consensus statement on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry. 61 Suppl 5:60-66. Author weblink.
  • Coupland NJ; Bell C; Potokar JP; Dorkins E; Nutt DJ. (2000). Flumazenil challenge in social phobia. Depress Anxiety. 11:27-30. Author weblink.
  • Wilson SJ; Bailey JE; Alford C; Nutt DJ. (2000). Sleep and daytime sleepiness the next day following single night-time dose of fluvoxamine, dothiepin and placebo in normal volunteers. J Psychopharmacol. 14:378-386. Author weblink.
  • Nutt DJ. (2000). The psychobiology of posttraumatic stress disorder. J Clin Psychiatry. 61 Suppl 5:24-29. Author weblink.
  • Potokar J; Lawson C; Wilson S; Nutt D. (15 Dec 1999). Behavioral, neuroendocrine, and cardiovascular response to flumazenil: no evidence for an altered benzodiazepine receptor sensitivity in panic disorder. Biol Psychiatry. 46:1709-1711. Author weblink.
  • Hudson AL; Robinson ES; Lalies MD; Tyacke RJ; Jackson HC; Nutt DJ. (Dec 1999). In vitro and in vivo approaches to the characterization of the alpha2-adrenoceptor. J Auton Pharmacol. 19:311-320. Author weblink.
  • Nutt DJ. (1 Dec 1999). The imaging science of PET. JOURNAL OF PSYCHOPHARMACOLOGY. 13:323-323. Author weblink.
  • Argyropoulos SV; Nutt DJ. (Dec 1999). The use of benzodiazepines in anxiety and other disorders. Eur Neuropsychopharmacol. 9 Suppl 6:S407-S412. Author weblink.
  • Ernst E; Gerada C; Hood S; Nutt D. (Nov 1999). A depressed man requesting St John's wort. Practitioner. 243:779-786. Author weblink.
  • Smith A; Clark R; Nutt D; Haller J; Hayward S; Perry K. (1 Oct 1999). Anti-oxidant vitamins and mental performance of the elderly. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL. 14:459-471. Author weblink DOI.
  • Robinson ES; Nutt DJ; Hall L; Jackson HC; Hudson AL. (Oct 1999). Autoradiographical and behavioural effects of a chronic infusion of antisense to the alpha2D-adrenoceptor in the rat. Br J Pharmacol. 128:515-522. Author weblink DOI.
  • Parker CA; Hudson AL; Nutt DJ; Dillon MP; Eglen RM; Crosby J. (1 Oct 1999). Reverse phase-HPLC analysis of clonidine-displacing substance present in NG108-15 cells. BRITISH JOURNAL OF PHARMACOLOGY. 128:U102-U102. Author weblink.
  • Potokar J; Coupland N; Wilson S; Rich A; Nutt D. (Sep 1999). Assessment of GABA(A)benzodiazepine receptor (GBzR) sensitivity in patients on benzodiazepines. Psychopharmacology (Berl). 146:180-184. Author weblink.
  • Nutt D; Law J. (Sep 1999). Treatment of cluster headache with mirtazapine. Headache. 39:586-587. Author weblink.
  • Parker CA; Hudson AL; Nutt DJ; Dillon MP; Eglen RM; Chan SL; Morgan NG; Crosby J. (6 Aug 1999). Extraction of active clonidine-displacing substance from bovine lung and comparison with clonidine-displacing substance extracted from other tissues. Eur J Pharmacol. 378:213-221. Author weblink.
  • Nutt D. (Aug 1999). Alcohol and the brain. Pharmacological insights for psychiatrists. Br J Psychiatry. 175:114-119. Author weblink.
  • Crofts HS; Muggleton NG; Bowditch AP; Pearce PC; Nutt DJ; Scott EA. (Jul 1999). Home cage presentation of complex discrimination tasks to marmosets and rhesus monkeys. Lab Anim. 33:207-214. Author weblink.
  • Nutt DJ; Forshall S; Bell C; Rich A; Sandford J; Nash J; Argyropoulos S. (Jul 1999). Mechanisms of action of selective serotonin reuptake inhibitors in the treatment of psychiatric disorders. Eur Neuropsychopharmacol. 9 Suppl 3:S81-S86. Author weblink.
  • Tyacke RJ; Nutt DJ; Hudson AL. (21 Jun 1999). Autoradiography of I2 receptors in frog brain. Ann N Y Acad Sci. 881:208-211. Author weblink.
  • Parker CA; Hudson AL; Nutt DJ; Dillon MP; Eglen RM; Crosby J. (21 Jun 1999). Comparison of crude methanolic CDS extracts from various tissues. Ann N Y Acad Sci. 881:92-96. Author weblink.
  • Hudson AL; Luscombe S; Gouch RE; Nutt DJ; Tyacke RJ. (21 Jun 1999). Endogenous indoleamines demonstrate moderate affinity for I2 binding sites. Ann N Y Acad Sci. 881:212-216. Author weblink.
  • Lalies MD; Hibell A; Hudson AL; Nutt DJ. (21 Jun 1999). Inhibition of central monoamine oxidase by imidazoline2 site-selective ligands. Ann N Y Acad Sci. 881:114-117. Author weblink.
  • Hudson AL; Gough R; Tyacke R; Lione L; Lalies M; Lewis J; Husbands S; Knight P; et alMurray F; Hutson P; Nutt DJ. (21 Jun 1999). Novel selective compounds for the investigation of imidazoline receptors. Ann N Y Acad Sci. 881:81-91. Author weblink.
  • Price RE; Luscombe S; Tyacke RJ; Nutt DJ; Hudson AL. (1 Jun 1999). Affinities of beta-carbolines for I-2-binding sites in rabbit brain membranes. BRITISH JOURNAL OF PHARMACOLOGY. 127:U34-U34. Author weblink.
  • Edwards MM; Jackson HC; Nutt DJ; Hudson AL. (1 Jun 1999). Investigation of the affinity of monoamine reuptake inhibitors for rat brain imidazoline 2 binding sites. BRITISH JOURNAL OF PHARMACOLOGY. 127:U33-U33. Author weblink.
  • Finn DP; Harbuz MS; Nutt DJ; Hudson AL. (1 Jun 1999). The effect of idazoxan on corticosterone levels in control and restraint-stressed rats. BRITISH JOURNAL OF PHARMACOLOGY. 127:U51-U51. Author weblink.
  • Parker CA; Hudson AL; Nutt DJ; Dillon MP; Eglen RM; Crosby J. (1 Jun 1999). Tryptophan: A distinct but biologically inactive component of clonidine-displacing substance. BRITISH JOURNAL OF PHARMACOLOGY. 127:U41-U41. Author weblink.
  • Lalies MD; Wilson J; Robinson ESJ; Nutt DJ; Hudson AL. (1 Jun 1999). Unilateral quinolinic acid lesion decreases imidazoline-2 site binding in rat striatum. BRITISH JOURNAL OF PHARMACOLOGY. 127:U34-U34. Author weblink.
  • Robinson ESJ; Nutt DJ; Jackson HC; Hudson AL. (1 Jun 1999). Uptake of fluorescently labelled antisense to alpha 2(A/D)-adrenoceptors into rat brain following i.c.v. injection. BRITISH JOURNAL OF PHARMACOLOGY. 127:U33-U33. Author weblink.
  • Bell C; Nutt D. (May 1999). Paroxetine and its uses in psychiatry. Hosp Med. 60:353-356. Author weblink.
  • Parker CA; Nutt DJ; Hudson AL. (1 Mar 1999). Autoradiographic study of [H-3]mivazerol binding sites in the rat heart following chemical sympathectomy. BRITISH JOURNAL OF PHARMACOLOGY. 126:U58-U58. Author weblink.
  • Hudson AL; Price R; Tyacke RJ; Lalies MD; Parker CA; Nutt DJ. (1 Mar 1999). Harmane, norharmane and tetrahydro beta-carboline have high affinity for rat imidazoline binding sites. BRITISH JOURNAL OF PHARMACOLOGY. 126:U6-U6. Author weblink.
  • Finn DP; Harbuz MS; Nutt DJ; Hudson AL. (1 Mar 1999). The imidazoline(2) (I-2) site-selective ligand BU224 elevates plasma corticosterone in rats. BRITISH JOURNAL OF PHARMACOLOGY. 126:U72-U72. Author weblink.
  • Nutt D. (1 Mar 1999). Traumatic brain injury and post-traumatic stress disorder - Author's reply. BRITISH JOURNAL OF PSYCHIATRY. 174:275-275. Author weblink.
  • Nutt DJ. (1999). Care of depressed patients with anxiety symptoms. J Clin Psychiatry. 60 Suppl 17:23-27. Author weblink.
  • Ballenger JC; Davidson JR; Lecrubier Y; Nutt DJ; Goldberg D; Magruder KM; Schulberg HC; Tylee A; et alWittchen HU. (1999). Consensus statement on the primary care management of depression from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry. 60 Suppl 7:54-61. Author weblink.
  • Smith A; Rich N; Sturgess W; Brice C; Collison C; Bailey J; Wilson S; Nutt D. (1 Jan 1999). Effects of the common cold on subjective alertness, reaction time, and eye movements. JOURNAL OF PSYCHOPHYSIOLOGY. 13:145-151. Author weblink DOI.
  • Chevalier H; Los F; Boichut D; Bianchi M; Nutt DJ; Hajak G; Hetta J; Hoffmann G; et alCrowe C. (1999). Evaluation of severe insomnia in the general population: results of a European multinational survey. J Psychopharmacol. 13:S21-S24. Author weblink.
  • Nutt DJ; Wilson S. (1999). Evaluation of severe insomnia in the general population--implications for the management of insomnia: the UK perspective. J Psychopharmacol. 13:S33-S34. Author weblink.
  • Nutt DJ; Doble A. (1 Jan 1999). Guest Editorial: Ten years of progress in understanding insomnia, 1988 to 1998. JOURNAL OF PSYCHOPHARMACOLOGY. 13:S3-S4. Author weblink.
  • Smith A; Sturgess W; Rich N; Brice C; Collison C; Bailey J; Wilson S; Nutt DJ. (1999). The effects of idazoxan on reaction times, eye movements and the mood of healthy volunteers and patients with upper respiratory tract illnesses. J Psychopharmacol. 13:148-151. Author weblink.
  • Bell CJ; Malizia AL; Nutt DJ. (1999). The neurobiology of social phobia. Eur Arch Psychiatry Clin Neurosci. 249 Suppl 1:S11-S18. Author weblink.
  • Parker CA; Nutt DJ; Hudson AL. (1 Dec 1998). [H-3]clonidine binding sites in rat kidney: A model for putative central imidazoline-1 sites. BRITISH JOURNAL OF PHARMACOLOGY. 125:U39-U39. Author weblink.
  • Robinson ESJ; Nutt DJ; Jackson HC; Hudson AL. (1 Dec 1998). Time course of spontaneous behavioural effects of antisense oligonucleotides targeting the alpha(2D)-adrenoceptor in the rat. BRITISH JOURNAL OF PHARMACOLOGY. 125:U36-U36. Author weblink.
  • Nutt D. (21 Nov 1998). Substance-P antagonists: a new treatment for depression?. Lancet. 352:1644-1646. Author weblink DOI.
  • Dalley JW; Parker CA; Wülfert E; Hudson AL; Nutt DJ. (Oct 1998). Potentiation of barbiturate-induced alterations in presynaptic noradrenergic function in rat frontal cortex by imidazol(in)e alpha2-adrenoceptor agonists. Br J Pharmacol. 125:441-446. Author weblink DOI.
  • Eglen RM; Hudson AL; Kendall DA; Nutt DJ; Morgan NG; Wilson VG; Dillon MP. (Sep 1998). 'Seeing through a glass darkly': casting light on imidazoline 'I' sites. Trends Pharmacol Sci. 19:381-390. Author weblink.
  • Brice CF; Rich N; Smith A; Nutt D. (1 Sep 1998). The effects of caffeine and clonidine on eye movements. INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY. 30:224-224. Author weblink DOI.
  • Malizia AL; Cunningham VJ; Bell CJ; Liddle PF; Jones T; Nutt DJ. (Aug 1998). Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study. Arch Gen Psychiatry. 55:715-720. Author weblink.
  • O'Brien M; Nutt D. (Aug 1998). Loss of consciousness and post-traumatic stress disorder. A clue to aetiology and treatment. Br J Psychiatry. 173:102-104. Author weblink.
  • Nutt D. (1 Aug 1998). National Institute of Drug Abuse Research Monograph Series: Assessing neurotoxicity of drugs of abuse. ADDICTION. 93:1270-1271. Author weblink.
  • Lione LA; Nutt DJ; Hudson AL. (17 Jul 1998). Characterisation and localisation of [3H]2-(2-benzofuranyl)-2-imidazoline binding in rat brain: a selective ligand for imidazoline I2 receptors. Eur J Pharmacol. 353:123-135. Author weblink.
  • Bell CJ; Nutt DJ. (Jun 1998). Serotonin and panic. Br J Psychiatry. 172:465-471. Author weblink.
  • Coupland NJ; Melichar J; Bailey JE; Wilson SJ; Nutt DJ. (15 Apr 1998). Effects of alpha(2)-adrenoceptor agonists and antagonists on saccades. BIOLOGICAL PSYCHIATRY. 43:44S-45S. Author weblink DOI.
  • Carpene C; Hudson D; Marti L; Remaury A; Morin N; Prevot D; Lalies M; Nutt D; et alLafontan M. (1 Jan 1998). Effects of imidazoline I2-ligands on monoamine oxidase in liver and adipocytes: Acute treatment inhibits activity but chronic treatment does not reduce monoamine oxidase expression. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. 358:R555-R555. Author weblink.
  • Carpene C; Hudson D; Marti L; Remaury A; Morin N; Prevot D; Lalies M; Nutt D; et alLafontan M. (1 Jan 1998). Effects of imidazoline I2-ligands on monoamine oxidase in liver and adipocytes: Acute treatment inhibits activity but chronic treatment does not reduce monoamine oxidase expression. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. 358:R556-R556. Author weblink.
  • Nutt DJ. (1998). Antidepressants in panic disorder: clinical and preclinical mechanisms. J Clin Psychiatry. 59 Suppl 8:24-28. Author weblink.
  • Hudson A; Gough R; Nutt D. (1 Jan 1998). Autoradiography of imidazoline-2 binding sites in marmoset forebrain. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. 358:R54-R54. Author weblink.
  • Nutt DJ; Bell CJ; Malizia AL. (1998). Brain mechanisms of social anxiety disorder. J Clin Psychiatry. 59 Suppl 17:4-11. Author weblink.
  • Ballenger JC; Davidson JR; Lecrubier Y; Nutt DJ; Baldwin DS; den Boer JA; Kasper S; Shear MK. (1998). Consensus statement on panic disorder from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry. 59 Suppl 8:47-54. Author weblink.
  • Ballenger JC; Davidson JR; Lecrubier Y; Nutt DJ; Bobes J; Beidel DC; Ono Y; Westenberg HG. (1998). Consensus statement on social anxiety disorder from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry. 59 Suppl 17:54-60. Author weblink.
  • Nutt DJ. (1998). Efficacy of mirtazapine in clinically relevant subgroups of depressed patients. Depress Anxiety. 7 Suppl 1:7-10. Author weblink.
  • Weinstein A; Feldtkeller B; Malizia A; Wilson S; Bailey J; Nutt DJ. (1998). Integrating the cognitive and physiological aspects of craving. J Psychopharmacol. 12:31-38. Author weblink.
  • Bell C; Wilson S; Nutt DJ. (1998). Pindolol augmentation of sertraline in resistant depression and its effect on sleep. J Psychopharmacol. 12:105-107. Author weblink.
  • Nutt D; Johnson FN. (1 Jan 1998). Potential applications of venlafaxine. REVIEWS IN CONTEMPORARY PHARMACOTHERAPY. 9:321-331. Author weblink.
  • Thomas DN; Nutt DJ; Holman RB. (1998). Sertraline, a selective serotonin reuptake inhibitor modulates extracellular noradrenaline in the rat frontal cortex. J Psychopharmacol. 12:366-370. Author weblink.
  • Lione LA; King PD; Nutt DJ; Hunter AJ; Hudson AL. (1 Dec 1997). An autoradiographic study of alpha(2)-adrenoceptors and imidazoline-2 (I-2) receptors in a rat model of permanent middle cerebral artery occlusion. BRITISH JOURNAL OF PHARMACOLOGY. 122:U141-U141. Author weblink.
  • Argyropoulos SV; Nutt DJ. (Dec 1997). Anhedonia and chronic mild stress model in depression. Psychopharmacology (Berl). 134:333-336. Author weblink.
  • Weinstein A; Wilson S; Bailey J; Myles J; Nutt D. (25 Oct 1997). Imagery of craving in opiate addicts undergoing detoxification. Drug Alcohol Depend. 48:25-31. Author weblink.
  • Tyacke RJ; Nutt DJ; Chan SLF; Ramsden CA; Morgan NG; Hudson AL. (1 Oct 1997). Affinities of efaroxan derivatives for alpha(2)-adrenoceptors and I-2-binding sites in rat brain membranes. BRITISH JOURNAL OF PHARMACOLOGY. 122:P66-P66. Author weblink.
  • Lione LA; Nutt DJ; Hudson AL. (1 Oct 1997). Autoradiographical localisation of imidazoline I-2 sites labelled with [H-3]2-(2-benzofuranyl)-2-imidazoline in rabbit brain. BRITISH JOURNAL OF PHARMACOLOGY. 122:P65-P65. Author weblink.
  • Parker CA; Hudson AL; Nutt DJ. (1 Oct 1997). Autoradiography of [H-3]mivazerol binding in the rat heart. BRITISH JOURNAL OF PHARMACOLOGY. 122:P68-P68. Author weblink.
  • Lalies MD; Nutt DJ; Hudson AL. (1 Oct 1997). Chronic clorgyline and deprenyl treatment decrease imidazoline(2) site density in rat interpeduncular nucleus. BRITISH JOURNAL OF PHARMACOLOGY. 122:P67-P67. Author weblink.
  • Hudson AL; Lalies MD; Lione LA; Tyacke RJ; Lewis JW; Nutt DJ. (1 Oct 1997). New ligands for studying imidazoline receptors. BRITISH JOURNAL OF PHARMACOLOGY. 122:P180-P180. Author weblink.
  • Potokar J; Coupland N; Glue P; Groves S; Malizia A; Bailey J; Wilson S; Nutt D. (Sep 1997). Flumazenil in alcohol withdrawal: a double-blind placebo-controlled study. Alcohol Alcohol. 32:605-611. Author weblink.
  • Nutt DJ. (1 Aug 1997). '''Tis a wonder it works at all!''. ADDICTION. 92:958-959. Author weblink DOI.
  • Wilson SJ; Lillywhite AR; Potokar JP; Bell CJ; Nutt DJ. (19 Jul 1997). Adult night terrors and paroxetine. Lancet. 350:185. Author weblink.
  • Coupland NJ; Lillywhite A; Bell CE; Potokar JP; Nutt DJ. (1 May 1997). A pilot controlled study of the effects of flumazenil in posttraumatic stress disorder. Biol Psychiatry. 41:988-990. Author weblink DOI.
  • Coupland NJ; Bailey JE; Potokar JP; Nutt DJ. (Apr 1997). 5-HT3 receptors, nausea, and serotonin reuptake inhibition. J Clin Psychopharmacol. 17:142-143. Author weblink.
  • Evans J; Battersby S; Ogilvie AD; Smith CA; Harmar AJ; Nutt DJ; Goodwin GM. (Apr 1997). Association of short alleles of a VNTR of the serotonin transporter gene with anxiety symptoms in patients presenting after deliberate self harm. Neuropharmacology. 36:439-443. Author weblink.
  • Burrows G; Evans L; Baumhackl U; Hebenstreit H; Katschnig H; Schony W; Scholz H; Wilmotte J; et alCampos J; Costa D; Nardi A; Versiani M; daSilva A; Bowen R; Bradwejn J; Johnston D; Plamondon J; Stein M; Swinson R; Chneiweiss L; Bellaire W; Osterheider M; Sonntag R; Cookson J; Freeman C; Hirsch S; Mullin J; Murray R; Nutt D; Petursson H; ODonoghue F; Min J; Allgulander C; Andersch S; Backa H; Realini R; Siegel JL; Buller R; Katschnig H; Stein MB; Buller R. (1 Apr 1997). Moclobemide in social phobia - A double-blind, placebo-controlled clinical study. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE. 247:71-80. Author weblink.
  • Law FD; Bailey JE; Allen DS; Melichar JK; Myles JS; Mitcheson MC; Lewis JW; Nutt DJ. (1 Apr 1997). The feasibility of abrupt methadone-buprenorphine transfer in British opiate addicts in an outpatient setting. ADDICTION BIOLOGY. 2:191-200. Author weblink DOI.
  • Robinson ESJ; Nutt DJ; Jackson HC; Hudson AL. (1 Mar 1997). alpha(2)-Adrenoceptor binding in rat brain following chronic infusion of a phosphorothioate antisense oligonucleotide to the alpha(2D) subtype. BRITISH JOURNAL OF PHARMACOLOGY. 120:P288-P288. Author weblink.
  • Tyacke RJ; Norton CL; Lewis JW; Nutt DJ; Hudson AL. (1 Mar 1997). Identification of new ligands selective for delta-opioid receptors in guinea-pig brain. BRITISH JOURNAL OF PHARMACOLOGY. 120:P225-P225. Author weblink.
  • Friston KJ; Malizia AL; Wilson S; Cunningham VJ; Jones T; Nutt DJ. (1 Jan 1997). Analysis of dynamic radioligand displacement or ''activation'' studies. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 17:80-93. Author weblink.
  • Coupland N; Wilson S; Nutt D. (1997). Antidepressant drugs and the cardiovascular system: a comparison of tricylics and selective serotonin reuptake inhibitors and their relevance for the treatment of psychiatric patients with cardiovascular problems. J Psychopharmacol. 11:83-92. Author weblink.
  • Robinson ES; Nutt DJ; Jackson HC; Hudson AL. (1997). Antisense oligonucleotides in psychopharmacology and behaviour: promises and pitfalls. J Psychopharmacol. 11:259-269. Author weblink.
  • George DT; Benkelfat C; Rawlings RR; Eckardt MJ; Phillips MJ; Nutt DJ; Wynne D; Murphy DL; et alLinnoila M. (Jan 1997). Behavioral and neuroendocrine responses to m-chlorophenylpiperazine in subtypes of alcoholics and in healthy comparison subjects. Am J Psychiatry. 154:81-87. Author weblink.
  • Malizia AL; Melichar JM; Brown DJ; Gunn RN; Reynolds A; Jones T; Nutt DJ. (1997). Demonstration of clomipramine and venlafaxine occupation at serotonin reuptake sites in man in vivo. J Psychopharmacol. 11:279-281. Author weblink.
  • Nutt DJ. (1 Jan 1997). Editorial: Psychopharmacology of the prefrontal cortex. JOURNAL OF PSYCHOPHARMACOLOGY. 11:98-98. Author weblink DOI.
  • Hudson AL; Chapleo CB; Lewis JW; Husbands S; Grivas K; Mallard NJ; Nutt DJ. (Jan 1997). Identification of ligands selective for central I2-imidazoline binding sites. Neurochem Int. 30:47-53. Author weblink.
  • Nutt D. (1997). Management of patients with depression associated with anxiety symptoms. J Clin Psychiatry. 58 Suppl 8:11-16. Author weblink.
  • Nutt D. (1997). Mirtazapine: pharmacology in relation to adverse effects. Acta Psychiatr Scand Suppl. 391:31-37. Author weblink.
  • Nutt DJ. (1997). Noradrenaline in depression: half a century of progress. J Psychopharmacol. 11:S3. Author weblink.
  • Nutt DJ; Lalies MD; Lione LA; Hudson AL. (1997). Noradrenergic mechanisms in the prefrontal cortex. J Psychopharmacol. 11:163-168. Author weblink.
  • Melichar JK; Malizia AL; Nutt DJ. (1 Jan 1997). Organization of opioid receptors in human brain and drug interactions studied by PET and SPECT imaging: Implications for treatment strategies for opiate addiction. SEMINARS IN NEUROSCIENCE. 9:131-139. Author weblink DOI.
  • Nutt D. (1 Jan 1997). Psychopharmacology: An introduction, 3rd edition - Spiegel,R. BRITISH JOURNAL OF PSYCHIATRY. 170:96-96. Author weblink.
  • Hume SP; Ashworth S; Lammertsma AA; Opacka-Juffry J; Law MP; McCarron JA; Clark RD; Nutt DJ; et alPike VW. (12 Dec 1996). Evaluation in rat of RS-79948-197 as a potential PET ligand for central alpha 2-adrenoceptors. Eur J Pharmacol. 317:67-73. Author weblink.
  • Dalley FA; Parker CA; Hudson AL; Nutt DJ. (1 Oct 1996). Synergistic suppression of extracellular noradrenaline content in the rat forebrain by sodium pentobarbitone and alpha(2)-adrenoceptor agonists. BRITISH JOURNAL OF PHARMACOLOGY. 119:P38-P38. Author weblink.
  • Lione LA; Hudson AL; Nutt DJ; Rogers DC; Davey PT; Hunter AJ. (1 Oct 1996). The effects of tacrine and the imidazoline 2 site ligand BU224 in the rat delayed T maze. BRITISH JOURNAL OF PHARMACOLOGY. 119:P205-P205. Author weblink.
  • Hudson AL; Bundey R; Nutt DJ; Tyacke RJ. (1 Oct 1996). The identification of putative imidazoline(2) binding sites in frog brain. BRITISH JOURNAL OF PHARMACOLOGY. 119:P39-P39. Author weblink.
  • Altman J; Everitt BJ; Glautier S; Markou A; Nutt D; Oretti R; Phillips GD; Robbins TW. (Jun 1996). The biological, social and clinical bases of drug addiction: commentary and debate. Psychopharmacology (Berl). 125:285-345. Author weblink.
  • Lione LA; Nutt DJ; Hudson AL. (23 May 1996). [3H]2-(2-benzofuranyl)-2-imidazoline: a new selective high affinity radioligand for the study of rabbit brain imidazoline I2 receptors. Eur J Pharmacol. 304:221-229. Author weblink.
  • Reynolds GP; Boulton RM; Pearson SJ; Hudson AL; Nutt DJ. (22 Apr 1996). Imidazoline binding sites in Huntington's and Parkinson's disease putamen. Eur J Pharmacol. 301:R19-R21. Author weblink.
  • Lione LA; Nutt DJ; Hudson AL. (1 Apr 1996). Affinity and selectivity of BU224 and BU239 for rat and guinea-pig brain I-2 imidazoline sites. BRITISH JOURNAL OF PHARMACOLOGY. 117:P297-P297. Author weblink.
  • Lalies MD; Husband C; Dalley JW; Nutt DJ; Hudson AL. (1 Apr 1996). An investigation of the effect of imidazoline(2)-site selective compounds 2-BFI and BU224 on [H-3]noradrenaline uptake in rat brain slices. BRITISH JOURNAL OF PHARMACOLOGY. 117:P341-P341. Author weblink.
  • Mirza NR; Jackson HC; Dickinson SL; Nutt DJ. (1 Apr 1996). Effect of the I-2-ligand 2-BFI on passive avoidance performance in the rat. BRITISH JOURNAL OF PHARMACOLOGY. 117:P177-P177. Author weblink.
  • Smith A; Nutt D. (28 Mar 1996). Noradrenaline and attention lapses. Nature. 380:291. Author weblink DOI.
  • Coupland N; Malizia A; Bailey J; Nutt D. (15 Mar 1996). Thyrotropin-releasing hormone: a potential comparator for the panicogenic effects of pentagastrin and CCK?. Biol Psychiatry. 39:465-466. Author weblink.
  • Nutt DJ; Pinder RM. (1 Jan 1996). alpha(2)-Adrenoceptors and depression. JOURNAL OF PSYCHOPHARMACOLOGY. 10:35-42. Author weblink.
  • Coupland NJ; Wilson SJ; Nutt DJ. (1 Jan 1996). alpha(2)-Adrenoceptors in panic and anxiety disorders. JOURNAL OF PSYCHOPHARMACOLOGY. 10:26-34. Author weblink.
  • Montgomery SA; Bakish D; Buller R; Gjerris A; Katschnig H; Lecrubier Y; Lepine JP; Mauri M; et alSartorius N; Cameron A; Cassano G; Costa e Silva J; den Boer JA; Freeman C; von Knorring L; Loo H; Nutt D; Rosenberg R. (Mar 1996). ECNP position paper on social phobia proceedings from an ECNP workshop in Jerusalem, October 1994. Eur Neuropsychopharmacol. 6:77-83. Author weblink.
  • Tolchard S; Hare AS; Nutt DJ; Clarke G. (Mar 1996). TNF alpha mimics the endocrine but not the thermoregulatory responses of bacterial lipopolysaccharide (LPS): correlation with FOS-expression in the brain. Neuropharmacology. 35:243-248. Author weblink.
  • Harley CW; Lalies MD; Nutt DJ. (26 Feb 1996). Estimating the synaptic concentration of norepinephrine in dentate gyrus which produces beta-receptor mediated long-lasting potentiation in vivo using microdialysis and intracerebroventricular norepinephrine. Brain Res. 710:293-298. Author weblink.
  • Nutt DJ. (21 Feb 1996). The psychopharmacology of anxiety. Br J Hosp Med. 55:187-191. Author weblink.
  • Nutt DJ. (6 Jan 1996). Addiction: brain mechanisms and their treatment implications. Lancet. 347:31-36. Author weblink.
  • Malizia AL; Gunn RN; Wilson SJ; Waters SH; Bloomfield PM; Cunningham VJ; Nutt DJ. (1 Jan 1996). Benzodiazepine site pharmacokinetic/pharmacodynamic quantification in man: Direct measurement of drug occupancy and effects on the human brain in vivo. NEUROPHARMACOLOGY. 35:1483-1491. Author weblink DOI.
  • Weinstein AM; Neal L; Lillywhite A; Potokar J; Nutt DJ. (1996). Cognitive processing in post-traumatic stress disorder. Anxiety. 2:130-139. Author weblink DOI.
  • Jordan S; Jackson HC; Nutt DJ; Handley SL. (1 Jan 1996). Discriminative stimulus produced by the imidazoline I-2 site ligand, 2-BFI. JOURNAL OF PSYCHOPHARMACOLOGY. 10:273-278. Author weblink DOI.
  • Nutt D. (1 Jan 1996). Early action of nefazodone in anxiety associated with depression. JOURNAL OF PSYCHOPHARMACOLOGY. 10:18-21. Author weblink.
  • Potokar J; Nutt D. (1 Jan 1996). Psychopharmacology. CURRENT OPINION IN PSYCHIATRY. 9:98-104. Author weblink DOI.
  • Nutt DJ. (1 Jan 1996). Psychopharmacology of social communication. JOURNAL OF PSYCHOPHARMACOLOGY. 10:1-1. Author weblink DOI.
  • Kalueff A; Nutt DJ. (1996). Role of GABA in memory and anxiety. Depress Anxiety. 4:100-110. Author weblink DOI.
  • Weinstein A; Wilson S; Bailey J; Nutt D. (1 Jan 1996). Sedative antidepressants impair visual detection mechanisms in humans. JOURNAL OF PSYCHOPHARMACOLOGY. 10:141-145. Author weblink DOI.
  • SITHERS AJ; NUTT DJ; HUDSON AL. (1 Dec 1995). BINDING OF THE NOVEL ALPHA(2)-ADRENOCEPTOR AGONIST [H-3] MIVAZEROL - COMPARISON WITH [H-3] CLONIDINE. BRITISH JOURNAL OF PHARMACOLOGY. 116:P439-P439. Author weblink.
  • BAINES IA; BOWEN WP; DAYANANDAN R; HUDSON AL; NUTT DJ; MEDHURST AD; HUNTER AJ. (1 Dec 1995). BU-224 AND 2-BFI HAVE HIGH-AFFINITY FOR 2 DIFFERENT IMIDAZOLINE SITES (I-SITES) IN THE RABBIT. BRITISH JOURNAL OF PHARMACOLOGY. 116:P374-P374. Author weblink.
  • MEDHURST AD; BAINES IA; BOWEN WP; HUDSON AL; NUTT DJ; HUNTER AJ. (1 Dec 1995). BU-224, 2-BFI, CIRAZOLINE AND IDAZOXAN SHOW SPECIES-DIFFERENCES FOR PUTATNE IMIDAZOLINE SITES (I-SITES) IN KIDNEY CORTEX. BRITISH JOURNAL OF PHARMACOLOGY. 116:P373-P373. Author weblink.
  • LIONE LA; NUTT DJ; HUDSON AL. (1 Dec 1995). CHARACTERIZATION AND AUTORADIOGRAPHICAL LOCALIZATION OF IMIDAZOLINE-2 (I-2) SITES LABELED BY [(3)H]2-(-2-BENZOFURANYL)-2-IMIDAZOLINE IN RAT-BRAIN. BRITISH JOURNAL OF PHARMACOLOGY. 116:P338-P338. Author weblink.
  • Coupland NJ; Wilson SJ; Potokar JP; Bell CE; Bailey JE; Nutt DJ. (Nov 1995). A comparison of the effects of phenelzine treatment with moclobemide treatment on cardiovascular reflexes. Int Clin Psychopharmacol. 10:229-238. Author weblink.
  • TOLCHARD S; HARE AS; NUTT D; CLARKE G. (1 Nov 1995). THE INVOLVEMENT OF MEDULLARY CATECHOLAMINERGIC NEURONS IN THE INTERACTION OF THE IMMUNE AND CENTRAL NERVOUS SYSTEMS. JOURNAL OF PHYSIOLOGY-LONDON. 489P:P176-P177. Author weblink.
  • DALLEY JW; TOLCHARD S; LALIES MD; NUTT DJ. (1 Oct 1995). ACTIVATION OF RAT LOCUS-COERULEUS NEURONS BY HALOTHANE - A REGIONAL EVALUATION OF TERMINAL NORADRENALINE OVERFLOW AND FOS PROTEIN IMMUNOREACTIVITY. BRITISH JOURNAL OF PHARMACOLOGY. 116:P100-P100. Author weblink.
  • LIONE LA; HUDSON AL; NUTT DJ; ROGERS DC; HUNTER AJ. (1 Oct 1995). BU224, A HIGH-AFFINITY SELECTIVE I-2 IMIDAZOLINE SITE LIGAND - A BEHAVIORAL-STUDY IN MODELS OF SPATIAL-LEARNING AND MEMORY. BRITISH JOURNAL OF PHARMACOLOGY. 116:P133-P133. Author weblink.
  • Coupland NJ; Bailey JE; Glue P; Nutt DJ. (Sep 1995). The cardiovascular and subjective effects of thyrotropin releasing hormone (TRH) and a stable analogue, dimethyl proline-TRH, in healthy volunteers. Br J Clin Pharmacol. 40:223-229. Author weblink.
  • COUPLAND N; NUTT D. (1 Aug 1995). SUCCESSFUL TREATMENT OF TARDIVE OCULOGYRIC SPASMS WITH VITAMIN-E. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY. 15:285-286. Author weblink DOI.
  • Nutt DJ; French N; Handley S; Hudson A; Husbands S; Jackson H; Jordan S; Lalies MD; et alLewis J; Lione L. (12 Jul 1995). Functional studies of specific imidazoline-2 receptor ligands. Ann N Y Acad Sci. 763:125-139. Author weblink.
  • JACKSON HC; GRIFFIN IJ; NUTT DJ. (1 Jul 1995). EFFECTS OF IMIDAZOLINE(2) (I-2) SITE LIGANDS ON FOOD AND WATER-INTAKE IN THE RAT. BRITISH JOURNAL OF PHARMACOLOGY. 115:P90-P90. Author weblink.
  • MALIZIA AL; NUTT DJ. (1 Jul 1995). PSYCHOPHARMACOLOGY OF BENZODIAZEPINES - AN UPDATE. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL. 10:S1-S14. Author weblink DOI.
  • French N; Lalies MD; Nutt DJ; Pratt JA. (Jun 1995). Idazoxan-induced reductions in cortical glucose use are accompanied by an increase in noradrenaline release: complementary [14C]2-deoxyglucose and microdialysis studies. Neuropharmacology. 34:605-613. Author weblink.
  • Coupland NJ; Bailey JE; Wilson SJ; Horvath R; Nutt D. (Jun 1995). The effects of clonidine on cardiovascular responses to standing in healthy volunteers. Clin Auton Res. 5:171-177. Author weblink.
  • Malizia AL; Nutt DJ. (Jun 1995). The effects of flumazenil in neuropsychiatric disorders. Clin Neuropharmacol. 18:215-232. Author weblink.
  • George DT; Lindquist T; Nutt DJ; Ragan PW; Alim T; McFarlane V; Leviss J; Eckardt MJ; et alLinnoila M. (May 1995). Effect of chloride or glucose on the incidence of lactate-induced panic attacks. Am J Psychiatry. 152:692-697. Author weblink.
  • LIONE LA; NUTT DJ; LEWIS J; HUNTER J; TOWERS P; HUDSON AL. (1 Apr 1995). [H-3] 2-(-2-BENZO-FURANYL)-2-IMIDAZOLINE - A NEW RADIOLIGAND FOR THE STUDY OF RABBIT BRAIN NON-ADRENOCEPTOR IDAZOXAN BINDING-SITES (I2-SITES). BRITISH JOURNAL OF PHARMACOLOGY. 114:P412-P412. Author weblink.
  • FRENCH N; NUTT DJ; PRATT JA. (1 Apr 1995). 2-(2-BENZO-FURANYL)-2-IMIDAZOLINE-INDUCED ALTERATIONS IN LOCAL CEREBRAL GLUCOSE-UTILIZATION. BRITISH JOURNAL OF PHARMACOLOGY. 114:P408-P408. Author weblink.
  • HUDSON AL; MALLARD NJ; NUTT DJ; CHAPLEO CB. (1 Apr 1995). AFFINITY AND SELECTIVITY OF 2-(-2-BENZO-FURANYL)-2-IMIDAZOLINE FOR MAMMALIAN BRAIN NON-ADRENOCEPTOR IDAZOXAN BINDING-SITES (I2-SITES). BRITISH JOURNAL OF PHARMACOLOGY. 114:P411-P411. Author weblink.
  • LALIES MD; NUTT DJ. (1 Apr 1995). THE EFFECT OF A SELECTIVE I2-SITE LIGAND, 2-(-2-BENZOFURANYL)-2-IMIDAZOLINE, ON IN-VIVO NORADRENALINE RELEASE IN RAT-BRAIN. BRITISH JOURNAL OF PHARMACOLOGY. 114:P413-P413. Author weblink.
  • Carpéné C; Collon P; Remaury A; Cordi A; Hudson A; Nutt D; Lafontan M. (Feb 1995). Inhibition of amine oxidase activity by derivatives that recognize imidazoline I2 sites. J Pharmacol Exp Ther. 272:681-688. Author weblink.
  • George DT; Nutt DJ; Rawlings RR; Phillips MJ; Eckardt MJ; Potter WZ; Linnoila M. (15 Jan 1995). Behavioral and endocrine responses to clomipramine in panic disorder patients with or without alcoholism. Biol Psychiatry. 37:112-119. Author weblink DOI.
  • WEINSTEIN AM; NUTT DJ. (1 Jan 1995). A COGNITIVE DYSFUNCTION IN ANXIETY AND ITS AMELIORATION BY EFFECTIVE TREATMENT WITH SSRIS. JOURNAL OF PSYCHOPHARMACOLOGY. 9:83-89. Author weblink DOI.
  • Malizia A; Forse F; Haida A; Gunn R; Melichar J; Poole K; Bateman D; Fahy D; et alSchnorr L; Brown D; Rhodes C; Nutt DJ; Jones T. (1 Jan 1995). A new human (psycho)pharmacology tool: The multiple organs coincidences counter (MOCC). JOURNAL OF PSYCHOPHARMACOLOGY. 9:294-306. Author weblink DOI.
  • Malizia AL; Coupland NJ; Nutt DJ. (1995). Benzodiazepine receptor function in anxiety disorders. Adv Biochem Psychopharmacol. 48:115-133. Author weblink.
  • JORDAN S; JACKSON HC; NUTT DJ; HANDLEY SL. (1 Jan 1995). DISCRIMINATIVE STIMULUS PROPERTIES OF ETHOXY IDAZOXAN. JOURNAL OF PSYCHOPHARMACOLOGY. 9:228-233. Author weblink DOI.
  • NUTT DJ. (1 Jan 1995). EDITORIAL - VENLAFAXINE - THE YIN AND YANG OF ANTIDEPRESSANTS. JOURNAL OF PSYCHOPHARMACOLOGY. 9:205-206. Author weblink DOI.
  • NUTT D. (1 Jan 1995). NEW APPROACHES TO ALCOHOL-WITHDRAWAL. JOURNAL OF PSYCHOPHARMACOLOGY. 9:75-75. Author weblink.
  • Nutt DJ. (1 Jan 1995). Psychopharmacological imaging. JOURNAL OF PSYCHOPHARMACOLOGY. 9:293-293. Author weblink DOI.
  • BAILEY JE; POTOKAR J; COUPLAND N; NUTT DJ. (1 Jan 1995). THE 5-HT3 ANTAGONIST ONDANSETRON REDUCES GASTROINTESTINAL SIDE-EFFECTS INDUCED BY A SPECIFIC SEROTONIN REUPTAKE INHIBITOR IN MAN. JOURNAL OF PSYCHOPHARMACOLOGY. 9:137-141. Author weblink DOI.
  • NUTT D. (1 Jan 1995). THE ANXIETY FACTOR IN DEPRESSION. JOURNAL OF PSYCHOPHARMACOLOGY. 9:185-189. Author weblink.
  • GLUE P; WILSON S; COUPLAND N; BALL D; NUTT D. (1 Jan 1995). THE RELATIONSHIP BETWEEN BENZODIAZEPINE RECEPTOR SENSITIVITY AND NEUROTICISM. JOURNAL OF ANXIETY DISORDERS. 9:33-45. Author weblink DOI.
  • Nutt DJ; Wilson SJ; Coupland NJ. (Jan 1995). Use of selective serotonin reuptake inhibitors and other serotonergic drugs in the biological dissection of affective disorders. Int Clin Psychopharmacol. 9 Suppl 4:53-59. Author weblink.
  • Nutt DJ. (1 Jan 1995). Venlaxine: The yin and yang of antidepressants (vol 9, pg 205, 1995). JOURNAL OF PSYCHOPHARMACOLOGY. 9:402-402. Author weblink DOI.
  • WILSON SW; LILLYWHITE AR; NUTT DJ. (1 Dec 1994). NIGHT TERRORS - REPLY. BRITISH JOURNAL OF PSYCHIATRY. 165:835-835. Author weblink.
  • Coupland NJ; Bailey JE; Wilson SJ; Potter WZ; Nutt DJ. (Oct 1994). A pharmacodynamic study of the alpha 2-adrenergic receptor antagonist ethoxyidazoxan in healthy volunteers. Clin Pharmacol Ther. 56:420-429. Author weblink.
  • Thomas DN; Nutt D; Holman RB. (11 Aug 1994). Regionally specific changes in extracellular noradrenaline following chronic idazoxan as revealed by in vivo microdialysis. Eur J Pharmacol. 261:53-57. Author weblink.
  • Smith J; Williams K; Birkett S; Nicholson H; Glue P; Nutt DJ. (Aug 1994). Neuroendocrine and clinical effects of electroconvulsive therapy and their relationship to treatment outcome. Psychol Med. 24:547-555. Author weblink.
  • Arnott S; Nutt D. (Jun 1994). Successful treatment of fluvoxamine-induced anorgasmia by cyproheptadine. Br J Psychiatry. 164:838-839. Author weblink.
  • HUDSON AL; HUSBANDS S; LEWIS JW; NUTT DJ. (1 May 1994). AFFINITY AND SELECTIVITY OF BU224 AND BU239 FOR RABBIT BRAIN NON-ADRENOCEPTOR IDAZOXAN BINDING-SITES (I-2-SITES). BRITISH JOURNAL OF PHARMACOLOGY. 112:U162-U162. Author weblink.
  • POTOKAR J; NUTT DJ. (1 Apr 1994). ANXIOLYTIC POTENTIAL OF BENZODIAZEPINE RECEPTOR PARTIAL AGONISTS. CNS DRUGS. 1:305-315. Author weblink.
  • Lillywhite AR; Wilson SJ; Nutt DJ. (Apr 1994). Successful treatment of night terrors and somnambulism with paroxetine. Br J Psychiatry. 164:551-554. Author weblink.
  • FRENCH N; LALIES MD; NUTT DJ; PRATT JA. (1 Jan 1994). A COMPARISON OF THE EFFECT OF IDAZOXAN ON NORADRENALINE RELEASE IN FREELY-MOVING AND PARTIALLY RESTRAINED RATS. BRITISH JOURNAL OF PHARMACOLOGY. 111:P296-P296. Author weblink.
  • NUTT DJ; PETERS TJ. (1 Jan 1994). ALCOHOL - THE DRUG. BRITISH MEDICAL BULLETIN. 50:5-17. Author weblink.
  • Nutt DJ; Peters TJ. (Jan 1994). Alcohol: the drug. Br Med Bull. 50:5-17. Author weblink.
  • NUTT D. (1 Jan 1994). NEW APPROACHES TO DRUG DEPENDENCY. JOURNAL OF PSYCHOPHARMACOLOGY. 8:68-68. Author weblink DOI.
  • NUTT D. (1 Jan 1994). PSYCHOTROPIC-DRUG DEVELOPMENT - SOCIAL, SCIENTIFIC AND ECONOMIC-ISSUES BAP AUTUMN MEETING, NOVEMBER 1993. JOURNAL OF PSYCHOPHARMACOLOGY. 8:136-138. Author weblink DOI.
  • NUTT DJ. (1 Jan 1994). PUTTING THE A IN ATYPICAL - DOES ALPHA(2)-ADRENOCEPTOR ANTAGONISM ACCOUNT FOR THE THERAPEUTIC ADVANTAGE OF NEW ANTIPSYCHOTICS. JOURNAL OF PSYCHOPHARMACOLOGY. 8:193-195. Author weblink DOI.
  • MONTGOMERY SA; HENRY J; MCDONALD G; DINAN T; LADER M; HINDMARCH I; CLARE A; NUTT D. (1 Dec 1994). SELECTIVE SEROTONIN REUPTAKE INHIBITORS - METAANALYSIS OF DISCONTINUATION RATES (VOL 9, PG 50, 1994). INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY. 9:U1-U1. Author weblink.
  • Montgomery SA; Henry J; McDonald G; Dinan T; Lader M; Hindmarch I; Clare A; Nutt D. (1994). Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates. Int Clin Psychopharmacol. 9:47-53. Author weblink.
  • ALLEN D; HORVATH R; NUTT D. (1 Sep 1993). ANTIDEPRESSANTS AND MANIA - TO STOP OR NOT TO STOP. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL. 8:357-360. Author weblink DOI.
  • LALIES MD; NUTT DJ. (1 Jul 1993). A MICRODIALYSIS STUDY OF THE NEUROCHEMICAL EFFECTS IN RAT STRIATUM OF RX821039, A SELECTIVE LIGAND FOR NON-ADRENOCEPTOR IDAZOXAN BINDING-SITES. BRITISH JOURNAL OF PHARMACOLOGY. 109:P85-P85. Author weblink.
  • Jackson HC; Nutt DJ. (Jul 1993). A single preexposure produces sensitization to the locomotor effects of cocaine in mice. Pharmacol Biochem Behav. 45:733-735. Author weblink.
  • Jackson HC; Griffin IJ; Nutt DJ. (Jul 1993). Buprenorphine-cocaine interactions in mice: effect on locomotor activity and hole-dipping behaviour. J Pharm Pharmacol. 45:636-640. Author weblink.
  • HUDSON AL; NUTT DJ; LEWIS JW; MALLARD NJ; CHAPLEO CB. (1 Jul 1993). NEW 2-IODO SUBSTITUTED DERIVATIVES OF IDAZOXAN WITH HIGH-AFFINITY FOR MAMMALIAN ALPHA(2)-ADRENOCEPTORS. BRITISH JOURNAL OF PHARMACOLOGY. 109:P24-P24. Author weblink.
  • Pike VW; Halldin C; Crouzel C; Barré L; Nutt DJ; Osman S; Shah F; Turton DR; et alWaters SL. (May 1993). Radioligands for PET studies of central benzodiazepine receptors and PK (peripheral benzodiazepine) binding sites--current status. Nucl Med Biol. 20:503-525. Author weblink.
  • PIKE VW; HALLDIN C; CROUZEL C; BARRE L; NUTT DJ; OSMAN S; SHAH F; TURTON DR; et alWATERS SL. (1 May 1993). RADIOLIGANDS FOR PET STUDIES OF CENTRAL BENZODIAZEPINE RECEPTORS AND PK (PERIPHERAL BENZODIAZEPINE) BINDING-SITES - CURRENT STATUS. NUCLEAR MEDICINE AND BIOLOGY. 20:503-525. Author weblink DOI.
  • Nutt DJ. (Apr 1993). The approach to new anxiolytics. J Pharm Pharmacol. 45 Suppl 1:352-354. Author weblink.
  • Jordan S; Jackson HC; Nutt DJ; Handley SL. (1993). Central alpha-2 adrenoceptors are responsible for a clonidine-induced cue in a rat drug discrimination paradigm. Psychopharmacology (Berl). 110:209-212. Author weblink.
  • ALLEN D; NUTT D. (1 Jan 1993). COEXISTENCE OF PANIC DISORDER AND SLEEP PARALYSIS. JOURNAL OF PSYCHOPHARMACOLOGY. 7:293-294. Author weblink DOI.
  • Nutt D; Glue P; Wilson S; Groves S; Coupland N; Bailey J. (1993). Flumazenil in alcohol withdrawal. Alcohol Alcohol Suppl. 2:337-341. Author weblink.
  • Jackson HC; Nutt DJ. (1993). Investigation of the involvement of opioid receptors in the action of anticonvulsants. Psychopharmacology (Berl). 111:486-490. Author weblink.
  • Wilson SJ; Glue P; Ball D; Nutt DJ. (Jan 1993). Saccadic eye movement parameters in normal subjects. Electroencephalogr Clin Neurophysiol. 86:69-74. Author weblink.
  • NUTT DJ; DEAKIN JFW; CROW TJ. (1 Jan 1993). THE PSYCHOPHARMACOLOGY OF SOCIAL COMMUNICATION AND ITS DISORDERS. JOURNAL OF PSYCHOPHARMACOLOGY. 7:226-229. Author weblink DOI.
  • Jackson HC; Nutt DJ. (Nov 1992). Are 5-HT receptors or beta-adrenoceptors involved in idazoxan-induced food and water intake?. Neuropharmacology. 31:1081-1087. Author weblink.
  • Hume SP; Lammertsma AA; Opacka-Juffry J; Ahier RG; Myers R; Cremer JE; Hudson AL; Nutt DJ; et alPike VW. (Nov 1992). Quantification of in vivo binding of [3H]RX 821002 in rat brain: evaluation as a radioligand for central alpha 2-adrenoceptors. Int J Rad Appl Instrum B. 19:841-849. Author weblink.
  • Jackson HC; Nutt DJ. (20 Oct 1992). Effects of benzodiazepine receptor inverse agonists on locomotor activity and exploration in mice. Eur J Pharmacol. 221:199-203. Author weblink.
  • Mallard NJ; Hudson AL; Nutt DJ. (Aug 1992). Characterization and autoradiographical localization of non-adrenoceptor idazoxan binding sites in the rat brain. Br J Pharmacol. 106:1019-1027. Author weblink.
  • Jackson HC; Griffin IJ; Nutt DJ. (Aug 1992). Endogenous opioids may be involved in idazoxan-induced food intake. Neuropharmacology. 31:771-776. Author weblink.
  • Jackson HC; Ramsay E; Nutt DJ. (Jul 1992). Attenuation of the behavioural effects of ethanol in mice by des-enkephalin-gamma-endorphin (ORG 5878). Alcohol Alcohol. 27:373-379. Author weblink.
  • JORDAN S; JACKSON HC; NUTT DJ; HANDLEY SL. (1 Jul 1992). THE DISCRIMINATORY STIMULUS (CUE) TO CLONIDINE APPEARS TO BE MEDIATED BY ITS ALPHA-2-ADRENOCEPTOR AGONIST PROPERTIES. BRITISH JOURNAL OF PHARMACOLOGY. 106:P131-P131. Author weblink.
  • Williams K; Smith J; Glue P; Nutt D. (Jul 1992). The effects of electroconvulsive therapy on plasma insulin and glucose in depression. Br J Psychiatry. 161:94-98. Author weblink.
  • Thomas DN; Nutt DJ; Holman RB. (Jun 1992). Effects of acute and chronic electroconvulsive shock on noradrenaline release in the rat hippocampus and frontal cortex. Br J Pharmacol. 106:430-434. Author weblink.
  • Jackson HC; Griffin IJ; Birkett SD; Nutt DJ. (Jun 1992). The effects of idazoxan and other alpha 2-adrenoceptor antagonists on urine output in the rat. Br J Pharmacol. 106:443-446. Author weblink.
  • Jackson HC; Ramsay E; Nutt DJ. (27 May 1992). Effect of the cyclopyrrolones suriclone and RP 59037 on body temperature in mice. Eur J Pharmacol. 216:23-27. Author weblink.
  • Glue P; Wilson S; Campling GM; Knightly M; Franklin M; Cowen PJ; Nutt DJ. (May 1992). Alpha-2-adrenoceptor control of cortisol and ACTH in normal volunteers: preliminary open trial of the effects of acute and chronic idazoxan. Psychoneuroendocrinology. 17:261-266. Author weblink.
  • NUTT DJ; GLUE P; WILSON S. (1 Apr 1992). CHRONIC USE OF ALCOHOL AND OR BENZODIAZEPINES MAY ACCOUNT FOR EVIDENCE OF ALTERED BENZODIAZEPINE RECEPTOR SENSITIVITY IN PANIC DISORDER - REPLY. ARCHIVES OF GENERAL PSYCHIATRY. 49:330-331. Author weblink.
  • Nutt D; Lawson C. (Feb 1992). Panic attacks. A neurochemical overview of models and mechanisms. Br J Psychiatry. 160:165-178. Author weblink.
  • NUTT DJ; GROVES S. (1 Jan 1992). A DOUBLE-BLIND COMPARISON OF ACUTE BUPRENORPHINE WITH PLACEBO IN SCHIZOPHRENIA. SCHIZOPHRENIA RESEARCH. 6:113-113. Author weblink DOI.
  • Jackson HC; Griffin IJ; Nutt DJ. (1992). Alpha 2-adrenoceptor antagonists block the stimulant effects of cocaine in mice. Life Sci. 50:PL155-PL159. Author weblink.
  • Coupland N; Glue P; Nutt DJ. (1992). Challenge tests: assessment of the noradrenergic and GABA systems in depression and anxiety disorders. Mol Aspects Med. 13:221-247. Author weblink.
  • Nutt DJ; Glue P; Wilson S; Coupland N; Lillywhite A. (1992). Clinical correlates of benzodiazepine receptor function. Clin Neuropharmacol. 15 Suppl 1 Pt A:679A-680A. Author weblink.
  • WILSON S; GLUE P; NUTT D. (1 Jan 1992). FLUMAZENIL AND SACCADIC EYE-MOVEMENTS IN PATIENTS WITH PANIC DISORDER AND NORMAL CONTROLS. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL. 7:45-50. Author weblink DOI.
  • Nutt DJ; Smith CF; Bennett R; Jackson HC. (1992). Investigations on the "set-point" theory of benzodiazepine receptor function. Adv Biochem Psychopharmacol. 47:419-429. Author weblink.
  • NUTT DJ; SMITH CF; BENNETT R; JACKSON HC. (1 Jan 1992). INVESTIGATIONS ON THE SET-POINT THEORY OF BENZODIAZEPINE RECEPTOR FUNCTION. ADVANCES IN BIOCHEMICAL PSYCHOPHARMACOLOGY. 47:419-429. Author weblink.
  • Nutt DJ. (1992). Pharmacoendocrine studies in anxiety. Clin Neuropharmacol. 15 Suppl 1 Pt A:214A-215A. Author weblink.
  • Jackson HC; Nutt DJ. (1992). Strain differences in sensitivity to the hypothermic effects of benzodiazepine receptor ligands in mice. Psychopharmacology (Berl). 109:365-368. Author weblink.
  • Glue P; Bailey J; Wilson S; Hudson A; Nutt DJ. (1992). Thyrotropin-releasing hormone selectively reverses lorazepam-induced sedation but not slowing of saccadic eye movements. Life Sci. 50:PL25-PL30. Author weblink.
  • Lamparski DM; Roy A; Nutt DJ; Linnoila M. (Dec 1991). The criteria of Cloninger et al. and von Knorring et al. for subgrouping alcoholics: a comparison in a clinical population. Acta Psychiatr Scand. 84:497-502. Author weblink.
  • Jackson HC; Nutt DJ. (26 Nov 1991). Comparison of the effects of benzodiazepine and beta-carboline inverse agonists on body temperature in mice. Eur J Pharmacol. 205:213-216. Author weblink.
  • NUTT D. (1 Oct 1991). STRESSORS AND THE ADJUSTMENT DISORDERS - NOSHPITZ,JD, CODDINGTON,RD. STRESS MEDICINE. 7:261-261. Author weblink DOI.
  • Jackson HC; Nutt DJ. (Sep 1991). Investigation of the different types of opioid receptor involved in electroconvulsive shock-induced antinociception and catalepsy in the rat. J Pharm Pharmacol. 43:640-643. Author weblink.
  • Jackson HC; Griffin IJ; Nutt DJ. (Sep 1991). The effects of idazoxan and other alpha 2-adrenoceptor antagonists on food and water intake in the rat. Br J Pharmacol. 104:258-262. Author weblink.
  • Adinoff B; Risher-Flowers D; De Jong J; Ravitz B; Bone GH; Nutt DJ; Roehrich L; Martin PR; et alLinnoila M. (Aug 1991). Disturbances of hypothalamic-pituitary-adrenal axis functioning during ethanol withdrawal in six men. Am J Psychiatry. 148:1023-1025. Author weblink.
  • Jackson HC; Ripley TL; Dickinson SL; Nutt DJ. (Jul 1991). Anticonvulsant activity of the imidazoline 6,7-benzoidazoxan. Epilepsy Res. 9:121-126. Author weblink.
  • Jackson HC; Nutt DJ. (May 1991). Inhibition of baclofen-induced hypothermia in mice by the novel GABAB antagonist CGP 35348. Neuropharmacology. 30:535-538. Author weblink.
  • Benkelfat C; Murphy DL; Hill JL; George DT; Nutt D; Linnoila M. (Apr 1991). Ethanollike properties of the serotonergic partial agonist m-chlorophenylpiperazine in chronic alcoholic patients. Arch Gen Psychiatry. 48:383. Author weblink.
  • Hart YM; Meinardi H; Sander JW; Nutt DJ; Shorvon SD. (Apr 1991). The effect of intravenous flumazenil on interictal electroencephalographic epileptic activity: results of a placebo-controlled study. J Neurol Neurosurg Psychiatry. 54:305-309. Author weblink.
  • Hart YM; Sander JW; Meinardi H; Nutt DJ; Shorvon SD. (23 Mar 1991). Flumazenil as an anti-epileptic agent. Lancet. 337:744. Author weblink.
  • Glue P; Nutt DJ. (2 Mar 1991). Benzodiazepine receptor sensitivity in panic disorder. Lancet. 337:563. Author weblink.
  • GROVES S; NUTT D. (1 Mar 1991). BUPRENORPHINE AND SCHIZOPHRENIA. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL. 6:71-72. Author weblink DOI.
  • NUTT DJ; GLUE P. (1 Mar 1991). IRRITABILITY IN PANIC DISORDER - EFFECTS OF IMIPRAMINE TREATMENT. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL. 6:49-52. Author weblink DOI.
  • Jackson HC; Nutt DJ. (7 Feb 1991). Effect of benzodiazepine and beta-carboline antagonists and partial agonists on loprazolam- and ZK 93423-induced hypothermia. Eur J Pharmacol. 193:179-184. Author weblink.
  • Jackson HC; Nutt DJ. (1991). Differential effects of selective mu-, kappa- and delta-opioid antagonists on electroshock seizure threshold in mice. Psychopharmacology (Berl). 103:380-383. Author weblink.
  • Jackson HC; Weinberger PJ; Nutt DJ. (1991). Do Opioid, alpha(2)-Adrenoreceptors, or Benzodiazepine Receptors Mediate ECS-Induced Hypothermia in Mice?. Convuls Ther. 7:20-27. Author weblink.
  • Glue P; Payvandi N; Kay G; Elliott JM; Nutt DJ. (1991). Effects of chronic alpha 2-adrenoceptor blockade on platelet and lymphocyte adrenoceptor binding in normal volunteers. Life Sci. 49:PL21-PL25. Author weblink.
  • Jackson HC; Dickinson SL; Nutt DJ. (1991). Exploring the pharmacology of the pro-convulsant effects of alpha 2-adrenoceptor antagonists in mice. Psychopharmacology (Berl). 105:558-562. Author weblink.
  • Ball DM; Glue P; Wilson S; Nutt DJ. (1991). Pharmacology of saccadic eye movements in man. 1. Effects of the benzodiazepine receptor ligands midazolam and flumazenil. Psychopharmacology (Berl). 105:361-367. Author weblink.
  • Glue P; White E; Wilson S; Ball DM; Nutt DJ. (1991). Pharmacology of saccadic eye movements in man. 2. Effects of the alpha 2-adrenoceptor ligands idazoxan and clonidine. Psychopharmacology (Berl). 105:368-373. Author weblink.
  • Nutt D. (6 Oct 1990). Closure of MRC units. Lancet. 336:884. Author weblink.
  • Nutt DJ; Glue P; Lawson C; Wilson S. (Oct 1990). Flumazenil provocation of panic attacks. Evidence for altered benzodiazepine receptor sensitivity in panic disorder. Arch Gen Psychiatry. 47:917-925. Author weblink.
  • Glue P; Nutt D. (Oct 1990). Overexcitement and disinhibition. Dynamic neurotransmitter interactions in alcohol withdrawal. Br J Psychiatry. 157:491-499. Author weblink.
  • Jackson HC; Nutt DJ. (28 Aug 1990). Body temperature discriminates between full and partial benzodiazepine receptor agonists. Eur J Pharmacol. 185:243-246. Author weblink.
  • NUTT DJ. (1 Aug 1990). BEHAVIOR, AUTONOMIC FUNCTION AND THE BRAIN. CURRENT OPINION IN NEUROLOGY AND NEUROSURGERY. 3:507-511. Author weblink.
  • Weiss SR; Post RM; Costello M; Nutt DJ; Tandeciarz S. (Aug 1990). Carbamazepine retards the development of cocaine-kindled seizures but not sensitization to cocaine-induced hyperactivity. Neuropsychopharmacology. 3:273-281. Author weblink.
  • George DT; Adinoff B; Ravitz B; Nutt DJ; De Jong J; Berrettini W; Mefford IN; Costa E; et alLinnoila M. (Jul 1990). A cerebrospinal fluid study of the pathophysiology of panic disorder associated with alcoholism. Acta Psychiatr Scand. 82:1-7. Author weblink.
  • GEORGE DT; NUTT DJ; WAXMAN RP; LINNOILA M. (1 Jun 1990). RESPONSE OF ALCOHOLIC AND NONALCOHOLIC PANIC PATIENTS TO LACTATE INFUSION - REPLY. AMERICAN JOURNAL OF PSYCHIATRY. 147:819-820. Author weblink.
  • Smith JE; Williams K; Burkett S; Glue P; Nutt DJ. (May 1990). Oxytocin and vasopressin responses to ECT. Psychiatry Res. 32:201-202. Author weblink.
  • NUTT D. (1 Apr 1990). NOT ONLY BUT ALSO - COMMENTS. NEUROPSYCHOPHARMACOLOGY. 3:93-95. Author weblink.
  • Nutt D. (Apr 1990). Not only but also? Comments on "How does convulsive therapy work"?. Neuropsychopharmacology. 3:93-95. Author weblink.
  • Peeters BW; Van Rijn CM; Nutt DJ; Titulaer MN; Vossen JM; Coenen AM. (13 Mar 1990). Diazepam and Ro 15-1788 increase absence epilepsy in WAG/Rij rats chronically exposed to diazepam. Eur J Pharmacol. 178:111-114. Author weblink.
  • Glue P; Nutt DJ. (Mar 1990). Lithium treatment effect on serotonin function. Arch Gen Psychiatry. 47:289-290. Author weblink.
  • George DT; Nutt DJ; Dwyer BA; Linnoila M. (Feb 1990). Alcoholism and panic disorder: is the comorbidity more than coincidence?. Acta Psychiatr Scand. 81:97-107. Author weblink.
  • Roy A; Lamparski D; De Jong J; Adinoff B; Ravitz B; George DT; Nutt D; Linnoila M. (Jan 1990). Cerebrospinal fluid monoamine metabolites in alcoholic patients who attempt suicide. Acta Psychiatr Scand. 81:58-61. Author weblink.
  • George DT; Glue P; Bacher JD; Waxman RP; Nutt DJ. (1 Jan 1990). Lactate-induced electrolyte changes in the cerebrospinal fluid of rabbits. Biol Psychiatry. 27:104-108. Author weblink.
  • Nutt DJ; Glue P. (1990). Neuropharmacological and clinical aspects of alcohol withdrawal. Ann Med. 22:275-281. Author weblink.
  • Jackson HC; Ball DM; Nutt DJ. (1990). Noradrenergic mechanisms appear not to be involved in cocaine-induced seizures and lethality. Life Sci. 47:353-359. Author weblink.
  • Nutt DJ. (1990). Pharmacological mechanisms of benzodiazepine withdrawal. J Psychiatr Res. 24 Suppl 2:105-110. Author weblink.
  • Glue P; Costello MJ; Pert A; Mele A; Nutt DJ. (1990). Regional neurotransmitter responses after acute and chronic electroconvulsive shock. Psychopharmacology (Berl). 100:60-65. Author weblink.
  • Nutt DJ; Glue P; Lawson C. (1990). The neurochemistry of anxiety: an update. Prog Neuropsychopharmacol Biol Psychiatry. 14:737-752. Author weblink.
  • Nutt DJ. (1990). The pharmacology of human anxiety. Pharmacol Ther. 47:233-266. Author weblink.
  • Jackson HC; Ripley TL; Nutt DJ. (Dec 1989). Exploring delta-receptor function using the selective opioid antagonist naltrindole. Neuropharmacology. 28:1427-1430. Author weblink.
  • George DT; Nutt DJ; Waxman RP; Linnoila M. (Sep 1989). Panic response to lactate administration in alcoholic and nonalcoholic patients with panic disorder. Am J Psychiatry. 146:1161-1165. Author weblink.
  • Nutt D; Lawson C; Glue P. (Aug 1989). Attitudes to anxiety. Br J Psychiatry. 155:268. Author weblink.
  • Nutt DJ; Lister RG. (8 Jun 1989). 3-(Methoxycarbonyl)-amino-beta-carboline reduces both the sedative and anticonvulsant effects of diazepam. Eur J Pharmacol. 165:135-138. Author weblink.
  • NUTT DJ. (1 Jun 1989). ENDOCRINE RESPONSE TO SYNCOPE IN PANIC DISORDER. PSYCHIATRY RESEARCH. 28:352-353. Author weblink.
  • George DT; Anderson P; Nutt DJ; Linnoila M. (May 1989). Aggressive thoughts and behavior: another symptom of panic disorder?. Acta Psychiatr Scand. 79:500-502. Author weblink.
  • Gleiter CH; Linnoila M; Nutt DJ. (Apr 1989). Low affinity hypothalamic [3H]mazindol binding: a probe for hypothalamic body weight regulation?. Appetite. 12:137-143. Author weblink.
  • Nutt D; Glue P. (Mar 1989). Monoamine oxidase inhibitors: rehabilitation from recent research?. Br J Psychiatry. 154:287-291. Author weblink.
  • Nutt DJ. (Feb 1989). Altered central alpha 2-adrenoceptor sensitivity in panic disorder. Arch Gen Psychiatry. 46:165-169. Author weblink.
  • Gleiter CH; Deckert J; Nutt DJ; Marangos PJ. (Feb 1989). Electroconvulsive shock (ECS) and the adenosine neuromodulatory system: effect of single and repeated ECS on the adenosine A1 and A2 receptors, adenylate cyclase, and the adenosine uptake site. J Neurochem. 52:641-646. Author weblink.
  • George DT; Nutt DJ; Walker WV; Porges SW; Adinoff B; Linnoila M. (Feb 1989). Lactate and hyperventilation substantially attenuate vagal tone in normal volunteers. A possible mechanism of panic provocation?. Arch Gen Psychiatry. 46:153-156. Author weblink.
  • GLEITER CH; DECKERT J; NUTT DJ; MARANGOS PJ. (1 Feb 1989). LONG-LASTING ADENOSINE A1 RECEPTOR UPREGULATION IN RAT CEREBRAL-CORTEX AFTER CHRONIC ELECTROCONVULSIVE SHOCK (ECS). CLINICAL PHARMACOLOGY & THERAPEUTICS. 45:172-172. Author weblink.
  • Bone GH; Majchrowicz E; Martin PR; Linnoila M; Nutt DJ. (1989). A comparison of calcium antagonists and diazepam in reducing ethanol withdrawal tremors. Psychopharmacology (Berl). 99:386-388. Author weblink.
  • Lister RG; Durcan MJ; Nutt DJ; Linnoila M. (1989). Attenuation of ethanol intoxication by alpha-2 adrenoceptor antagonists. Life Sci. 44:111-119. Author weblink.
  • Nutt D; Adinoff B; Linnoila M. (1989). Benzodiazepines in the treatment of alcoholism. Recent Dev Alcohol. 7:283-313. Author weblink.
  • Gleiter CH; Nutt DJ. (1989). Chronic electroconvulsive shock and neurotransmitter receptors--an update. Life Sci. 44:985-1006. Author weblink.
  • Nutt DJ; Glue P. (1989). Clinical pharmacology of anxiolytics and antidepressants: a psychopharmacological perspective. Pharmacol Ther. 44:309-334. Author weblink.
  • Gleiter CH; Costello MJ; Nutt DJ. (1989). Effect of Single and Repeated Electroconvulsive Shock on Body Temperature in Mice. Convuls Ther. 5:152-156. Author weblink.
  • Thiagarajan AB; Gleiter CH; Mefford IN; Eskay RL; Nutt DJ. (1989). Effect of single and repeated electroconvulsive shock on the hypothalamic-pituitary-adrenal axis and plasma catecholamines in rats. Psychopharmacology (Berl). 97:548-552. Author weblink.
  • Nutt DJ; Gleiter CH; Glue P. (1989). Neuropharmacological Aspects of ECT: In Search of the Primary Mechanism of Action. Convuls Ther. 5:250-260. Author weblink.
  • Glue P; Sellman JD; Nicholls MG; Abbott R; Joyce PR; Nutt DJ. (Jan 1989). Studies of alpha-2-adrenoceptor function in abstinent alcoholics. Br J Addict. 84:97-102. Author weblink.
  • Glue P; Bacher JD; Nutt DJ. (Dec 1988). A technique for chronic catheterization of the cisterna magna in rabbits. Lab Anim Sci. 38:740-742. Author weblink.
  • Nutt DJ; Linnoila M. (Dec 1988). Neuroreceptor science: a clarification of terms. J Clin Psychopharmacol. 8:387-389. Author weblink.
  • Nutt DJ; Lister RG. (Nov 1988). Antagonizing the anticonvulsant effect of ethanol using drugs acting at the benzodiazepine/GABA receptor complex. Pharmacol Biochem Behav. 31:751-755. Author weblink.
  • LISTER RG; NUTT DJ. (1 Nov 1988). ANTAGONIZING THE BEHAVIORAL-EFFECTS OF ETHANOL USING DRUGS THAT ACT AT THE BENZODIAZEPINE GABA RECEPTOR MACROMOLECULAR COMPLEX - PROCEEDINGS OF A SATELLITE SYMPOSIUM TO THE 17TH ANNUAL-MEETING OF THE SOCIETY-FOR-NEUROSCIENCE - NEW-ORLEANS, LA, NOVEMBER 15, 1987 - INTRODUCTION. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR. 31:731-731. Author weblink DOI.
  • Gleiter CH; Deckert J; Nutt DJ; Marangos PJ. (Nov 1988). The effect of acute and chronic electroconvulsive shock on [3H]phorbol-dibutyrate binding to rat brain membranes. Neurochem Res. 13:1023-1026. Author weblink.
  • Lister RG; Nutt DJ. (Aug 1988). Alcohol antagonists--the continuing quest. Alcohol Clin Exp Res. 12:566-569. Author weblink.
  • Nutt DJ; Lister RG; Rusche D; Bonetti EP; Reese RE; Rufener R. (22 Jun 1988). RO 15-4513 does not protect rats against the lethal effects of ethanol. Eur J Pharmacol. 151:127-129. Author weblink.
  • George DT; Zerby A; Noble S; Nutt DJ. (Jun 1988). Panic attacks and alcohol withdrawal: can subjects differentiate the symptoms?. Biol Psychiatry. 24:240-243. Author weblink.
  • Nutt DJ; Gleiter CH; Linnoila M. (17 May 1988). Repeated electroconvulsive shock normalizes blood glucose levels in genetically obese mice (C57BL/6J ob/ob) but not in genetically diabetic mice (C57BL/KsJ db/db). Brain Res. 448:377-380. Author weblink.
  • Glue P; Sellman JD; Joyce PR; Nicholls MG; Nutt DJ. (May 1988). The hypothermic response to clonidine is absent in alcohol withdrawal but returns in abstinence. Biol Psychiatry. 24:102-104. Author weblink.
  • RISHERFLOWERS D; BONE G; RAVITZ B; MARTIN PR; ADINOFF B; GEORGE DT; MOSS H; GOLD P; et alNUTT DJ; LINNOILA M. (1 Apr 1988). ARE VASOPRESSIN RESPONSES TO OSMOTIC LOAD REDUCED IN ALCOHOLIC MEN. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH. 12:336-336. Author weblink.
  • Little HJ; Gale R; Sellars N; Nutt DJ; Taylor SC. (Apr 1988). Chronic benzodiazepine treatment increases the effects of the inverse agonist FG7142. Neuropharmacology. 27:383-389. Author weblink.
  • Nutt D. (Mar 1988). Benzodiazepine terminology. Trends Pharmacol Sci. 9:86. Author weblink.
  • Nutt D; Glue P; Molyneux S; Clark E. (Feb 1988). Alpha-2-adrenoceptor function in alcohol withdrawal: a pilot study of the effects of iv. clonidine in alcoholics and normals. Alcohol Clin Exp Res. 12:14-18. Author weblink.
  • GLEITER CH; THIAGARAJAN AB; NUTT DJ. (1 Feb 1988). AN ANIMAL-MODEL FOR THE CNS ACTIONS OF ELECTRO-CONVULSIVE SHOCK (ECS). CLINICAL PHARMACOLOGY & THERAPEUTICS. 43:177-177. Author weblink.
  • Gleiter CH; Nutt DJ. (1988). A single electroconvulsive shock substantially lowers blood glucose levels in obese mice (C57BL/6J ob/ob). Psychopharmacology (Berl). 95:287-288. Author weblink.
  • Nutt DJ; Taylor SC; Little HJ; Standing BL; Gale RG. (1988). Changes in benzodiazepine/GABA receptor complex function in benzodiazepine-tolerant mice. Psychopharmacology (Berl). 95:407-412. Author weblink.
  • Gleiter CH; Deckert J; Nutt DJ. (1988). Changes in caffeine seizure threshold after electroconvulsive shock. Psychopharmacology (Berl). 95:544-545. Author weblink.
  • Risher-Flowers D; Adinoff B; Ravitz B; Bone GH; Martin PR; Nutt D; Linnoila M. (1988). Circadian rhythms of cortisol during alcohol withdrawal. Adv Alcohol Subst Abuse. 7:37-41. Author weblink DOI.
  • Thiagarajan AB; Gleiter CH; Nutt DJ. (1988). Electroconvulsive Shock Does Not Increase Plasma Insulin in Rats. Convuls Ther. 4:292-296. Author weblink.
  • Lister RG; Nutt DJ. (Jan 1988). Interactions of the imidazodiazepine Ro 15-4513 with chemical convulsants. Br J Pharmacol. 93:210-214. Author weblink.
  • LISTER RG; DURCAN MJ; NUTT DJ; LINNOILA M. (1 Jan 1988). PHARMACOLOGICAL ANTAGONISM OF ETHANOLS BEHAVIORAL-EFFECTS - A COMPARISON BETWEEN BENZODIAZEPINE RECEPTOR INVERSE AGONISTS AND ALPHA-2 RECEPTOR ANTAGONISTS. PSYCHOPHARMACOLOGY. 96:S35-S35. Author weblink.
  • Nutt DJ; Costello MJ. (1988). Rapid induction of lorazepam dependence and reversal with flumazenil. Life Sci. 43:1045-1053. Author weblink.
  • Gleiter CH; Nutt DJ. (1988). Repeated electroconvulsive shock does not change [3H]-paroxetine binding to the 5-HT uptake site in rat cortical membranes. Psychopharmacology (Berl). 95:68-70. Author weblink.
  • Gleiter CH; Nutt DJ. (1988). Repeated electroconvulsive shock increases the number of [3H]desipramine binding sites in rat cerebral cortex. Psychopharmacology (Berl). 96:426-427. Author weblink.
  • Lister RG; Nutt DJ. (1988). RO 15-4513 and its interaction with ethanol. Adv Alcohol Subst Abuse. 7:119-123. Author weblink DOI.
  • NUTT DJ; LISTER RG. (1 Jan 1988). STRAIN DIFFERENCES IN RESPONSE TO A BENZODIAZEPINE RECEPTOR INVERSE AGONIST (FG 7142) IN MICE. PSYCHOPHARMACOLOGY. 94:435-436. Author weblink.
  • Nutt DJ; Lister RG. (1988). Strain differences in response to a benzodiazepine receptor inverse agonist (FG 7142) in mice. Psychopharmacology (Berl). 94:335-336. Author weblink.
  • LINNOILA M; MEFFORD I; NUTT D; ADINOFF B. (1 Dec 1987). ALCOHOL-WITHDRAWAL AND NORADRENERGIC FUNCTION. ANNALS OF INTERNAL MEDICINE. 107:875-889. Author weblink.
  • Linnoila M; Mefford I; Nutt D; Adinoff B. (Dec 1987). NIH conference. Alcohol withdrawal and noradrenergic function. Ann Intern Med. 107:875-889. Author weblink.
  • Nutt D; Glue P; Stewart A. (Nov 1987). Platelet monamine receptor binding in alcoholics during withdrawal. Br J Addict. 82:1253-1255. Author weblink.
  • GLEITER CH; NUTT DJ; COSTELLO M; LINNOILA M. (1 Sep 1987). ANTIDIABETIC EFFECT OF ELECTROSHOCK (ECS) IN OB/OB MICE. JOURNAL OF CLINICAL PHARMACOLOGY. 27:716-716. Author weblink.
  • Little HJ; Nutt DJ; Taylor SC. (Sep 1987). Bidirectional effects of chronic treatment with agonists and inverse agonists at the benzodiazepine receptor. Brain Res Bull. 19:371-378. Author weblink.
  • NUTT D; COSTELLO M. (22 Aug 1987). FLUMAZENIL AND BENZODIAZEPINE WITHDRAWAL. LANCET. 2:463-463. Author weblink.
  • Nutt DJ; Cowen PJ. (Aug 1987). Diazepam alters brain 5-HT function in man: implications for the acute and chronic effects of benzodiazepines. Psychol Med. 17:601-607. Author weblink.
  • George DT; Ladenheim JA; Nutt DJ. (Aug 1987). Effect of pregnancy on panic attacks. Am J Psychiatry. 144:1078-1079. Author weblink.
  • Nutt DJ. (Jul 1987). Platelet alpha 2-adrenoceptor binding does not predict brain alpha 2-adrenoceptor function. Br J Clin Pharmacol. 24:122-123. Author weblink.
  • Nutt DJ; Lister RG. (9 Jun 1987). The effect of the imidazodiazepine Ro 15-4513 on the anticonvulsant effects of diazepam, sodium pentobarbital and ethanol. Brain Res. 413:193-196. Author weblink.
  • NUTT DJ. (1 Jun 1987). ABNORMAL ALPHA-2-ADRENOCEPTOR-MEDICATED ENDOCRINE RESPONSE IN PANIC DISORDER. NEUROENDOCRINOLOGY LETTERS. 9:210-210. Author weblink.
  • LISTER RG; NUTT DJ. (1 Jun 1987). IS RO-15-4513 A SPECIFIC ALCOHOL ANTAGONIST. TRENDS IN NEUROSCIENCES. 10:223-225. Author weblink DOI.
  • GEORGE DT; NUTT DJ; LINNOILA M. (1 Apr 1987). ARE ALCOHOLICS SUBSENSITIVE TO LACTATE. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH. 11:215-215. Author weblink.
  • Nutt D; Molyneux S. (Apr 1987). Benzodiazepines, plasma MHPG and alpha-2-adrenoceptor function in man. Int Clin Psychopharmacol. 2:151-157. Author weblink.
  • NUTT DJ; GLUE P. (1 Apr 1987). PHARMACOLOGICAL EVIDENCE OF KINDLING IN ALCOHOLICS. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH. 11:218-218. Author weblink.
  • RAVITZ B; TOWLE M; NUTT D; LANE E; BOWEN B. (1 Apr 1987). PSYCHOLOGICAL EFFECTS OF ETHANOL IN NORMAL-MALE VOLUNTEERS. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH. 11:219-219. Author weblink.
  • NUTT DJ; LISTER R. (1 Apr 1987). STUDIES ON THE PUTATIVE ALCOHOL ANTAGONIST RO15-4513. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH. 11:218-218. Author weblink.
  • Stanford SC; Little HJ; Nutt DJ; Taylor SC. (24 Feb 1987). A single dose of FG 7142 causes long-term increases in mouse cortical beta-adrenoceptors. Eur J Pharmacol. 134:313-319. Author weblink.
  • NUTT DJ; GLUE P. (1 Feb 1987). CLONIDINE RESPONSES IN ALCOHOL-WITHDRAWAL. CLINICAL PHARMACOLOGY & THERAPEUTICS. 41:231-231. Author weblink.
  • Glue P; Nutt D. (1987). Clonidine in alcohol withdrawal: a pilot study of differential symptom responses following i.v. clonidine. Alcohol Alcohol. 22:161-166. Author weblink.
  • GLUE P; NUTT DJ; KOLAKOWSKA T; COWEN PJ. (1 Jan 1987). LITHIUM ENHANCES 5-HT-MEDIATED NEUROENDOCRINE RESPONSES IN MAN. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 23:P108-P108. Author weblink.
  • Nutt DJ; Fraser S. (Jan 1987). Platelet binding studies in panic disorder. J Affect Disord. 12:7-11. Author weblink.
  • Little HJ; Nutt DJ; Taylor SC. (Jan 1987). Selective changes in the in vivo effects of benzodiazepine receptor ligands after chemical kindling with FG 7142. Neuropharmacology. 26:25-31. Author weblink.
  • Glue PW; Nutt DJ; Cowen PJ; Broadbent D. (1987). Selective effect of lithium on cognitive performance in man. Psychopharmacology (Berl). 91:109-111. Author weblink.
  • Idzikowski C; Cowen PJ; Nutt D; Mills FJ. (1987). The effects of chronic ritanserin treatment on sleep and the neuroendocrine response to L-tryptophan. Psychopharmacology (Berl). 93:416-420. Author weblink.
  • Nutt D; Middleton H; Franklin M. (1987). The neuroendocrine effects of oral imipramine. Psychoneuroendocrinology. 12:367-375. Author weblink.
  • Nutt D; Hackman A; Hawton K. (8 Nov 1986). Increased sexual function in benzodiazepine withdrawal. Lancet. 2:1101-1102. Author weblink.
  • NUTT D. (1 Nov 1986). BENZODIAZEPINE DEPENDENCE IN THE CLINIC - REASON FOR ANXIETY. TRENDS IN PHARMACOLOGICAL SCIENCES. 7:457-460. Author weblink DOI.
  • LITTLE HJ; NUTT DJ; TAYLOR SC. (1 Oct 1986). A SHORT COURSE OF BENZODIAZEPINE TREATMENT, IN MICE, CAUSES A PROLONGED INCREASE IN SENSITIVITY TO BENZODIAZEPINE INVERSE AGONISTS. BRITISH JOURNAL OF ADDICTION. 81:710-710. Author weblink.
  • Stanford SC; Little HJ; Nutt DJ; Taylor SC. (23 Sep 1986). Effects of chronic treatment with benzodiazepine receptor ligands on cortical adrenoceptors. Eur J Pharmacol. 129:181-184. Author weblink.
  • Nutt DJ; Taylor SC; Little HJ. (Sep 1986). Optimizing the pentetrazol infusion test for seizure threshold measurement. J Pharm Pharmacol. 38:697-698. Author weblink.
  • Lister RG; Nutt DJ. (6 Aug 1986). Mice and rats are sensitized to the proconvulsant action of a benzodiazepine-receptor inverse agonist (FG 7142) following a single dose of lorazepam. Brain Res. 379:364-366. Author weblink.
  • MIDDLETON HC; NUTT DJ. (1 Aug 1986). ARE THE CARDIOVASCULAR EFFECTS OF IMIPRAMINE CENTRALLY MEDIATED. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 22:P221-P221. Author weblink.
  • Brosan L; Broadbent D; Nutt D; Broadbent M. (Aug 1986). Performance effects of diazepam during and after prolonged administration. Psychol Med. 16:561-571. Author weblink.
  • NUTT DJ; MOLYNEUX SJ. (1 Aug 1986). THE EFFECT OF DIAZEPAM ON PLASMA-FREE MHPG (3-METHOXY 4-HYDROXY PHENYLGLYCOL) IN MAN. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 22:P230-P230. Author weblink.
  • NUTT DJ; MIDDLETON HC; MURDOCK PJ; ARKINSTALL SY; FRANKLIN M. (1 Aug 1986). THE NEUROENDOCRINE EFFECTS OF ORAL IMIPRAMINE. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 22:P222-P222. Author weblink.
  • Little HJ; Nutt DJ; Taylor SC. (Jul 1986). The effects of drugs acting at the GABAA-receptor/ionophore after chemical kindling with the benzodiazepine receptor ligand FG 7142. Br J Pharmacol. 88:507-514. Author weblink.
  • Nutt D; Glue P. (Jun 1986). Monoamines and alcohol. Br J Addict. 81:327-338. Author weblink.
  • FRANKLIN M; NUTT DJ; MIDDLETON H; MURDOCK P; ARKINSTALL S. (1 Jan 1986). PLASMA GROWTH-HORMONE, PROLACTIN AND CORTISOL-LEVELS FOLLOWING ACUTE ORAL IMIPRAMINE ADMINISTRATION AT 2 DOSE LEVELS IN NORMAL SUBJECTS. ACTA PHARMACOLOGICA ET TOXICOLOGICA. 59:211-211. Author weblink.
  • NUTT DJ; FRANKLIN M; GOSDEN B; MURDOCK P. (1 May 1986). THE EFFECT OF DIAZEPAM ON INDEXES OF ALPHA-2-ADRENOCEPTOR FUNCTION IN MAN. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 21:P588-P588. Author weblink.
  • Nutt DJ; Cowen PJ; Franklin M; Murdock P; Gosden B; Fraser S. (May 1986). The effect of diazepam on indices of 5-HT function in man. Pharmacol Biochem Behav. 24:1491-1495. Author weblink.
  • Nutt DJ; Little H. (Apr 1986). Benzodiazepine-receptor mediated convulsions in infant rats: effects of beta-carbolines. Pharmacol Biochem Behav. 24:841-844. Author weblink.
  • Nutt DJ. (1986). Increased central alpha 2-adrenoceptor sensitivity in panic disorder. Psychopharmacology (Berl). 90:268-269. Author weblink.
  • NUTT DJ; MOLYNEUX SG. (1 Jan 1986). STUDIES ON PLASMA-FREE MHPG (3-METHOXY-4-HYDROXY-PHENYLGLYCOL) AND THE CLONIDINE CHALLENGE TEST. INTERNATIONAL JOURNAL OF NEUROSCIENCE. 31:130-131. Author weblink.
  • Nutt DJ; Molyneux SG. (1986). The effect of clonidine on plasma MHPG: evidence against tonic alpha 2-adrenoceptor control of noradrenergic function. Psychopharmacology (Berl). 90:509-512. Author weblink.
  • Glue PW; Cowen PJ; Nutt DJ; Kolakowska T; Grahame-Smith DG. (1986). The effect of lithium on 5-HT-mediated neuroendocrine responses and platelet 5-HT receptors. Psychopharmacology (Berl). 90:398-402. Author weblink.
  • Quintero S; Mellanby J; Thompson MR; Nordeen H; Nutt D; McNaughton N; Gray JA. (Dec 1985). Septal driving of hippocampal theta rhythm: role of gamma-aminobutyrate-benzodiazepine receptor complex in mediating effects of anxiolytics. Neuroscience. 16:875-884. Author weblink.
  • Little HJ; Taylor SC; Nutt DJ; Cowen PJ. (8 Jan 1985). The benzodiazepine antagonist, Ro 15-1788 does not decrease ethanol withdrawal convulsions in rats. Eur J Pharmacol. 107:375-377. Author weblink.
  • Taylor SC; Little HJ; Nutt DJ; Sellars N. (Jan 1985). A benzodiazepine agonist and contragonist have hypothermic effects in rodents. Neuropharmacology. 24:69-73. Author weblink.
  • NUTT D. (1 Jan 1985). ANXIOLYTICS - NEUROCHEMICAL, BEHAVIORAL AND CLINICAL PERSPECTIVE - MALICK,JB, ENNA,SJ, YAMAMURA,HI. BRITISH JOURNAL OF ADDICTION. 80:327-328. Author weblink.
  • NUTT DJ; FRASER S; GOSDEN B; STUMP K; ELLIOTT JM. (1 Jan 1985). BENZODIAZEPINES AND HUMAN-PLATELET RECEPTOR-BINDING. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 19:P554-P555. Author weblink.
  • NUTT D. (1 Jan 1985). CLINICAL BIOCHEMISTRY OF ALCOHOLISM - ROSALKI,SB. BRITISH JOURNAL OF ADDICTION. 80:442-443. Author weblink.
  • NUTT DJ; MOLYNEUX SG. (1 Jan 1985). PLASMA 3-METHOXY-4-HYDROXYPHENYLGLYCOL AND THE CLONIDINE CHALLENGE TEST IN MAN. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 20:P542-P543. Author weblink.
  • MOLYNEUX SG; NUTT DJ. (1 Jan 1985). STUDIES ON PLASMA-FREE 3-METHOXY-4-HYDROXPHENYLGLYCOL IN MAN. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 20:P541-P542. Author weblink.
  • Little HJ; Nutt DJ; Taylor SC. (Dec 1984). Acute and chronic effects of the benzodiazepine receptor ligand FG 7142: proconvulsant properties and kindling. Br J Pharmacol. 83:951-958. Author weblink.
  • Minchin MC; Nutt DJ. (Oct 1984). The effect of repeated electroconvulsive shock on the function of THIP, a GABA agonist. Pharmacol Biochem Behav. 21:491-493. Author weblink.
  • Nutt DJ; Little HJ; Taylor SC; Minchin MC. (17 Aug 1984). Investigating benzodiazepine receptor function in vivo using an intravenous infusion of DMCM. Eur J Pharmacol. 103:359-362. Author weblink.
  • NUTT D; LITTLE H. (1 Jan 1984). KINDLING PRODUCED BY A BENZODIAZEPINE RECEPTOR CONTRAGONIST (INVERSE AGONIST). DEVELOPMENTS IN NEUROSCIENCE. 17:443-447. Author weblink.
  • File SE; Green AR; Nutt DJ; Vincent ND. (1984). On the convulsant action of Ro 5-4864 and the existence of a micromolar benzodiazepine binding site in rat brain. Psychopharmacology (Berl). 82:199-202. Author weblink.
  • Minchin MC; Nutt DJ. (Dec 1983). Studies on [3H]diazepam and [3H]ethyl-beta-carboline carboxylate binding to rat brain in vivo. I. Regional variations in displacement. J Neurochem. 41:1507-1512. Author weblink.
  • Nutt DJ; Minchin MC. (Dec 1983). Studies on [3H]diazepam and [3H]ethyl-beta-carboline carboxylate binding to rat brain in vivo. II. Effects of electroconvulsive shock. J Neurochem. 41:1513-1517. Author weblink.
  • Atterwill CK; Nutt DJ. (Nov 1983). Thyroid hormones do not alter rat brain benzodiazepine receptor function in-vivo. J Pharm Pharmacol. 35:767-768. Author weblink.
  • Heal DJ; O'Shaughnessy KM; Smith SL; Nutt DJ. (22 Apr 1983). Hypophysectomy alters both 5-hydroxytryptamine- and alpha 2-adrenoceptor-mediated behavioural changes in the rat. Eur J Pharmacol. 89:167-171. Author weblink.
  • Stanford C; Nutt DJ; Cowen PJ. (Jan 1983). Comparison of the effects of chronic desmethylimipramine administration on alpha 2- and beta-adrenoceptors in different regions of rat brain. Neuroscience. 8:161-164. Author weblink.
  • Nutt D. (1983). Pharmacological and behavioural studies of benzodiazepine antagonists and contragonists. Adv Biochem Psychopharmacol. 38:153-173. Author weblink.
  • Bowdler JM; Green AR; Minchin MC; Nutt DJ. (1983). Regional GABA concentration and [3H]-diazepam binding in rat brain following repeated electroconvulsive shock. J Neural Transm. 56:3-12. Author weblink.
  • File SE; Lister RG; Nutt DJ. (8 Oct 1982). Intrinsic actions of benzodiazepine antagonists. Neurosci Lett. 32:165-168. Author weblink.
  • File SE; Lister RG; Nutt DJ. (Oct 1982). The anxiogenic action of benzodiazepine antagonists. Neuropharmacology. 21:1033-1037. Author weblink.
  • Nutt DJ; Smith SL; Heal DJ. (Sep 1982). Hypophysectomy does not prevent the enhanced monoamine-mediated behavioural responses following repeated electroconvulsive shocks. Neuropharmacology. 21:881-884. Author weblink.
  • Cowen PJ; Nutt DJ. (14 Aug 1982). Abstinence symptoms after withdrawal of tranquillising drugs: is there a common neurochemical mechanism?. Lancet. 2:360-362. Author weblink.
  • Stanford SC; Nutt DJ. (Jul 1982). Comparison of the effects of repeated electroconvulsive shock on alpha 2- and beta-adrenoceptors in different regions of rat brain. Neuroscience. 7:1753-1757. Author weblink.
  • Nutt DJ; Cowen PJ; Little HJ. (4 Feb 1982). Unusual interactions of benzodiazepine receptor antagonists. Nature. 295:436-438. Author weblink.
  • Nutt DJ; Cowen PJ; Batts CC; Grahame-Smith DG; Green AR. (1982). Repeated administration of subconvulsant doses of GABA antagonist drugs. I. Effect on seizure threshold (kindling). Psychopharmacology (Berl). 76:84-87. Author weblink.
  • Cowen PJ; Nutt DJ; Batts CC; Green AR; Heal DJ. (1982). Repeated administration of subconvulsant doses of GABA antagonist drugs. II. Effect on monoamine-mediated behaviour. Psychopharmacology (Berl). 76:88-91. Author weblink.
  • Green AR; Nutt DJ; Cowen PJ. (1982). Using Ro 15-1788 to investigate the benzodiazepine receptor in vivo: studies on the anticonvulsant and sedative effect of melatonin and the convulsant effect of the benzodiazepine Ro 05-3663. Psychopharmacology (Berl). 78:293-295. Author weblink.
  • Nutt DJ; Cowen PJ; Green AR. (8 May 1981). Studies on the post-ictal rise in seizure threshold. Eur J Pharmacol. 71:287-295. Author weblink.
  • Cowen PJ; Green AR; Nutt DJ. (5 Mar 1981). Ethyl beta-carboline carboxylate lowers seizure threshold and antagonizes flurazepam-induced sedation in rats. Nature. 290:54-55. Author weblink.
  • NUTT D; STANFORD C. (1 Jan 1981). DECREASED ALPHA-2-ADRENOCEPTOR NUMBERS IN RAT-BRAIN FOLLOWING REPEATED ELECTROCONVULSIVE SHOCK. BRITISH JOURNAL OF PHARMACOLOGY. 74:P885-P886. Author weblink.
  • COWEN PJ; GREEN AR; NUTT DJ. (1 Jan 1981). DRUG-INDUCED ALTERATIONS OF THE POST-ICTAL SEIZURE THRESHOLD INCREASE. BRITISH JOURNAL OF PHARMACOLOGY. 73:P265-P266. Author weblink.
  • NUTT D; STANFORD C. (1 Jan 1981). EFFECTS OF REPEATED ELECTROCONVULSIVE SHOCK ON BETA-ADRENERGIC RECEPTORS IN RAT-BRAIN. JOURNAL OF PHYSIOLOGY-LONDON. 320:P51-P51. Author weblink.
  • Nutt DJ; Cowen PJ; Green AR. (Oct 1980). On the measurement in rats of the convulsant effect of drugs and the changes which follow electroconvulsive shock. Neuropharmacology. 19:1017-1023. Author weblink.
  • Cowen PJ; Nutt DJ; Green AR. (Oct 1980). Repeated electroconvulsive shock does not increase the susceptibility of rats to a cage convulsant (isopropylbicyclophosphate). Neuropharmacology. 19:1025-1026. Author weblink.
  • Nutt DJ; Green AR; Grahame-Smith DG. (Sep 1980). Enhanced 5-hydroxytryptamine and dopamine-mediated behavioural responses following convulsions--I. The effects of single and repeated bicuculline-induced seizures. Neuropharmacology. 19:897-900. Author weblink.
  • Cowen PJ; Nutt DJ; Green AR. (Sep 1980). Enhanced 5-hydroxytryptamine and dopamine-mediated behavioural responses following convulsions--II. The effects of anaesthesia and current conditions on the appearance of enhanced responses following electroconvulsive shock. Neuropharmacology. 19:901-906. Author weblink.
  • GREEN AR; NUTT DJ. (1 Jan 1980). ALTERED MONOAMINE-MEDIATED BEHAVIORS FOLLOWING BICUCULLINE-INDUCED CONVULSIONS. BRITISH JOURNAL OF PHARMACOLOGY. 70:P72-P73. Author weblink.
  • COWEN PJ; GREEN AR; NUTT DJ. (1 Jan 1980). EFFECT OF ANESTHETIC ADMINISTRATION ON THE APPEARANCE OF ENHANCED MONOAMINE-MEDIATED BEHAVIORS FOLLOWING ELECTROCONVULSIVE SHOCK. BRITISH JOURNAL OF PHARMACOLOGY. 70:P73-P74. Author weblink.

Conferences

  • Quelch D; Parker C; Nutt D; Tyacke R. The effects of different cellular environments on opioid receptor binding. 9th International Symposium on Functional Neuroreceptor Mapping of the Living Brain (NRM), 9 Aug 2012 - 11 Aug 2012. 32:S53-S54. NATURE PUBLISHING GROUP (1 Aug 2012). Author weblink.
  • Lingford-Hughes A; Meyers J; Wilson S; Taylor L; Feeney A; Rosso L; Turkheimer F; Cunningham VJ; et alNutt DJ. IMAGING THE GABA-BENZODIAZEPINE RECEPTOR IN ALCOHOLISM WITH PET. 16th World Congress of the International-Society-for-Biomedical-Research-on-Alcoholism (ISBRA), 9 Sep 2012 - 12 Sep 2012. 36:40A-40A. WILEY-BLACKWELL (1 Sep 2012). Author weblink.
  • Myers JFM; Stokes PRA; Kalk NJ; Watson BJ; Erritzoe D; Wilson SJ; Lingford-Hughes AR; Nutt DJ. Sensitivity of the benzodiazepine inverse agonist PET ligand [C-11]Ro15-4513 to changes in endogenous GABA. 9th International Symposium on Functional Neuroreceptor Mapping of the Living Brain (NRM), 9 Aug 2012 - 11 Aug 2012. 32:S66-S66. NATURE PUBLISHING GROUP (1 Aug 2012). Author weblink.
  • Stokes P; Myers J; Benecke A; Watson B; Kalk N; Taylor L; Barros DR; Hammers A; et alNutt D; Lingford-Hughes A. History of cigarette smoking associated with increased limbic GABA(A) receptor availability. 9th International Symposium on Functional Neuroreceptor Mapping of the Living Brain (NRM), 9 Aug 2012 - 11 Aug 2012. 32:S46-S47. NATURE PUBLISHING GROUP (1 Aug 2012). Author weblink.
  • Myers JFM; Stokes PRA; Kalk NJ; Watson BJ; Erritzoe D; Wilson SJ; Lingford-Hughes AR; Nutt DJ. PET imaging of brain inflammation during epileptogenesis in the rat. 9th International Symposium on Functional Neuroreceptor Mapping of the Living Brain (NRM), 9 Aug 2012 - 11 Aug 2012. 32:S66-S67. NATURE PUBLISHING GROUP (1 Aug 2012). Author weblink.
  • Erritzoe D; Tziortzi A; Bargiela D; Searle G; Gunn RN; Beaver JD; Waldman A; Nutt DJ; et alBani M; Merlo-Pich E; Rabiner EA; Lingford-Hughes A. In vivo imaging of dopamine D3 receptors in alcoholism using [C-11]PHNO-PET, and a selective D3 receptor antagonist. 9th International Symposium on Functional Neuroreceptor Mapping of the Living Brain (NRM), 9 Aug 2012 - 11 Aug 2012. 32:S77-S78. NATURE PUBLISHING GROUP (1 Aug 2012). Author weblink.
  • Nutt DJ. The role of neuroimaging in anxiety disorders. 24th Congress Meeting of European-College-of-Neuropsychopharmacology, 3 Sep 2011 - 7 Sep 2011. 21:S630-S630. ELSEVIER SCIENCE BV (1 Sep 2011). Author weblink.
  • Lees R; Williams T; Nutt D; Henderson G; Hickman M; Lingford-Hughes M. Comparison of a benzodiazepine and alcohol challenge in opioid dependent human participants. 24th Congress Meeting of European-College-of-Neuropsychopharmacology, 3 Sep 2011 - 7 Sep 2011. 21:S580-S581. ELSEVIER SCIENCE BV (1 Sep 2011). Author weblink.
  • Watson BJ; Taylor LG; Reid A; Wilson SJ; Stokes PR; Brooks DJ; Bose SK; Turkheimer F; et alLingford-Hughes AR; Nutt DJ. Investigating the effect of expectation on striatal dopamine release in heroin addicts: an C-11-raclopride PET study. 24th Congress of the European-College-of-Neuropsychopharmacology, 3 Sep 2011 - 7 Sep 2011. 21:S320-S320. ELSEVIER SCIENCE BV (1 Sep 2011). Author weblink.
  • Carhart-Harris R; Erritzoe D; Stone J; Wise RG; Nutt D. The functional brain correlates of the psychedelic state: an arterial spin labelling study with psilocybin. 24th Congress Meeting of European-College-of-Neuropsychopharmacology, 3 Sep 2011 - 7 Sep 2011. 21:S313-S313. ELSEVIER SCIENCE BV (1 Sep 2011). Author weblink.
  • Nutt D. Setting the stage - Antidepressants. 24th Congress Meeting of European-College-of-Neuropsychopharmacology, 3 Sep 2011 - 7 Sep 2011. 21:S234-S235. ELSEVIER SCIENCE BV (1 Sep 2011). Author weblink.
  • Wilson SJ; Paterson LM; Durant CF; Sinclair L; Rich AS; Wood B; Lightman S; Nutt DJ; et alMalizia AL. ACUTE EFFECTS OF HIGH DOSE HYDROCORTISONE ON SLEEP IN PATIENTS WITH TREATMENT RESISTANT DEPRESSION: A DOUBLE BLIND PLACEBO CONTROLLED STUDY. Summer Meeting of the British-Association-for-Psychopharmacology, 24 Jul 2011 - 27 Jul 2011. 25:A23-A23. SAGE PUBLICATIONS LTD (1 Aug 2011). Author weblink.
  • Carhart-Harris RL; Erritzoe DE; Williams TM; Stone JM; Reed L; Tyacke R; Wise RG; Nutt DJ. DECREASED CEREBRAL BLOOD FLOW AFTER INTRAVENOUS PSILOCYBIN. Summer Meeting of the British-Association-for-Psychopharmacology, 24 Jul 2011 - 27 Jul 2011. 25:A39-A39. SAGE PUBLICATIONS LTD (1 Aug 2011). Author weblink.
  • Mitchell EN; Marston H; Nutt DJ; Robinson ESJ. DIAZEPAM ATTENUATES THE INSTRUMENTAL SUCCESSIVE NEGATIVE CONTRAST EFFECT IN A PROGRESSIVE RATIO OPERANT MODEL. Summer Meeting of the British-Association-for-Psychopharmacology, 24 Jul 2011 - 27 Jul 2011. 25:A51-A51. SAGE PUBLICATIONS LTD (1 Aug 2011). Author weblink.
  • Benecke A; Shotbolt JP; Egerton A; Nutt D; Lingford-Hughes AR; Howes O; Stokes PRA. DOES PRESYNAPTIC STRIATAL DOPAMINE SYNTHESIS CAPACITY PREDICT SOCIALLY DESIRABLE RESPONDING?. Summer Meeting of the British-Association-for-Psychopharmacology, 24 Jul 2011 - 27 Jul 2011. 25:A42-A42. SAGE PUBLICATIONS LTD (1 Aug 2011). Author weblink.
  • Tyacke RJ; Durant CF; Paterson LM; Dineen P; Bachurova G; Wilson S; Nutt DJ; Malizia AL. EFFECTS OF ACUTE INHALATION OF VAPORIZED CANNABIS OR PLACEBO ON CARDIOVASCULAR AND SACCADIC EYE MOVEMENT MEASURES: A PILOT STUDY. Summer Meeting of the British-Association-for-Psychopharmacology, 24 Jul 2011 - 27 Jul 2011. 25:A37-A37. SAGE PUBLICATIONS LTD (1 Aug 2011). Author weblink.
  • Quelch DR; Nutt DJ; Parker CA; Tyacke RJ. EFFECTS OF CELLULAR ENVIRONMENTS ON PET RADIOLIGAND BINDING - AN APPLICATION TO DOPAMINE AND OPIOID RECEPTOR IMAGING. Summer Meeting of the British-Association-for-Psychopharmacology, 24 Jul 2011 - 27 Jul 2011. 25:A60-A60. SAGE PUBLICATIONS LTD (1 Aug 2011). Author weblink.
  • Nutt DJ. EVALUATING THE HUMAN HARMS AND POSSIBLE THERAPEUTIC USES OF ECSTASY. Summer Meeting of the British-Association-for-Psychopharmacology, 24 Jul 2011 - 27 Jul 2011. 25:A2-A2. SAGE PUBLICATIONS LTD (1 Aug 2011). Author weblink.
  • Stokes PR; Clark L; Wu K; Michalczuk R; Watson B; Egerton A; Lappin J; Piccini P; et alNutt D; Bowden-Jones H; Lingford-Hughes A. IMAGING THE DOPAMINE SYSTEM IN PATHOLOGICAL GAMBLING: AN [11C]-RACLOPRIDE PET STUDY. Summer Meeting of the British-Association-for-Psychopharmacology, 24 Jul 2011 - 27 Jul 2011. 25:A61-A61. SAGE PUBLICATIONS LTD (1 Aug 2011). Author weblink.
  • Stuart SA; Butler P; Nutt DJ; Robinson ESJ. INVESTIGATING AFFECTIVE STATE AND MEMORY USING A NOVEL RODENT ASSAY: IMPLICATIONS FOR THE CAUSE AND TREATMENT OF DEPRESSION. Summer Meeting of the British-Association-for-Psychopharmacology, 24 Jul 2011 - 27 Jul 2011. 25:A50-A50. SAGE PUBLICATIONS LTD (1 Aug 2011). Author weblink.
  • Colasanti A; Searle GE; Long CJ; Hill SP; Reiley RR; Tziortzi AC; Quelch D; Gunn R; et alWaldman AD; Schruers KJ; Matthews PM; Nutt DJ; Rabiner EA. OPIOID RELEASE IN HUMAN BRAIN REWARD SYSTEM INDUCED BY AN ACUTE AMPHETAMINE CHALLENGE: A [11C]CARFENTANIL PET STUDY. Summer Meeting of the British-Association-for-Psychopharmacology, 24 Jul 2011 - 27 Jul 2011. 25:A60-A60. SAGE PUBLICATIONS LTD (1 Aug 2011). Author weblink.
  • Lingford-Hughes A; Myers J; Wilson S; Stokes P; Taylor L; Watson B; Kalk N; Besson M; et alFeeney A; Rosso L; Turkheimer F; Cunningham VJ; Pike VW; Brooks DJ; Marshall EJ; Kerwin RW; Nutt DJ. THE GABA-BENZODIAZEPINE RECEPTOR, ITS SUBTYPES AND ALCOHOL MISUSE: INSIGHTS FROM IMAGING AND PHARMACOLOGICAL CHALLENGE STUDIES. Summer Meeting of the British-Association-for-Psychopharmacology, 24 Jul 2011 - 27 Jul 2011. 25:A79-A79. SAGE PUBLICATIONS LTD (1 Aug 2011). Author weblink.
  • Diaper A; Bailey JE; Rich AS; Craig KJ; Dawson GR; Dourish CT; Nutt DJ. VENLAFAXINE AND PREGABALIN REDUCE CO2-INDUCED SYMPTOMS OF ANXIETY IN AN EXPERIMENTAL HUMAN MODEL. Summer Meeting of the British-Association-for-Psychopharmacology, 24 Jul 2011 - 27 Jul 2011. 25:A73-A73. SAGE PUBLICATIONS LTD (1 Aug 2011). Author weblink.
  • Erritzoe D; Tziortzi A; Bargiela D; Searle G; Gunn RN; Beaver JD; Waldman A; Nutt D; et alBani M; Merlo-Pich E; Rabiner EA; Lingford-Hughes A. In Vivo Imaging of Dopamine D3 Receptors in Alcoholism Using Positron Emission Tomography, [11C]PHNO, and a Selective D3 Receptor Antagonist. 66th Annual Meeting of the Society-of-Biological-Psychiatry, 12 May 2011 - 14 May 2011. 69:271S-271S. ELSEVIER SCIENCE INC (1 May 2011). Author weblink.
  • Quelch DR; Tyacke RJ; Nutt DJ; Parker CA. Assessment of cellular environments on radioligand binding - an application to opioid receptor PET imaging. European-College-of-Neuropsychopharmacology Workshop on Neuropsychopharmacology for Young Scientists in Europe, 3 Mar 2011 - 6 Mar 2011. 21:S7-S8. ELSEVIER SCIENCE BV (1 Mar 2011). Author weblink DOI.
  • Paterson LM; Nutt DJ; Knudsen GM. A critical review of studies measuring endogenous 5-HT release by emission tomography. 8th International Symposium on Functional Neuroreceptor Mapping of the Living Brain, 22 Jul 2010 - 24 Jul 2010. 52:S107-S107. ACADEMIC PRESS INC ELSEVIER SCIENCE (1 Aug 2010). Author weblink DOI.
  • Mitchell EN; Marston H; Nutt D; Robinson ESJ. Acute anxiolytic drug treatment has no effect on the instrumental successive negative contrast effect using a modified forced choice serial reaction time task. 23rd Congress Meeting of European-College-of-Neuropsychopharmacology, 28 Aug 2010 - 1 Sep 2010. 20:S536-S536. ELSEVIER SCIENCE BV (1 Aug 2010). Author weblink.
  • Christmas D; Davies SJC; Hince DA; Williams J; Schroeder K; Nutt DJ. Day 3&7 jitteriness symptoms predict poor 6 week outcome in SSRI treatment and correlate with day 7 nocturnal activity. 23rd Congress Meeting of European-College-of-Neuropsychopharmacology, 28 Aug 2010 - 1 Sep 2010. 20:S544-S545. ELSEVIER SCIENCE BV (1 Aug 2010). Author weblink.
  • Attwood AS; Bailey JE; Nutt DJ; Ataya AF; Munafo MR. Effects of nicotinised and denicotinised cigarette smoking on response to 7.5% carbon dioxide anxiety challenge. 23rd Congress Meeting of European-College-of-Neuropsychopharmacology, 28 Aug 2010 - 1 Sep 2010. 20:S591-S591. ELSEVIER SCIENCE BV (1 Aug 2010). Author weblink.
  • Attwood AS; Bailey JE; Nutt DJ; Ataya AF; Munafo MR. EFFECTS OF NICOTINIZED AND DENICOTINIZED CIGARETTE SMOKING ON RESPONSE TO 7.5% CARBON DIOXIDE ANXIETY CHALLENGE. Summer Meeting of the British-Association-for-Psychopharmacology, 25 Jul 2010 - 28 Jul 2010. 24:A75-A75. SAGE PUBLICATIONS LTD (1 Aug 2010). Author weblink.
  • Lingford-Hughes AR; Watson B; Daglish MR; Reid A; Williams TM; Wilson SJ; Taylor LG; Stokes P; et alNutt DJ. IMAGING THE ROLE OF DOPAMINE IN HUMAN OPIOID ADDICTS. Summer Meeting of the British-Association-for-Psychopharmacology, 25 Jul 2010 - 28 Jul 2010. 24:A8-A8. SAGE PUBLICATIONS LTD (1 Aug 2010). Author weblink.
  • Mitchell EN; Marston H; Nutt D; Robinson ESJ. MANIPULATION OF ENVIRONMENTAL CONDITIONS ALTERS THE MAGNITUDE OF THE INSTRUMENTAL SUCCESSIVE NEGATIVE CONTRAST EFFECT IN RATS. Summer Meeting of the British-Association-for-Psychopharmacology, 25 Jul 2010 - 28 Jul 2010. 24:A77-A77. SAGE PUBLICATIONS LTD (1 Aug 2010). Author weblink.
  • Stokes PRA; Shotbolt JP; Copeland C; Nutt D; Lingford-Hughes AR; Howes O. PREVIOUS COCAINE USE DECREASES PRESYNAPTIC LIMBIC DOPAMINERGIC FUNCTION: A [18F]-DOPA PET STUDY. Summer Meeting of the British-Association-for-Psychopharmacology, 25 Jul 2010 - 28 Jul 2010. 24:A57-A57. SAGE PUBLICATIONS LTD (1 Aug 2010). Author weblink.
  • Quelch DR; Withey SL; Nutt DJ; Parker CA; Tyacke. SPECIES COMPARISON OF THE BINDING PROPERTIES FOR THREE D2/D3-DAR RADIOLIGANDS WIDELY USED IN PET IMAGING. Summer Meeting of the British-Association-for-Psychopharmacology, 25 Jul 2010 - 28 Jul 2010. 24:A33-A33. SAGE PUBLICATIONS LTD (1 Aug 2010). Author weblink.
  • Kealey S; Husbands S; Casey EM; Salinas CA; Parker CA; Jakobsen S; Tyacke RJ; Nutt DJ; et alGee AD. Synthesis and in vivo evaluation of [11C]BU99008 as a ligand for the imidazoline 12 binding site. 8th International Symposium on Functional Neuroreceptor Mapping of the Living Brain, 22 Jul 2010 - 24 Jul 2010. 52:S127-S128. ACADEMIC PRESS INC ELSEVIER SCIENCE (1 Aug 2010). Author weblink DOI.
  • Carhart-Harris RL; Williams TM; Sessa B; Tyacke RJ; Rich AS; Feilding A; Nutt DJ. THE ADMINISTRATION OF PSILOCYBIN TO HEALTHY HALLUCINOGEN-EXPERIENCED VOLUNTEERS IN A MOCK-FMRI ENVIRONMENT: A PRELIMINARY INVESTIGATION OF TOLERABILITY. Summer Meeting of the British-Association-for-Psychopharmacology, 25 Jul 2010 - 28 Jul 2010. 24:A60-A60. SAGE PUBLICATIONS LTD (1 Aug 2010). Author weblink.
  • Myers JFM; Rosso L; Kalk NJ; Watson BJ; Wilson S; Brooks DJ; Nutt DJ; Turkheimer FE; et alLingford-Hughes AR. The effects of zolpidem on in vivo binding of [C11]-flumazenil and [C11]-Ro15-4513. 8th International Symposium on Functional Neuroreceptor Mapping of the Living Brain, 22 Jul 2010 - 24 Jul 2010. 52:S191-S192. ACADEMIC PRESS INC ELSEVIER SCIENCE (1 Aug 2010). Author weblink DOI.
  • Nutt D. Treatments for generalised anxiety disorder: mechanism of action and clinical effect. 23rd Congress Meeting of European-College-of-Neuropsychopharmacology, 28 Aug 2010 - 1 Sep 2010. 20:S639-S639. ELSEVIER SCIENCE BV (1 Aug 2010). Author weblink.
  • Fitz-Simon N; Lewis SJ; Smith GD; Zuccolo L; Sayal K; Draper ES; Fraser R; Barrow M; et alRing S; Golding J; Nutt DJ; Heron J; Gray R. Alcohol Consumption during Pregnancy and Children's Cognitive Development: Mendelian Randomization Study Using the ADH1B Genotype. 57th Annual Meeting of the Society-for-Gynecologic-Investigation, 24 Mar 2010 - 27 Mar 2010. 17:99A-100A. SAGE PUBLICATIONS INC (1 Mar 2010). Author weblink.
  • Maron E; Toeru I; Hirvonen J; Vasar V; Shlik J; Nutt DJ; Tiihonen J; Hietala J. Brain serotonin transporter availability in panic disorder: Gender differences and implications for treatment response to escitalopram. 27th CINP Congress Meeting 2010, 6 Jun 2010 - 10 Jun 2010. 13:45-45. CAMBRIDGE UNIV PRESS (1 Jan 2010). Author weblink.
  • Quera-Salva M-A; Hajak G; Keufer-Le Gall S; Nutt D. Efficacy and safety of agomelatine in patients with major depressive disorder compared to escitalopram: a randomized, double-blind study. 27th CINP Congress Meeting 2010, 6 Jun 2010 - 10 Jun 2010. 13:82-82. CAMBRIDGE UNIV PRESS (1 Jan 2010). Author weblink.
  • Watson BJ; Bowsher B; Wilson S; Taylor LG; Kalk NJ; Griffin L; Lingford-Hughes AR; Munafo M; et alNutt DJ. A pilot study of the effectiveness of D-cycloserine during cue-exposure therapy in abstinent alcohol dependent subjects. 22nd Congress of the European-College-of-Neuropsychopharmacology, 12 Sep 2009 - 16 Sep 2009. 19:S640-S640. ELSEVIER SCIENCE BV (1 Sep 2009). Author weblink.
  • Williams TM; Davies SJC; Taylor LG; Nutt DJ; Lingford-Hughes A. Association between opioid receptor availability and anxiety in healthy controls but not in substance dependence. 22nd Congress of the European-College-of-Neuropsychopharmacology, 12 Sep 2009 - 16 Sep 2009. 19:S653-S654. ELSEVIER SCIENCE BV (1 Sep 2009). Author weblink.
  • Nutt D. Clinical aspects of GABA. 22nd Congress of the European-College-of-Neuropsychopharmacology, 12 Sep 2009 - 16 Sep 2009. 19:S219-S219. ELSEVIER SCIENCE BV (1 Sep 2009). Author weblink.
  • Bell C; Potokar J; Hood S; Nash J; Frampton C; Hince D; Argyropoulos S; Nutt D. Do changes in 5HT function underlie CBT efficacy in panic disorder?. 22nd Congress of the European-College-of-Neuropsychopharmacology, 12 Sep 2009 - 16 Sep 2009. 19:S201-S201. ELSEVIER SCIENCE BV (1 Sep 2009). Author weblink.
  • Bailey JE; Phillips S; Diaper A; Rich A; Lightman S; Nutt DJ. Does the inhalation of CO2 activate neurosteroids in healthy participants? A pilot study. 22nd Congress of the European-College-of-Neuropsychopharmacology, 12 Sep 2009 - 16 Sep 2009. 19:S615-S616. ELSEVIER SCIENCE BV (1 Sep 2009). Author weblink.
  • Bailey JE; Diaper A; Rich AS; Dawson GR; Nutt DJ. Dose-dependent effects of a clinically effective and non-effective dose of lorazepam on 7.5% CO2-induced anxiety. 22nd Congress of the European-College-of-Neuropsychopharmacology, 12 Sep 2009 - 16 Sep 2009. 19:S609-S609. ELSEVIER SCIENCE BV (1 Sep 2009). Author weblink.
  • Paterson LM; Nutt DJ; Durant C; Wilson SJ. Efficacy of trazodone in primary insomnia; a double-blind randomised placebo controlled polysomnographic study. 22nd Congress of the European-College-of-Neuropsychopharmacology, 12 Sep 2009 - 16 Sep 2009. 19:S385-S386. ELSEVIER SCIENCE BV (1 Sep 2009). Author weblink.
  • Gallagher AM; de Vries F; Nutt DJ; Donoghue J; Tylee AT; Cockle SM; van Staa TP; Lader MH. Initiation of hypnotics or anxiolytics in depressed patients treated in UK primary care. 22nd Congress of the European-College-of-Neuropsychopharmacology, 12 Sep 2009 - 16 Sep 2009. 19:S379-S379. ELSEVIER SCIENCE BV (1 Sep 2009). Author weblink.
  • de Vries F; Gallagher AM; Lader MH; Tylee AT; Donoghue J; Cockle SM; van Staa TP; Nutt DJ. Insomnia as a predictor of depression in UK primary care. 22nd Congress of the European-College-of-Neuropsychopharmacology, 12 Sep 2009 - 16 Sep 2009. 19:S372-S373. ELSEVIER SCIENCE BV (1 Sep 2009). Author weblink.
  • Paterson L; Wilson SJ; Nutt DJ. NAtional Patient Sleep Assessment Questionnaire III (Napsaq-III) in depression; a survey for psychiatrists. 22nd Congress of the European-College-of-Neuropsychopharmacology, 12 Sep 2009 - 16 Sep 2009. 19:S388-S388. ELSEVIER SCIENCE BV (1 Sep 2009). Author weblink.
  • Tyacke RJ; Robinson ESJ; Harris A; Lingford-Hughes AR; Nutt DJ. Paradoxical effects of GABA on the in vivo uptake of the partial inverse GABA agonist [3H]Ro15-4513 in rat brain. 22nd Congress of the European-College-of-Neuropsychopharmacology, 12 Sep 2009 - 16 Sep 2009. 19:S276-S277. ELSEVIER SCIENCE BV (1 Sep 2009). Author weblink.
  • Gallagher AM; de Vries F; Donoghue J; Nutt DJ; Tylee AT; Cockle SM; van Staa TP; Lader MH. Persistence with hypnotics in depressed patients treated in UK primary care. 22nd Congress of the European-College-of-Neuropsychopharmacology, 12 Sep 2009 - 16 Sep 2009. 19:S380-S381. ELSEVIER SCIENCE BV (1 Sep 2009). Author weblink.
  • Davies SJC; Bjerkeset O; Jackson PR; Nutt DJ; Lewis G. Quadratic relation of frequent panic attacks with systolic blood pressure - the HUNT study. 22nd Congress of the European-College-of-Neuropsychopharmacology, 12 Sep 2009 - 16 Sep 2009. 19:S595-S596. ELSEVIER SCIENCE BV (1 Sep 2009). Author weblink.
  • Gallagher AM; de Vries F; Nutt DJ; Donoghue J; Tylee AT; Cockle SM; van Staa TP; Lader MH. Resource use in depressed patients with sleep disturbance. 22nd Congress of the European-College-of-Neuropsychopharmacology, 12 Sep 2009 - 16 Sep 2009. 19:S378-S379. ELSEVIER SCIENCE BV (1 Sep 2009). Author weblink.
  • Bailey JE; Rich A; Wilson S; Nutt DJ. The cardiovascular effects of a subtype selective and non-selective benzodiazepine agonist in healthy volunteers. 22nd Congress of the European-College-of-Neuropsychopharmacology, 12 Sep 2009 - 16 Sep 2009. 19:S606-S607. ELSEVIER SCIENCE BV (1 Sep 2009). Author weblink.
  • Gallagher AM; de Vries F; Tylee AT; Lader MH; Donoghue J; Cockle SM; van Staa TP; Nutt DJ. The risk of suicide and suicidal ideation in depressed patients with sleep disturbance. 22nd Congress of the European-College-of-Neuropsychopharmacology, 12 Sep 2009 - 16 Sep 2009. 19:S379-S380. ELSEVIER SCIENCE BV (1 Sep 2009). Author weblink.
  • Nutt D. WHAT WE KNOW AND WHAT WE DON'T KNOW ABOUT HOW NEUROLEPTICS WORK?. 22nd Annual Meeting of the British-Neuropsychiatry-Association, 4 Feb 2008. 80:817-817. B M J PUBLISHING GROUP (1 Jul 2009). Author weblink.
  • Nutt D. Antidepressant pharmacotherapy-2009 and beyond. 10th Regional Meeting of the European-College-of-Neuropsychopharmacology, 23 Apr 2009 - 25 Apr 2009. 19:S108-S109. ELSEVIER SCIENCE BV (1 Apr 2009). Author weblink.
  • Christmas D; Wilson S; Diaper A; Rich A; do Haes JU; Sjogren M; Nutt D. A double-blind, placebo-controlled, parallel group study of the effect of Org 25935 on cognitive performance. European-College-of-Neuropsychopharmacology Workshop on Neuropsychopharmacology for Young Scientists in Europe, 5 Mar 2009 - 8 Mar 2009. 19:S64-S65. ELSEVIER SCIENCE BV (1 Mar 2009). Author weblink.
  • Durant C; Wilson S; Paterson L; Nutt D; Gill S; Patel N; Malizia A. Sleep changes during deep brain stimulation for treatment resistant depression: preliminary findings from a case study. European-College-of-Neuropsychopharmacology Workshop on Neuropsychopharmacology for Young Scientists in Europe, 5 Mar 2009 - 8 Mar 2009. 19:S67-S68. ELSEVIER SCIENCE BV (1 Mar 2009). Author weblink.
  • Dickens R; Jessop D; Lightman S; Nutt D; Wilson S. Morning cortisol response in patients with parasomnia and insomnia. 19th Congress of the European-Sleep-Research-Society, 9 Sep 2008 - 13 Sep 2008. 17:193-193. WILEY-BLACKWELL PUBLISHING, INC (1 Dec 2008). Author weblink.
  • Paterson LM; Nutt DJ; Wilson SJ. NAPSAQ II; national patient sleep assessment questionnaire in depression; a survey for general practitioners. 19th Congress of the European-Sleep-Research-Society, 9 Sep 2008 - 13 Sep 2008. 17:260-260. WILEY-BLACKWELL PUBLISHING, INC (1 Dec 2008). Author weblink.
  • Green A; Hicks J; Nutt D; Wilson S. Perception of drug treatment in patients with chronic insomnia. 19th Congress of the European-Sleep-Research-Society, 9 Sep 2008 - 13 Sep 2008. 17:193-194. WILEY-BLACKWELL PUBLISHING, INC (1 Dec 2008). Author weblink.
  • Durant CF; Wilson SJ; Paterson LM; Nutt DJ; Gill SS; Patel NK; Malizia AL. Sleep changes associated with mood improvement during acute deep brain stimulation of two different brain targets for treatment resistant depression. 19th Congress of the European-Sleep-Research-Society, 9 Sep 2008 - 13 Sep 2008. 17:259-260. WILEY-BLACKWELL PUBLISHING, INC (1 Dec 2008). Author weblink.
  • Phillips S; Lightman S; Nutt D; Wilson S. Sleep stages and automatic overnight cortisol sampling. 19th Congress of the European-Sleep-Research-Society, 9 Sep 2008 - 13 Sep 2008. 17:228-228. WILEY-BLACKWELL PUBLISHING, INC (1 Dec 2008). Author weblink.
  • Paterson LM; Nutt DJ; Wilson SJ. A national patient sleep assessment questionnaire in depression (NAPSAQ II); a survey for general practitioners. 21st Congress of the European-College-of-Neuropsychopharmacology, 30 Aug 2008 - 3 Sep 2008. 18:S342-S342. ELSEVIER SCIENCE BV (1 Aug 2008). Author weblink DOI.
  • Nutt DJ. Can neurobiology guide the choice of treatment?. 21st Congress of the European-College-of-Neuropsychopharmacology, 30 Aug 2008 - 3 Sep 2008. 18:S599-S599. ELSEVIER SCIENCE BV (1 Aug 2008). Author weblink DOI.
  • Williams TM; Davies SJC; Taylor LG; Daglish MR; Nutt DJ; Lingford-Hughes A. Can personality traits elucidate the relationship between substance dependence and opioid receptor availability?. 21st Congress of the European-College-of-Neuropsychopharmacology, 30 Aug 2008 - 3 Sep 2008. 18:S536-S536. ELSEVIER SCIENCE BV (1 Aug 2008). Author weblink DOI.
  • Tyacke RJ; Reid RHA; Grant EJ; Henry B; Zelaya F; Reul JMHM; Lightman S; Williams SCR; et alNutt DJ; Malizia AL. Hydrocortisone induces limbic, hippocampal and limbic/paralimbic cerebral perfusion changes as measured by 3T blood oxygenation level dependent (BOLD) phMRI. 21st Congress of the European-College-of-Neuropsychopharmacology, 30 Aug 2008 - 3 Sep 2008. 18:S269-S269. ELSEVIER SCIENCE BV (1 Aug 2008). Author weblink.
  • Wilson SJ; Dickens R; Jessop D; Lightma SL; Nutt DJ. Morning cortisol response in patients with parasomnias and insomnia. 21st Congress of the European-College-of-Neuropsychopharmacology, 30 Aug 2008 - 3 Sep 2008. 18:S584-S584. ELSEVIER SCIENCE BV (1 Aug 2008). Author weblink.
  • Brunello N; Bettica P; Amato D; Maier G; Nutt D. Pharmacokinetics of (S)-zopiclone and (S)-desmethylzopiclone following dosing with zopiclone and eszopiclone. 21st Congress of the European-College-of-Neuropsychopharmacology, 30 Aug 2008 - 3 Sep 2008. 18:S581-S582. ELSEVIER SCIENCE BV (1 Aug 2008). Author weblink DOI.
  • Bailey JE; Papadopoulos A; Diaper A; Phillips S; Schmidt M; van der Ark P; Dawson G; Nutt DJ. Preliminary evidence of efficacy of a CRF1 receptor antagonist in the 7.5% CO2 model of anxiety. 21st Congress of the European-College-of-Neuropsychopharmacology, 30 Aug 2008 - 3 Sep 2008. 18:S494-S494. ELSEVIER SCIENCE BV (1 Aug 2008). Author weblink DOI.
  • Maron E; Tammiste A; Kallassalu K; Eller T; Vasar V; Nutt D; Metspalu A. Serotonin transporter promoter polymorphism does not influence treatment response to escitalopram in depression. 21st Congress of the European-College-of-Neuropsychopharmacology, 30 Aug 2008 - 3 Sep 2008. 18:S331-S331. ELSEVIER SCIENCE BV (1 Aug 2008). Author weblink DOI.
  • Wilson S; Phillips S; Lightman SL; Nutt DJ. Sleep stages and automatic overnight cortisol sampling. 21st Congress of the European-College-of-Neuropsychopharmacology, 30 Aug 2008 - 3 Sep 2008. 18:S584-S585. ELSEVIER SCIENCE BV (1 Aug 2008). Author weblink.
  • Nutt D. Brain circuits and insomnia: role of GABA. 26th Collegium Internationale Neuro-Psychopharmacologicum Congress (CINP), 13 Jul 2008 - 17 Jul 2008. 11:315-316. CAMBRIDGE UNIV PRESS (1 Jul 2008). Author weblink.
  • Nutt D. GABA-(A) receptor subtypes as a target for anxiolytic drugs. 26th Collegium Internationale Neuro-Psychopharmacologicum Congress (CINP), 13 Jul 2008 - 17 Jul 2008. 11:73-73. CAMBRIDGE UNIV PRESS (1 Jul 2008). Author weblink.
  • Nutt D. Multiple acting agents in depression. 26th Collegium Internationale Neuro-Psychopharmacologicum Congress (CINP), 13 Jul 2008 - 17 Jul 2008. 11:52-52. CAMBRIDGE UNIV PRESS (1 Jul 2008). Author weblink.
  • Hood S; Melichar J; Taylor L; Daglish M; Holmes RB; Parkin VJ; Rees M; Kalk N; et alLenox-Smith A; Lingford-Hughes A; Nutt D. Noradrenergic function in generalised anxiety disorder (GAD): A single photon emission tomography (SPET) study. 26th Collegium Internationale Neuro-Psychopharmacologicum Congress (CINP), 13 Jul 2008 - 17 Jul 2008. 11:278-278. CAMBRIDGE UNIV PRESS (1 Jul 2008). Author weblink.
  • Nutt D. GABA-A receptor inverse agonists as alcohol antagonists: the first human study. Conference on Alcoholism and Stress - A Framework for Future Treatment Strategies, 6 May 2008 - 8 May 2008. 42:313-313. ELSEVIER SCIENCE INC (1 Jun 2008). Author weblink.
  • Kerr JR; Petty R; Burke B; Gough J; Fear D; Sinclair LI; Mattey DL; Richards SCM; et alMontgomery J; Baldwin DA; Kellam P; Harrison TJ; Griffin GE; Main J; Enlander D; Nutt DJ; Holgate ST. Gene expression subtypes in patients with chronic fatigue syndrome/myalgic encephalomyelitis. Conference of the International-Association-for-Chronic-Fatigue-Syndrome/Myalgic Encephalomyelits, 10 Jan 2007 - 14 Jan 2007. 197:1171-1184. OXFORD UNIV PRESS INC (15 Apr 2008). Author weblink DOI.
  • Carhart-Harris R; Nutt DJ; Munaf M; Wilson SJ. Current and former ecstasy users report different sleep to matched controls: a web based questionnaire study. European-College-of-Neuropsychopharmacology Workshop on Neuropsychopharmacology for Young Scientists in Europe, 6 Mar 2008 - 9 Mar 2008. 18:S66-S67. ELSEVIER SCIENCE BV (1 Mar 2008). Author weblink DOI.
  • Parker CA; Tyacke RJ; Rabiner EA; Salinas CA; Gunn RN; Richards SN; Rosalki J; Gee AD; et alJakobsen S; Greedy B; Husbands SM; Slifstein M; Nutt DJ; Laruelle M. [(11)C](+)RX-821024: A novel tracer for imaging alpha(2)-adrenoceptors. 7th International Symposium on Functional Neuroreceptor Mapping of the Living Brain, 17 Jul 2008 - 19 Jul 2008. 41:T98-T98. ACADEMIC PRESS INC ELSEVIER SCIENCE (1 Jan 2008). Author weblink DOI.
  • Christmas D; Davies S; Sinclair L; Hood S; Potokar J; Srivastava S; Nutt D. A systematic review of antidepressant induced jitteriness/anxiety syndrome. 20th Congress of the European-College-of-Neuropsychopharmacology, 13 Oct 2007 - 17 Oct 2007. 17:S353-S353. ELSEVIER SCIENCE BV (1 Oct 2007). Author weblink DOI.
  • Hoodl S; Hince DA; Robinson H; Christmas D; Nutt DJ. Acute tryptophan depletion increases plasma prolactin in women but not men. 20th Congress of the European-College-of-Neuropsychopharmacology, 13 Oct 2007 - 17 Oct 2007. 17:S336-S337. ELSEVIER SCIENCE BV (1 Oct 2007). Author weblink DOI.
  • Williams TM; Lingford-Hughes A; Davies SJC; Daglish MRC; Taylor LG; Hammers A; Brooks DJ; Grasby P; et alMyles JS; Nutt DJ. Increased opioid receptor binding in early abstinence from dependent opioid and alcohol use and relationship to craving. 20th Congress of the European-College-of-Neuropsychopharmacology, 13 Oct 2007 - 17 Oct 2007. 17:S187-S188. ELSEVIER SCIENCE BV (1 Oct 2007). Author weblink DOI.
  • Nutt DJ; Mandel F; Baldinetti F. Rapid onset anxiolitic efficacy after a single dose of pregabalin: evaluation using dental anxiety model. 20th Congress of the European-College-of-Neuropsychopharmacology, 13 Oct 2007 - 17 Oct 2007. 17:S503-S503. ELSEVIER SCIENCE BV (1 Oct 2007). Author weblink DOI.
  • Paterson LM; Dinotaro KD; Nutt DJ; Wilson SJ. Sleep disturbance in depression: results from a UK survey. 20th Congress of the European-College-of-Neuropsychopharmacology, 13 Oct 2007 - 17 Oct 2007. 17:S320-S320. ELSEVIER SCIENCE BV (1 Oct 2007). Author weblink DOI.
  • Tyacke RJ; Reid A; Holmes R; Grant E; Zelaya F; Reul JMHM; Lightman S; Williams SCR; et alNutt DJ; Malizia AL. Subjective effects of acute dose of hydrocortisone in healthy volunteers. 20th Congress of the European-College-of-Neuropsychopharmacology, 13 Oct 2007 - 17 Oct 2007. 17:S288-S289. ELSEVIER SCIENCE BV (1 Oct 2007). Author weblink DOI.
  • Papadopoulos A; Bailey JE; Rich A; Nutt DJ. The further development of a new model of GAD: I - the effects of single dose alprazolam and zolpidem. 20th Congress of the European-College-of-Neuropsychopharmacology, 13 Oct 2007 - 17 Oct 2007. 17:S521-S522. ELSEVIER SCIENCE BV (1 Oct 2007). Author weblink DOI.
  • Bailey JE; Papadopoulos A; Rich A; Nutt DJ. The further development of a new model of GAD: II - The effects of single dose anxiolytic medication. 20th Congress of the European-College-of-Neuropsychopharmacology, 13 Oct 2007 - 17 Oct 2007. 17:S520-S521. ELSEVIER SCIENCE BV (1 Oct 2007). Author weblink DOI.
  • Bailey JE; Phillips SM; Papadopoulos A; Diaper A; Rich A; Tyacke RJ; Seddon K; Nutt DJ. The further development of a new model of GAD: no effect of 7.5% CO2 on HPA axis activation in healthy volunteers. 20th Congress of the European-College-of-Neuropsychopharmacology, 13 Oct 2007 - 17 Oct 2007. 17:S521-S521. ELSEVIER SCIENCE BV (1 Oct 2007). Author weblink DOI.
  • Nutt D; Bailey J; Papadopoulos A. Validation of CO2 stress test in humans. 20th Congress of the European-College-of-Neuropsychopharmacology, 13 Oct 2007 - 17 Oct 2007. 17:S194-S194. ELSEVIER SCIENCE BV (1 Oct 2007). Author weblink DOI.
  • Steckler T; den Boer JA; Nutt D; Van Laere K; Langlois X; Warnock G; Drinkenburg WHIM; Schmidt M. Translational models of anxiety disorders for drug discovery and development. 12th Biennial Meeting of the European-Pharmacology-Society, 31 Aug 2007 - 3 Sep 2007. 18:S110-S110. LIPPINCOTT WILLIAMS & WILKINS (1 Sep 2007). Author weblink.
  • Nutt DJ. Validation studies on CO2 models of anxiety in normal volunteers. 62nd Annual Scientific Meeting of the Society-of-Biological-Psychiatry, 2007. 61:197S-198S. ELSEVIER SCIENCE INC (15 Apr 2007). Author weblink.
  • Williams TM; Lingford-Hughes A; Daglish MRC; Taylor LG; Hammers A; Brooks DJ; Grasby P; Nutt DJ. Increased opiold receptor binding in early abstinence from dependent opioid and alcohol use and relationship to craving. ECNP Workshop on Neuropsychopharmacology for Young Scientists in Europe, 8 Mar 2007 - 11 Mar 2007. 17:S78-S79. ELSEVIER SCIENCE BV (1 Mar 2007). Author weblink DOI.
  • Papadopoulos A; Bailey JE; Nutt DJ. The effects of C-cycloserine on a cognitive task under different states of anxiety. ECNP Workshop on Neuropsychopharmacology for Young Scientists in Europe, 8 Mar 2007 - 11 Mar 2007. 17:S37-S37. ELSEVIER SCIENCE BV (1 Mar 2007). Author weblink DOI.
  • Davies SJ; Jackson PR; Lewis G; Hood SD; Nutt DJ; Potokar JP. Panic attacks more likely to include autonomic symptoms in patients with hypertension than in normotensives - A comparison of symptoms, and factor analysis. 45th Annual Meeting of the American-College-of-Neuropsychopharmacolgy, 3 Dec 2006 - 7 Dec 2006. 31:S231-S231. NATURE PUBLISHING GROUP (1 Dec 2006). Author weblink.
  • Bailey JE; Papadopoulos A; Nutt DJ. A pooled analysis of the effects of 7.5% CO2 inhalation in healthy participants: a useful model of human anxiety?. 19th Congress of the European-College-of-Neuropsychopharmacology, 16 Sep 2006 - 20 Sep 2006. 16:S474-S474. ELSEVIER SCIENCE BV (1 Sep 2006). Author weblink DOI.
  • Nutt D. Assessing the noradrenalin system in humans. 19th Congress of the European-College-of-Neuropsychopharmacology, 16 Sep 2006 - 20 Sep 2006. 16:S206-S206. ELSEVIER SCIENCE BV (1 Sep 2006). Author weblink DOI.
  • Argyropoulos SV; Hood SD; Davies SJC; Hince DA; Morris K; Nutt DJ; Potokar JP. Dopaminergic challenges in social anxiety disorder. 19th Congress of the European-College-of-Neuropsychopharmacology, 16 Sep 2006 - 20 Sep 2006. 16:S186-S186. ELSEVIER SCIENCE BV (1 Sep 2006). Author weblink DOI.
  • Paterson L; Ivarsson M; Hutson P; Nutt DJ; Wilson SJ. Effects on sleep of caffeine and its combination with trazodone or zolpidem in healthy volunteers. 19th Congress of the European-College-of-Neuropsychopharmacology, 16 Sep 2006 - 20 Sep 2006. 16:S551-S551. ELSEVIER SCIENCE BV (1 Sep 2006). Author weblink DOI.
  • Nutt D. Evolving therapy for managing depression: a brief look into the future. 19th Congress of the European-College-of-Neuropsychopharmacology, 16 Sep 2006 - 20 Sep 2006. 16:S591-S591. ELSEVIER SCIENCE BV (1 Sep 2006). Author weblink DOI.
  • Davies SJC; Hood SD; Argyropoulos SV; Hince DA; Morris K; Nutt DJ; Potokar J. Serotonin reuptake inhibition and dopamine receptor antagonism together buffer the blood pressure response to stress in social anxiety disorder. 19th Congress of the European-College-of-Neuropsychopharmacology, 16 Sep 2006 - 20 Sep 2006. 16:S458-S458. ELSEVIER SCIENCE BV (1 Sep 2006). Author weblink DOI.
  • Hood SD; Argyropoulos SV; Davies SJC; Hince DA; Bell CJ; Nutt DJ; Potokar J. The effect of acute tryptophan depletion on challenge induced anxiety in anxiety disorder patients is independent of a history of depression. 19th Congress of the European-College-of-Neuropsychopharmacology, 16 Sep 2006 - 20 Sep 2006. 16:S473-S474. ELSEVIER SCIENCE BV (1 Sep 2006). Author weblink DOI.
  • Bailey JE; Papadopoulos A; Nutt DJ. The effects of D-cycloserine on a cognitive function task under different states of anxiety in healthy volunteers. 19th Congress of the European-College-of-Neuropsychopharmacology, 16 Sep 2006 - 20 Sep 2006. 16:S457-S458. ELSEVIER SCIENCE BV (1 Sep 2006). Author weblink DOI.
  • Paterson L; Ivarsson M; Hutson P; Nutt DJ; Wilson SJ. Validation of a translational model of insomnia in rats and human volunteers. 19th Congress of the European-College-of-Neuropsychopharmacology, 16 Sep 2006 - 20 Sep 2006. 16:S550-S550. ELSEVIER SCIENCE BV (1 Sep 2006). Author weblink DOI.
  • Paterson LM; Wilson SJ; Nutt DJ; Hutson PH; Ivarsson M. Validation of a translational model of insomnia in rats and human volunteers. 18th Congress of the European-Sleep-Research-Society, 12 Sep 2006 - 16 Sep 2006. 15:38-38. BLACKWELL PUBLISHING (1 Sep 2006). Author weblink.
  • Nutt DJ. Modelling anxiety disorders in human volunteers. Workshop on Neuropsychopharmacology for Young Scienctists in Europe, 9 Mar 2006 - 12 Mar 2006. 16:S86-S86. ELSEVIER SCIENCE BV (1 Mar 2006). Author weblink DOI.
  • Davies S; Jackson PR; Lewis G; Hood S; Nutt DJ. Panic attacks are more likely to include autonomic symptoms in patients with hypertension than in normotensives - a comparison of symptoms, and factor analysis. Workshop on Neuropsychopharmacology for Young Scienctists in Europe, 9 Mar 2006 - 12 Mar 2006. 16:S94-S94. ELSEVIER SCIENCE BV (1 Mar 2006). Author weblink DOI.
  • Papakostas GI; Nutt DJ; Tucker VL; Krishen A; Fava M. Resolution of sleepiness and fatigue in the treatment of major depressive disorder: A comparison of bupropion and the selective serotonin reuptake inhibitors. 44th Annual Meeting of the American-College-Neuropsychopharmacology, 11 Dec 2005 - 15 Dec 2005. 30:S186-S187. NATURE PUBLISHING GROUP (1 Dec 2005). Author weblink.
  • Bailey S; Zhang Z; Nutt DJ. 5-HT1A receptor activation induces upregulation of GABAAR gene expression in neurones. 18th ECNP Congress 2005, 22 Oct 2005 - 26 Oct 2005. 15:S530-S531. ELSEVIER SCIENCE BV (1 Oct 2005). Author weblink.
  • Toru I; Shlik J; Maron E; Vasar V; Nutt DJ. Acute tryptophan depletion does not modify the response to cck-4 challenge in patients with panic disorder after citalopram treatment. 18th ECNP Congress 2005, 22 Oct 2005 - 26 Oct 2005. 15:S555-S556. ELSEVIER SCIENCE BV (1 Oct 2005). Author weblink.
  • Davies SJC; Hood SD; Argyropoulos SV; Morris K; Bell CJ; Witchel HJ; Jackson PR; Nutt DJ; et alPotokar J. Depleting brain serotonin enhances both cardiovascular and psychological responses to stress in recovered patients with anxiety disorders. 18th ECNP Congress 2005, 22 Oct 2005 - 26 Oct 2005. 15:S536-S536. ELSEVIER SCIENCE BV (1 Oct 2005). Author weblink.
  • Daglish M; Lingford-Hughes AR; Grasby PG; Brooks DJ; Nutt DJ. Does heroin release dopamine? A positron emission tomography study. 18th ECNP Congress 2005, 22 Oct 2005 - 26 Oct 2005. 15:S341-S341. ELSEVIER SCIENCE BV (1 Oct 2005). Author weblink.
  • Lingford-Hughes AR; Daglish M; Brooks DJ; Nutt DJ. Imaging brain opioid receptors in alcohol and heroin dependence. 18th ECNP Congress 2005, 22 Oct 2005 - 26 Oct 2005. 15:S331-S331. ELSEVIER SCIENCE BV (1 Oct 2005). Author weblink.
  • Bailey JE; Kendrick AH; Diaper A; Nutt DJ. The 7.5% CO2 model of anxiety: effects of anxiolytic medication on psychological and physiological measures. 18th ECNP Congress 2005, 22 Oct 2005 - 26 Oct 2005. 15:S548-S548. ELSEVIER SCIENCE BV (1 Oct 2005). Author weblink.
  • Welch S; Lingford-Hughes AR; Nutt DJ. Treatment of nicotine dependence and cocaine addiction. 18th ECNP Congress 2005, 22 Oct 2005 - 26 Oct 2005. 15:S361-S362. ELSEVIER SCIENCE BV (1 Oct 2005). Author weblink.
  • Wilson SJ; Besson M; Lingford-Hughes A; Dawson GR; Nutt DJ. Antagonisinc alcohol's actions by an inverse agonist at alpha 5 subtype GABA(A) receptors in humans. Summer Meeting of the British-Association-for-Psychoparmacology, 24 Jul 2005 - 27 Jul 2005. 19:A24-A24. SAGE PUBLICATIONS LTD (1 Sep 2005). Author weblink.
  • Bailey JE; Nutt DJ. Are personality factors related to the CO2 response in healthy volunteers?. Summer Meeting of the British-Association-for-Psychopharmacology, 24 Jul 2005 - 27 Jul 2005. 19:A18-A18. SAGE PUBLICATIONS LTD (1 Sep 2005). Author weblink.
  • Anderson NJ; Nutt DJ; Hudson AL; Robinson ESJ. C-fos activation in rat brain following administration of imidazoline binding site and monoamine oxidase ligands. Summer Meeting of the British-Association-for-Psychopharmacology, 24 Jul 2005 - 27 Jul 2005. 19:A38-A38. SAGE PUBLICATIONS LTD (1 Sep 2005). Author weblink.
  • Davies SJC; Hood SC; Argyropoulos SV; Morris K; Bell CJ; Witchel HJ; Jackson PR; Nutt DJ; et alPotokar J. Depleting brain 5HT enhances both cardiovascular and psychological stress reactivity in humans. Summer Meeting of the British-Association-for-Psychoparmacology, 24 Jul 2005 - 27 Jul 2005. 19:A20-A20. SAGE PUBLICATIONS LTD (1 Sep 2005). Author weblink.
  • Anderson NJ; Tyacke RJ; Husbands SM; Nutt DJ; Hudson AL; Robinson ESJ. Distribution of the endogenous B-carboline, harmane, in rat brain. Summer Meeting of the British-Association-for-Psychopharmacology, 24 Jul 2005 - 27 Jul 2005. 19:A38-A38. SAGE PUBLICATIONS LTD (1 Sep 2005). Author weblink.
  • Man J; Geys H; Hudson AL; Nutt DJ; Ashton D. Further validation of the quinpirole-induced compulsive checking paradigm as a model for obsessive-compulsive disorder (OCD)-restraint stress exacerbates some compulsive checking measures. Summer Meeting of the British-Association-for-Psychoparmacology, 24 Jul 2005 - 27 Jul 2005. 19:A16-A16. SAGE PUBLICATIONS LTD (1 Sep 2005). Author weblink.
  • Bailey JE; Kendrick A; Diaper A; Nutt DJ. The effects of lorazepam and paroxetine on the 7.5% CO2 model of anxiety. Summer Meeting of the British-Association-for-Psychopharmacology, 24 Jul 2005 - 27 Jul 2005. 19:A18-A18. SAGE PUBLICATIONS LTD (1 Sep 2005). Author weblink.
  • Potokar J; Shufflebotham J; Hood S; Hendry J; Rich A; Probert C; Nutt D. Tryptophan depletion in irritable bowel syndrome patient subgroups. Summer Meeting of the British-Association-for-Psychoparmacology, 24 Jul 2005 - 27 Jul 2005. 19:A20-A20. SAGE PUBLICATIONS LTD (1 Sep 2005). Author weblink.
  • Davies S; Hood S; Argyropoulis S; Bell C; Jackson P; Nutt D; Potokar J. Hypertension and anxiety - Serotonin depletion associated with consistent excess pressor response to stress challenge in patients with treated anxiety disorders. 15th European Meeting on Hypertension, 17 Jun 2005 - 21 Jun 2005. 23:S139-S139. LIPPINCOTT WILLIAMS & WILKINS (1 Jun 2005). Author weblink.
  • Zhang Z; Nutt DJ; Bailey SJ. 5-HT1A receptor activation induces upregulation of GABA(A)R gene expression in neurones. Workshop on Neuropsychopharmacology for Young Scientists in Europe, 12 Mar 2004 - 14 Mar 2004. 15:S27-S27. ELSEVIER SCIENCE BV (1 Mar 2005). Author weblink DOI.
  • Ignjatovic D; Ignjatovic M; Nutt DJ. Pharmacological treatment of late-life depression. International Meeting on Pharmacovigilance in Psychiatry, Therapetic Drug Monitoring and Pharmacognetics of Psychotropic Drugs, 1 Sep 2004 - 3 Sep 2004. 38:53-54. GEORG THIEME VERLAG KG (1 Jan 2005). Author weblink.
  • Nash JR; Sargent PA; Rabiner EA; Hood SD; Argyropoulos S; Grasby PM; Nutt DJ. Altered 5HT1A binding in panic disorder demonstrated by positron emission tomography. 17th Congress of the European-College-of-Neuropsychopharmacology, 9 Oct 2004 - 13 Oct 2004. 14:S322-S323. ELSEVIER SCIENCE BV (1 Oct 2004). Author weblink DOI.
  • Nutt DJ; Bailey JE. Can CO2 be used to model different anxiety disorders?. 17th Congress of the European-College-of-Neuropsychopharmacology, 9 Oct 2004 - 13 Oct 2004. 14:S153-S154. ELSEVIER SCIENCE BV (1 Oct 2004). Author weblink DOI.
  • Nutt DJ. Generalized anxiety disorder: A comorbid disease. 17th Congress of the European-College-of-Neuropsychopharmacology, 9 Oct 2004 - 13 Oct 2004. 14:S411-S412. ELSEVIER SCIENCE BV (1 Oct 2004). Author weblink DOI.
  • Melichar JK; Heath T; Jackson LN; Watson B; Nutt DJ; Donaldson LF. Serotonin and the 5HT(1A) receptor in the signalling of taste: A novel human surrogate marker?. 17th Congress of the European-College-of-Neuropsychopharmacology, 9 Oct 2004 - 13 Oct 2004. 14:S225-S226. ELSEVIER SCIENCE BV (1 Oct 2004). Author weblink DOI.
  • Law FD; Myles JS; Daglish MRC; Nutt DJ. The clinical use of buprenorphine in opiate addiction: evidence and practice. Joint Meeting on Innovations in the Treatment of Addications, May 2003. 16:246-274. BLACKWELL MUNKSGAARD (1 Oct 2004). Author weblink DOI.
  • Hood SD; Argyropoulos SV; Potokar J; Bell CJ; Shufflebotham J; Rich AS; Nutt DJ. A meta-analysis of acute tryptophan depletion studies in anxiety disorders using individual patients' data. Summer Meeting of the British-Association-for-Psychopharmacology, 25 Jul 2004 - 28 Jul 2004. 18:A22-A22. SAGE PUBLICATIONS LTD (1 Sep 2004). Author weblink.
  • Linford-Hughes AR; Davies SJC; Taylor LG; Williams TM; Daglish MRC; Pandit S; Hammers A; Brooks DJ; et alNutt DJ. A PET study of opioid receptors in abstinent alcohol dependent patients. Summer Meeting of the British-Association-for-Psychopharmacology, 25 Jul 2004 - 28 Jul 2004. 18:A41-A41. SAGE PUBLICATIONS LTD (1 Sep 2004). Author weblink.
  • Anderson NJ; Lupo PA; Nutt DJ; Hudson AL; Robinson ESJ. Brain 12 binding does not correspond to monoamine oxidase A or B populations across five species. Summer Meeting of the British-Association-for-Psychopharmacology, 25 Jul 2004 - 28 Jul 2004. 18:A34-A34. SAGE PUBLICATIONS LTD (1 Sep 2004). Author weblink.
  • Man J; Willems R; Hudson A; Nutt D; Ashton D. Chronic quinpirole-induced compulsive checking in rats - What is the temporal distribution of compulsive checking parameters?. Summer Meeting of the British-Association-for-Psychopharmacology, 25 Jul 2004 - 28 Jul 2004. 18:A30-A30. SAGE PUBLICATIONS LTD (1 Sep 2004). Author weblink.
  • Wilson SJ; Bailey JE; Rich AS; Nutt DJ. Dizziness after 5HT(1A) receptor agonists is not due to postural hypotension. Summer Meeting of the British-Association-for-Psychopharmacology, 25 Jul 2004 - 28 Jul 2004. 18:A20-A20. SAGE PUBLICATIONS LTD (1 Sep 2004). Author weblink.
  • Lingford-Hughes AR; Hayward RC; Mill J; Ball D; Nutt DJ. Dopamine receptor genotypes in non-dependent and dependent smokers. Summer Meeting of the British-Association-for-Psychopharmacology, 25 Jul 2004 - 28 Jul 2004. 18:A30-A30. SAGE PUBLICATIONS LTD (1 Sep 2004). Author weblink.
  • Hood SD; Nash JR; Bell CJ; Hurst J; Adrover MDM; Pyle AC; Rich AS; Slattery HL; et alPotokar JP; Nutt DJ. Early results from a tryptophan depiction study in panic disorder patients treated with cognitive behavioural therapy. Summer Meeting of the British-Association-for-Psychopharmacology, 25 Jul 2004 - 28 Jul 2004. 18:A22-A22. SAGE PUBLICATIONS LTD (1 Sep 2004). Author weblink.
  • Abu Ghazaleh H; Lalies M; Nutt DJ; Hudson AL. In vitro [3H]harmane (1-methyl-(beta)-carboline) uptake in the rat cortex. Summer Meeting of the British-Association-for-Psychopharmacology, 25 Jul 2004 - 28 Jul 2004. 18:A31-A31. SAGE PUBLICATIONS LTD (1 Sep 2004). Author weblink.
  • Tyacke RJ; Robinson ESJ; Hume S; Nutt DJ; Hudson AL. Is P-glycoprotein responsible for the poor brain accumulation of the potential pet ligand BU97001 in rat brain?. Summer Meeting of the British-Association-for-Psychopharmacology, 25 Jul 2004 - 28 Jul 2004. 18:A35-A35. SAGE PUBLICATIONS LTD (1 Sep 2004). Author weblink.
  • Bailey JE; Rich N; Wilson SJ; Nutt DJ. Subjective ratings in volunteer populations: Two methods, same task, different outcome. Summer Meeting of the British-Association-for-Psychopharmacology, 25 Jul 2004 - 28 Jul 2004. 18:A20-A20. SAGE PUBLICATIONS LTD (1 Sep 2004). Author weblink.
  • Bailey JE; Kendrick A; Wilson SJ; Nutt DJ. The effects of the CO2 challenge on a novel group performance task. Summer Meeting of the British-Association-for-Psychopharmacology, 25 Jul 2004 - 28 Jul 2004. 18:A46-A46. SAGE PUBLICATIONS LTD (1 Sep 2004). Author weblink.
  • Nutt D. Anxiety and depression: individual entities or two sides of the same coin?. 16th Congress of the European-College-of-Neuropsychopharmacology, 20 Sep 2003 - 24 Sep 2003. 8:19-24. TAYLOR & FRANCIS AS (1 Aug 2004). Author weblink DOI.
  • Daglish MRC; Lingford-Hughes AR; Nutt DJ. Brain imaging alcohol cue-reactivity. 12th International Congress of the International-Society-for-Biomedical-Research-on-Alcoholism, 29 Sep 2004 - 2 Oct 2004. 28:65A-65A. LIPPINCOTT WILLIAMS & WILKINS (1 Aug 2004). Author weblink DOI.
  • Hood SD; Argyropoulos S; Potokar J; Bell C; Shufflebotham J; Nutt DJ. A meta-analysis of acute tryptophan Depletion studies in anxiety disorders using individual patients' data. 24th CINP Congress, 20 Jun 2004 - 24 Jun 2004. 7:S194-S194. CAMBRIDGE UNIV PRESS (1 Jun 2004). Author weblink.
  • Nutt D. Imaging receptors in human anxiety. 24th CINP Congress, 20 Jun 2004 - 24 Jun 2004. 7:S17-S17. CAMBRIDGE UNIV PRESS (1 Jun 2004). Author weblink.
  • Tyacke R; Robinson E; Hudson A; Nutt D; Lingford-Huges A. Effects of endogenous noradrenaline on the in vivo binding of [H-3]2-methoxyidazoxan ([H-3]RX821002) in rat brain. 5th International Symposium on Functional Neuroreceptor Mapping of the Living Brain, 15 Jul 2004 - 17 Jul 2004. 22:T94-T95. ACADEMIC PRESS INC ELSEVIER SCIENCE (1 Jan 2004). Author weblink.
  • Nash JR; Sargent PA; Rabiner EA; Hood SD; Argyropoulos SV; Grasby PM; Nutt DJ. Altered 5HT(1A) binding in panic disorder demonstrated by PET scanning. Summer Meeting of the British-Association-for-Psychopharmacology, 20 Jul 2003 - 23 Jul 2003. 17:A30-A30. SAGE PUBLICATIONS LTD (1 Sep 2003). Author weblink.
  • Nutt DJ; Nash JR; Bell C; Adrover M; Sargent PA; Rabiner EA; Hood S; Argyropoulos S; et alGrasby R. Antidepressant mechanisms in anxiety disorders. 16th Congress of the European-College-of-Neuropsychopharmacology, 20 Sep 2003 - 24 Sep 2003. 13:S173-S173. ELSEVIER SCIENCE BV (1 Sep 2003). Author weblink DOI.
  • Anderson NJ; Robinson ESJ; Husbands S; DeLagrange P; Nutt DJ; Hudson AL. Characterisation [H-3]harman binding to rat whole brain membranes. Summer Meeting of the British-Association-for-Psychopharmacology, 20 Jul 2003 - 23 Jul 2003. 17:A39-A39. SAGE PUBLICATIONS LTD (1 Sep 2003). Author weblink.
  • Wilson SJ; Bailey JE; Rich AS; Tournoux A; Nutt DJ. Effects of 5HT(1A) agonists on sleep in normal volunteers: a comparison of eptapirone, buspirone, and placebo. Summer Meeting of the British-Association-for-Psychopharmacology, 20 Jul 2003 - 23 Jul 2003. 17:A73-A73. SAGE PUBLICATIONS LTD (1 Sep 2003). Author weblink.
  • Cambridge NJ; Edwards ME; Nutt DJ; Hudson AL; Robinson ESJ. Effects of BU98008, a novel I-1-binding site ligand, on food intake in rats. Summer Meeting of the British-Association-for-Psychopharmacology, 20 Jul 2003 - 23 Jul 2003. 17:A74-A74. SAGE PUBLICATIONS LTD (1 Sep 2003). Author weblink.
  • Melichar JK; Witchel HJ; Taylor LG; Lingford-Hughes AR; Nutt DJ. Heart rate variability (HRV) and noradrenergic dysfunction in generalised anxiety disorder (GAD): Assessment using a clonidine challenge. Summer Meeting of the British-Association-for-Psychopharmacology, 20 Jul 2003 - 23 Jul 2003. 17:A29-A29. SAGE PUBLICATIONS LTD (1 Sep 2003). Author weblink.
  • Kimura A; Tyacke RJ; Minchin MCW; Nutt DJ; Hudson AL. Identification of a 55kDa imidazoline-2 binding protein in rabbit brain. Summer Meeting of the British-Association-for-Psychopharmacology, 20 Jul 2003 - 23 Jul 2003. 17:A38-A38. SAGE PUBLICATIONS LTD (1 Sep 2003). Author weblink.
  • Paterson LM; Robinson ESJ; Nutt DJ; Hudson AL. In vivo estimation of I-2 binding site turnover in rat brain. Summer Meeting of the British-Association-for-Psychopharmacology, 20 Jul 2003 - 23 Jul 2003. 17:A39-A39. SAGE PUBLICATIONS LTD (1 Sep 2003). Author weblink.
  • Tyacke RJ; Westaway J; Grella B; Glennon RA; Nutt DJ; Hudson AL. Initial evaluation of two novel beta-carbolines for rat brain imidazoline(2) binding sites. Summer Meeting of the British-Association-for-Psychopharmacology, 20 Jul 2003 - 23 Jul 2003. 17:A39-A39. SAGE PUBLICATIONS LTD (1 Sep 2003). Author weblink.
  • Nutt DJ. Opiate partial agonists. Summer Meeting of the British-Association-for-Psychopharmacology, 20 Jul 2003 - 23 Jul 2003. 17:A3-A3. SAGE PUBLICATIONS LTD (1 Sep 2003). Author weblink.
  • Paterson L; Tyacke RJ; Robinson ESJ; Nutt DJ; Hudson AL. Role of monoamine oxidase in imidazoline(2) binding site mediated function in rat brain. 16th Congress of the European-College-of-Neuropsychopharmacology, 20 Sep 2003 - 24 Sep 2003. 13:S104-S105. ELSEVIER SCIENCE BV (1 Sep 2003). Author weblink DOI.
  • Shufflebotham J; Hendry J; Rich A; Probert C; Nutt D; Potokar J; Hood S. Tryptophan depletion study in irritable bowel syndrome (IBS). Summer Meeting of the British-Association-for-Psychopharmacology, 20 Jul 2003 - 23 Jul 2003. 17:A17-A17. SAGE PUBLICATIONS LTD (1 Sep 2003). Author weblink.
  • Kimura A; Tyacke RJ; Minchin MCW; Nutt DJ; Hudson AL. Identification of a putative imidazoline-2 binding protein. Meeting of the British-Pharmacological-Society-Clinical-Pharmacology-Section, 7 Jan 2003 - 10 Jan 2003. 138:U87-U87. NATURE PUBLISHING GROUP (1 Apr 2003). Author weblink.
  • Daglish MRC; Nutt DJ. Brain imaging studies in human addicts. 4th ECNP Workshop 2003, 15 Mar 2003 - 17 Mar 2003. 13:S7-S9. ELSEVIER SCIENCE BV (1 Mar 2003). Author weblink DOI.
  • Williams TM; Daglish MRC; Lingford-Hughes A; Hammers A; Brooks DJ; Myles JS; Nutt DJ. Regional cerebral increases in opioid receptor density in early abstinence from methadone: a PET study in man. 4th ECNP Workshop 2003, 15 Mar 2003 - 17 Mar 2003. 13:S31-S31. ELSEVIER SCIENCE BV (1 Mar 2003). Author weblink DOI.
  • Bailey JE; Nash J; Argyropoulos SV; Nutt DJ. 7.5% CO2: A model of GAD?. Summer Meeting of the British-Association-for-Psychopharmacology, 21 Jul 2002 - 24 Jul 2002. 16:A51-A51. SAGE PUBLICATIONS LTD (1 Sep 2002). Author weblink.
  • Williams TM; Daglish MRC; Lingford-Hughes A; Hammers A; Brooks DJ; Myles JS; Nutt DJ. Altered brain opioid receptor density after withdrawal from methadone treatment. Summer Meeting of the British-Association-for-Psychopharmacology, 21 Jul 2002 - 24 Jul 2002. 16:A54-A54. SAGE PUBLICATIONS LTD (1 Sep 2002). Author weblink.
  • Anderson NJ; Nutt DJ; Hudson AL; Robinson ESJ. Characterisation of imidazoline(2) binding in pig brain. Summer Meeting of the British-Association-for-Psychopharmacology, 21 Jul 2002 - 24 Jul 2002. 16:A64-A64. SAGE PUBLICATIONS LTD (1 Sep 2002). Author weblink.
  • Bailey JE; Argyropoulos SV; Nash J; Lightman SL; Nutt DJ. Does the locus coeruleus mediate the effects of the CO2 challenge?. Summer Meeting of the British-Association-for-Psychopharmacology, 21 Jul 2002 - 24 Jul 2002. 16:A52-A52. SAGE PUBLICATIONS LTD (1 Sep 2002). Author weblink.
  • Adrover M; Nash J; Rich A; Nutt DJ; Potokar J. Effects of abstinence from alcohol in social drinkers on GABA(A) benzodiazepine receptor (GBzR) sensitivity. Summer Meeting of the British-Association-for-Psychopharmacology, 21 Jul 2002 - 24 Jul 2002. 16:A56-A56. SAGE PUBLICATIONS LTD (1 Sep 2002). Author weblink.
  • Daglish MRC; Weinstein A; Malizia AL; Wilson S; Melichar JK; Lingford-Hughes A; Myles JS; Grasby P; et alNutt DJ. Functional connectivity analysis of rCBF in opiate craving. Summer Meeting of the British-Association-for-Psychopharmacology, 21 Jul 2002 - 24 Jul 2002. 16:A55-A55. SAGE PUBLICATIONS LTD (1 Sep 2002). Author weblink.
  • Tyacke RJ; Davis N; Nutt DJ; Hudson AL. Initial evaluation of four potential imidazoline(2) pet ligands in rat whole brain. Summer Meeting of the British-Association-for-Psychopharmacology, 21 Jul 2002 - 24 Jul 2002. 16:A63-A63. SAGE PUBLICATIONS LTD (1 Sep 2002). Author weblink.
  • Man J; Tyacke RJ; Saczewski F; Nutt DJ; Hudson AL. Initial evaluation of three novel selective ligands of imidazoline-2 receptors in rat whole brain. Summer Meeting of the British-Association-for-Psychopharmacology, 21 Jul 2002 - 24 Jul 2002. 16:A63-A63. SAGE PUBLICATIONS LTD (1 Sep 2002). Author weblink.
  • Kimura A; Tyacke RJ; Nutt DJ; Hudson AL. Microautoradiography of imidazoline-2 binding sites in rabbit hypothalamus. Summer Meeting of the British-Association-for-Psychopharmacology, 21 Jul 2002 - 24 Jul 2002. 16:A63-A63. SAGE PUBLICATIONS LTD (1 Sep 2002). Author weblink.
  • Melichar JK; Taylor LG; Daglish MRC; Holmes RB; Parkin VJ; Rees MR; Lenox-Smith A; Lingford-Hughes AR; et alNutt DJ. Noradrenergic dysfunction in generalised anxiety disorder (GAD): A SPET study using a clonidine challenge. Summer Meeting of the British-Association-for-Psychopharmacology, 21 Jul 2002 - 24 Jul 2002. 16:A52-A52. SAGE PUBLICATIONS LTD (1 Sep 2002). Author weblink.
  • Wilson SJ; Bailey JE; Nutt DJ. Probing serotonergic activity in the brain using sleep. Summer Meeting of the British-Association-for-Psychopharmacology, 21 Jul 2002 - 24 Jul 2002. 16:A41-A41. SAGE PUBLICATIONS LTD (1 Sep 2002). Author weblink.
  • Nutt DJ. The drug treatment of PTSD. Summer Meeting of the British-Association-for-Psychopharmacology, 21 Jul 2002 - 24 Jul 2002. 16:A5-A5. SAGE PUBLICATIONS LTD (1 Sep 2002). Author weblink.
  • Paterson LM; Tyacke RJ; Nutt DJ; Hudson AL. The irreversible I-2 ligand BU99006 abolishes [H-3]2BFI binding without effect on monoamine oxidase activity. Summer Meeting of the British-Association-for-Psychopharmacology, 21 Jul 2002 - 24 Jul 2002. 16:A63-A63. SAGE PUBLICATIONS LTD (1 Sep 2002). Author weblink.
  • Argyropoulos SV; Adrover M; Hood SD; Bell CJ; Rich AS; Nash JR; Rich NC; Nutt DJ. Tryptophan depletion in treated social anxiety disorder: effects of autobiographical scripts and stressful speaking tasks. Summer Meeting of the British-Association-for-Psychopharmacology, 21 Jul 2002 - 24 Jul 2002. 16:A51-A51. SAGE PUBLICATIONS LTD (1 Sep 2002). Author weblink.
  • Wilson SJ; Bailey JE; Rich AS; Adrover M; Nutt DJ. Using sleep to measure relative 5HT uptake blockade. Summer Meeting of the British-Association-for-Psychopharmacology, 21 Jul 2002 - 24 Jul 2002. 16:A41-A41. SAGE PUBLICATIONS LTD (1 Sep 2002). Author weblink.
  • Nutt DJ. Brain imaging in anxiety disorders. Collegium Internationale Neuro-Psychopharmacologicum (CINP), 2 Oct 2001 - 5 Oct 2001. 17:S1-S1. LIPPINCOTT WILLIAMS & WILKINS (1 Aug 2002). Author weblink.
  • Witchel HJ; Bell C; Mazzeo L; Hennessy E; Nash J; Argyropoulos S; Adrover M; Rich A; et alPotokar J; Wilson SJ; Nutt DJ. Paroxetine-remitted panic patients on a tryptophan depletion diet have a higher change in blood pressure and heart rate in response to either flumazenil or saline infusions than when not tryptophan depleted: a regression analysis. Scientific Meeting of the Physiological-Society, 5 Sep 2001 - 7 Sep 2001. 536:145P-145P. CAMBRIDGE UNIV PRESS (1 Nov 2001). Author weblink.
  • Argyropoulos SV; Nutt DJ. The use of benzodiazepines in anxiety and other disorders. 11th European-College-of-Neuropsychopharmacology Congress, 31 Oct 1998 - 4 Nov 1998. 9:407-412. ELSEVIER SCIENCE BV (1 Dec 1999). Author weblink.
  • Nutt DJ. The neurochemistry of addiction. 6th Milford Symposium, Jun 1996. 12:S53-S58. JOHN WILEY & SONS LTD (1 Jun 1997). Author weblink DOI.
  • Nutt DJ; Seivewright N. Receptor pharmacology of buprenorphine. Meeting on Buprenorphine - a Substitution Agent for the Treatment of Opioid Addiction: A UK Perspective, 10 Oct 1996. 19:9-15. WELLS MEDICAL LTD (1 Jan 1997). Author weblink.
  • Nutt D; Montgomery SA. Moclobemide in the treatment of social phobia. 4th International Symposium on Moclobemide, 15 Sep 1995 - 16 Sep 1995. 11:77-82. RAPID SCIENCE PUBLISHERS (1 Jun 1996). Author weblink DOI.
  • Nutt D; Edwards G; Lader M. The changing pharmacology of addiction. Meeting on Addiction - Processes of Change, Apr 1992. 33-49. OXFORD UNIVERSITY PRESS (1 Jan 1994). Author weblink.
  • NUTT D; LALIES M; HUDSON A; Briley M; Marien M. THE EFFECTS OF ALPHA(2)-ADRENOCEPTOR ANTAGONISTS ON EXTRACELLULAR DOPAMINE CONCENTRATIONS IN RAT STRIATUM. Symposium on Noradrenergic Mechanisms in Parkinsons Disease, 3 Dec 1992 - 4 Dec 1992. 159-172. CRC PRESS INC (1 Jan 1994). Author weblink.
  • NUTT D; Wonnacott S; Lunt GG. OVERVIEW - UNANSWERED QUESTIONS AND CLINICAL PROSPECTS. Biochemical-Society Symposium no. 59, Dec 1992. 59:205-211. PORTLAND PRESS LTD (1 Jan 1993). Author weblink.
  • NUTT DJ; HOLMAN RB; THOMAS DN; Elliott JM; Heal DJ; Marsden CA. NORADRENERGIC MECHANISMS IN ANXIOLYTIC AND ANTIDEPRESSANT DRUG-ACTION. 41ST SYMP OF THE BIOLOGICAL COUNCIL SYMPOSIA ON DRUG ACTION, Apr 1991. 101-116. JOHN WILEY & SONS LTD (1 Jan 1992). Author weblink.
  • NUTT DJ; MENDLEWICZ J; RACAGNI G. THE CRITICAL ISSUES IN BENZODIAZEPINE TOLERANCE AND WITHDRAWAL. WORKSHOP ON TARGET RECEPTORS FOR ANXIOLYTICS AND HYPNOTICS : FROM MOLECULAR PHARMACOLOGY TO THERAPEUTICS, 24 Nov 1991 - 26 Nov 1991. 3:74-77. KARGER (1 Jan 1992). Author weblink.
  • HUDSON AL; MALLARD NJ; NUTT DJ; SZABADI E; BRADSHAW CM. [3H]RX821002 - A NEW ALPHA-2-ADRENOCEPTOR LIGAND FOR INVITRO AUTORADIOGRAPHY AND BINDING-STUDIES IN THE MAMMALIAN CNS. 3RD MANCHESTER SYMP ON THE PHARMACOLOGY OF ADRENOCEPTORS, Jun 1990. 299-300. BIRKHAUSER VERLAG (1 Jan 1991). Author weblink.
  • NUTT DJ; Briley M; File SE. ANXIETY AND ITS THERAPY - TODAY AND TOMORROW. SYMP ON NEW CONCEPTS IN ANXIETY, Apr 1990. 4:1-12. CRC PRESS INC (1 Jan 1991). Author weblink.
  • HOLMAN RB; THOMAS DN; NUTT DJ; RACAGNI G; BRUNELLO N; FUKUDA T. NEW INSIGHTS INTO THE NEUROBIOLOGY OF ECT - REGIONALLY SELECTIVE ALTERATIONS IN NORADRENALINE RELEASE REVEALED BY MICRODIALYSIS. 5TH WORLD CONGRESS OF BIOLOGICAL PSYCHIATRY, 9 Jun 1991 - 14 Jun 1991. 968:268-271. ELSEVIER SCIENCE PUBL B V (1 Jan 1991). Author weblink.
  • NUTT DJ; HINDMARCH I; BEAUMONT G; BRANDON S; LEONARD BE. BENZODIAZEPINE DEPENDENCE - NEW INSIGHTS FROM BASIC RESEARCH. WORKSHOP ON BENZODIAZEPINES : THE WAY FORWARD, 14 Apr 1989 - 16 Apr 1989. 19-41. JOHN WILEY & SONS LTD (1 Jan 1990). Author weblink.
Share this on Delicious
Tweet this
Digg this
Stumble this
Share this on Facebook